CA2803747C - Physiological sensor delivery device and method - Google Patents
Physiological sensor delivery device and method Download PDFInfo
- Publication number
- CA2803747C CA2803747C CA2803747A CA2803747A CA2803747C CA 2803747 C CA2803747 C CA 2803747C CA 2803747 A CA2803747 A CA 2803747A CA 2803747 A CA2803747 A CA 2803747A CA 2803747 C CA2803747 C CA 2803747C
- Authority
- CA
- Canada
- Prior art keywords
- sensor
- blood pressure
- patient
- signal
- distal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims description 77
- 230000036772 blood pressure Effects 0.000 claims abstract description 49
- 239000012530 fluid Substances 0.000 claims description 74
- 238000002347 injection Methods 0.000 claims description 53
- 239000007924 injection Substances 0.000 claims description 53
- 238000004891 communication Methods 0.000 claims description 42
- 230000007704 transition Effects 0.000 claims description 30
- 238000011144 upstream manufacturing Methods 0.000 claims description 25
- 230000000747 cardiac effect Effects 0.000 claims description 6
- 230000000004 hemodynamic effect Effects 0.000 claims description 6
- 230000003902 lesion Effects 0.000 abstract description 61
- 230000002966 stenotic effect Effects 0.000 abstract description 31
- 230000002792 vascular Effects 0.000 abstract description 16
- 210000003709 heart valve Anatomy 0.000 abstract description 10
- 210000001367 artery Anatomy 0.000 abstract description 8
- 230000002093 peripheral effect Effects 0.000 abstract description 3
- 239000000835 fiber Substances 0.000 description 32
- 238000005259 measurement Methods 0.000 description 31
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 29
- 239000011780 sodium chloride Substances 0.000 description 28
- 229920000728 polyester Polymers 0.000 description 22
- 208000031481 Pathologic Constriction Diseases 0.000 description 18
- 239000000463 material Substances 0.000 description 17
- 230000036262 stenosis Effects 0.000 description 16
- 208000037804 stenosis Diseases 0.000 description 16
- 239000002872 contrast media Substances 0.000 description 12
- 239000003550 marker Substances 0.000 description 12
- 238000009530 blood pressure measurement Methods 0.000 description 11
- 229940039231 contrast media Drugs 0.000 description 11
- 238000002560 therapeutic procedure Methods 0.000 description 11
- 238000004364 calculation method Methods 0.000 description 10
- 230000006870 function Effects 0.000 description 10
- 238000012545 processing Methods 0.000 description 10
- 210000004351 coronary vessel Anatomy 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 238000005086 pumping Methods 0.000 description 9
- 230000000007 visual effect Effects 0.000 description 9
- 210000004204 blood vessel Anatomy 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 238000012544 monitoring process Methods 0.000 description 8
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 8
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 230000000712 assembly Effects 0.000 description 6
- 238000000429 assembly Methods 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 239000000499 gel Substances 0.000 description 6
- 239000004642 Polyimide Substances 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 230000009977 dual effect Effects 0.000 description 5
- 230000003287 optical effect Effects 0.000 description 5
- 229920001721 polyimide Polymers 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 241000180579 Arca Species 0.000 description 4
- 239000000853 adhesive Substances 0.000 description 4
- 230000001070 adhesive effect Effects 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 229910052697 platinum Inorganic materials 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 125000006850 spacer group Chemical group 0.000 description 4
- 229910001220 stainless steel Inorganic materials 0.000 description 4
- 239000010935 stainless steel Substances 0.000 description 4
- 230000009471 action Effects 0.000 description 3
- 210000000709 aorta Anatomy 0.000 description 3
- 230000008878 coupling Effects 0.000 description 3
- 238000010168 coupling process Methods 0.000 description 3
- 238000005859 coupling reaction Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000010606 normalization Methods 0.000 description 3
- 238000010926 purge Methods 0.000 description 3
- 238000012552 review Methods 0.000 description 3
- 210000005166 vasculature Anatomy 0.000 description 3
- 238000012935 Averaging Methods 0.000 description 2
- 0 CC(*C1)OC1=C Chemical compound CC(*C1)OC1=C 0.000 description 2
- 239000004696 Poly ether ether ketone Substances 0.000 description 2
- 210000003484 anatomy Anatomy 0.000 description 2
- 238000002399 angioplasty Methods 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 238000007598 dipping method Methods 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- -1 for example Substances 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052763 palladium Inorganic materials 0.000 description 2
- 230000002572 peristaltic effect Effects 0.000 description 2
- 229920002530 polyetherether ketone Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 230000002787 reinforcement Effects 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 241000417436 Arcotheres Species 0.000 description 1
- YPJRYQGOKHKNKZ-UHFFFAOYSA-N CCC1(C)CCCCC1 Chemical compound CCC1(C)CCCCC1 YPJRYQGOKHKNKZ-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229920001651 Cyanoacrylate Polymers 0.000 description 1
- 238000001057 Duncan's new multiple range test Methods 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 241000201776 Steno Species 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000002583 angiography Methods 0.000 description 1
- 210000002376 aorta thoracic Anatomy 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 238000013131 cardiovascular procedure Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000002591 computed tomography Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- NLCKLZIHJQEMCU-UHFFFAOYSA-N cyano prop-2-enoate Chemical class C=CC(=O)OC#N NLCKLZIHJQEMCU-UHFFFAOYSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011982 device technology Methods 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 230000003205 diastolic effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229920002313 fluoropolymer Polymers 0.000 description 1
- 239000004811 fluoropolymer Substances 0.000 description 1
- 238000005242 forging Methods 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000013152 interventional procedure Methods 0.000 description 1
- 238000002697 interventional radiology Methods 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 238000003698 laser cutting Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000004115 mitral valve Anatomy 0.000 description 1
- 208000005907 mitral valve insufficiency Diseases 0.000 description 1
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 1
- 229910001000 nickel titanium Inorganic materials 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 238000005476 soldering Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000003856 thermoforming Methods 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 229920001187 thermosetting polymer Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- 231100000756 time-weighted average Toxicity 0.000 description 1
- 238000013024 troubleshooting Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/02028—Determining haemodynamic parameters not otherwise provided for, e.g. cardiac contractility or left ventricular ejection fraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0015—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by features of the telemetry system
- A61B5/0017—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by features of the telemetry system transmitting optical signals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0015—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by features of the telemetry system
- A61B5/0022—Monitoring a patient using a global network, e.g. telephone networks, internet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/02007—Evaluating blood vessel condition, e.g. elasticity, compliance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/02007—Evaluating blood vessel condition, e.g. elasticity, compliance
- A61B5/02014—Determining aneurysm
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/0205—Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
- A61B5/02055—Simultaneously evaluating both cardiovascular condition and temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/021—Measuring pressure in heart or blood vessels
- A61B5/0215—Measuring pressure in heart or blood vessels by means inserted into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/021—Measuring pressure in heart or blood vessels
- A61B5/0215—Measuring pressure in heart or blood vessels by means inserted into the body
- A61B5/02154—Measuring pressure in heart or blood vessels by means inserted into the body by optical transmission
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/021—Measuring pressure in heart or blood vessels
- A61B5/0215—Measuring pressure in heart or blood vessels by means inserted into the body
- A61B5/02158—Measuring pressure in heart or blood vessels by means inserted into the body provided with two or more sensor elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/021—Measuring pressure in heart or blood vessels
- A61B5/022—Measuring pressure in heart or blood vessels by applying pressure to close blood vessels, e.g. against the skin; Ophthalmodynamometers
- A61B5/0225—Measuring pressure in heart or blood vessels by applying pressure to close blood vessels, e.g. against the skin; Ophthalmodynamometers the pressure being controlled by electric signals, e.g. derived from Korotkoff sounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/026—Measuring blood flow
- A61B5/0261—Measuring blood flow using optical means, e.g. infrared light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A61B5/14551—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
- A61B5/14552—Details of sensors specially adapted therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
- A61B5/6851—Guide wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
- A61B5/6852—Catheters
- A61B5/6853—Catheters with a balloon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
- A61B5/6862—Stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient ; user input means
- A61B5/742—Details of notification to user or communication with user or patient ; user input means using visual displays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/09—Guide wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/007—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests for contrast media
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/12—Manufacturing methods specially adapted for producing sensors for in-vivo measurements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/01—Measuring temperature of body parts ; Diagnostic temperature sensing, e.g. for malignant or inflamed tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
- A61B6/50—Clinical applications
- A61B6/507—Clinical applications involving determination of haemodynamic parameters, e.g. perfusion CT
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M2025/0001—Catheters; Hollow probes for pressure measurement
- A61M2025/0002—Catheters; Hollow probes for pressure measurement with a pressure sensor at the distal end
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0021—Catheters; Hollow probes characterised by the form of the tubing
- A61M25/0023—Catheters; Hollow probes characterised by the form of the tubing by the form of the lumen, e.g. cross-section, variable diameter
- A61M25/0026—Multi-lumen catheters with stationary elements
- A61M2025/0034—Multi-lumen catheters with stationary elements characterized by elements which are assembled, connected or fused, e.g. splittable tubes, outer sheaths creating lumina or separate cores
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0021—Catheters; Hollow probes characterised by the form of the tubing
- A61M25/0023—Catheters; Hollow probes characterised by the form of the tubing by the form of the lumen, e.g. cross-section, variable diameter
- A61M25/0026—Multi-lumen catheters with stationary elements
- A61M2025/0037—Multi-lumen catheters with stationary elements characterized by lumina being arranged side-by-side
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M2025/0183—Rapid exchange or monorail catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/09—Guide wires
- A61M2025/091—Guide wires having a lumen for drug delivery or suction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0021—Catheters; Hollow probes characterised by the form of the tubing
- A61M25/0023—Catheters; Hollow probes characterised by the form of the tubing by the form of the lumen, e.g. cross-section, variable diameter
- A61M25/0026—Multi-lumen catheters with stationary elements
- A61M25/0029—Multi-lumen catheters with stationary elements characterized by features relating to least one lumen located at the middle part of the catheter, e.g. slots, flaps, valves, cuffs, apertures, notches, grooves or rapid exchange ports
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0068—Static characteristics of the catheter tip, e.g. shape, atraumatic tip, curved tip or tip structure
- A61M25/007—Side holes, e.g. their profiles or arrangements; Provisions to keep side holes unblocked
Abstract
An intravascular sensor delivery device for measuring a physiological parameter of a patient, such as blood pressure, within a vascular structure or passage. In some embodiments, the device can be used to measure the pressure gradient across a stenotic lesion or heart valve. For example, such a device may be used to measure fractional flow reserve (FFR) across a stenotic lesion in order to assess the severity of the lesion. The sensor delivery device has a distal sleeve configured to pass or slide over a standard medical guidewire. Some distance back from the sensor and distal sleeve, the device separates from the guidewire to permit independent control of the sensor delivery device and the guidewire. The sensor delivery device can be sized to pass over different sizes of guidewires to enable usage in coronary and peripheral arteries, for example.
Description
PHYSIOLOGICAL SENSOR DELIVERY DEVICE AND METHOD
TECHNICAL FIELD
10002.1 This application relates generally to the field of medical device technology and, more particularly, to devices and methods for positioning and utilizing physiological sensors in anatomical (e.g., vascular) structures of patients, such as in blood vessels or across heart valves.
BACKGROUND
[0003] Certain physiological measurements may be made by positioning a sensor within a patient. Such physiological measurements may include, for example, measurements of blood parameters, such as blood pressure, oxygen saturation levels, blood pH, etc. Some such measurements may have diagnostic value and/or may form the basis for therapy decisions.
100041 A technique for evaluating the degree to which a stenotic lesion obstructs flow through a blood vessel is called the Fractional Flow Reserve measurement (FFR). To calculate the FFR for a given stenosis, two blood pressure readings are taken.
One pressure reading is taken on the distal side of the stenosis (e.g., downstream from the stenosis), the other pressure reading is taken on the proximal side of the stenosis (e.g., upstream from the stenosis, towards the aorta). The FFR is defined as the ratio of maximal blood flow in a stenotic artery, taken distal to the lesion, to normal maximal flow, and is typically calculated based on a measured pressure gradient of the distal pressure to the proximal pressure, The FFR is therefore a unitless ratio of the distal and proximal pressures. The pressure gradient, or pressure drop, across a stenotic lesion is an indicator of the severity of the stcnosis, and the FFR is a useful tool in assessing the pressure drop. The more restrictive the stcnosis is, the greater the
TECHNICAL FIELD
10002.1 This application relates generally to the field of medical device technology and, more particularly, to devices and methods for positioning and utilizing physiological sensors in anatomical (e.g., vascular) structures of patients, such as in blood vessels or across heart valves.
BACKGROUND
[0003] Certain physiological measurements may be made by positioning a sensor within a patient. Such physiological measurements may include, for example, measurements of blood parameters, such as blood pressure, oxygen saturation levels, blood pH, etc. Some such measurements may have diagnostic value and/or may form the basis for therapy decisions.
100041 A technique for evaluating the degree to which a stenotic lesion obstructs flow through a blood vessel is called the Fractional Flow Reserve measurement (FFR). To calculate the FFR for a given stenosis, two blood pressure readings are taken.
One pressure reading is taken on the distal side of the stenosis (e.g., downstream from the stenosis), the other pressure reading is taken on the proximal side of the stenosis (e.g., upstream from the stenosis, towards the aorta). The FFR is defined as the ratio of maximal blood flow in a stenotic artery, taken distal to the lesion, to normal maximal flow, and is typically calculated based on a measured pressure gradient of the distal pressure to the proximal pressure, The FFR is therefore a unitless ratio of the distal and proximal pressures. The pressure gradient, or pressure drop, across a stenotic lesion is an indicator of the severity of the stcnosis, and the FFR is a useful tool in assessing the pressure drop. The more restrictive the stcnosis is, the greater the
2 PCT/US2009/056664 pressure drop, and the lower the resulting FFR. The FFR measurement may be a useful diagnostic tool. For example, clinical studies have shown that an FFR
of less than about 0.75 may be a useful criterion on which to base certain therapy decisions.
Pijls, DeBnlyne et al., Measurement of Fractional Flow Reserve to Assess the Functional Severity of corona-Artery Stenoses, 334:1703-1708, New England Journal of Medicine, June 27, 1996. A physician might decide, for example, to perform an interventional procedure (e.g., angioplasty or stent placement) when the FFR for a given stenotic lesion is below 0.75, and may decide to forego such treatment for lesions where the FFR is above 0.75. Thus, the FFR measurement could J 0 become a decision point for guiding treatment decisions.
100051 One method of measuring the pressure gradient across a lesion is to use a small catheter connected to a blood pressure measurement sensor. The catheter would be passed over the guidewire which has already been placed across the lesion.
The catheter would bc advanced down the guidewire until the tip of thc catheter crosses the lesion. The blood pressure on the distal side of the lesion is recorded.
This pressure would be divided by the pressure value recorded in the aorta. A
disadvantage of using this method is that some error may be introduce(' due to the cross sectional size of the catheter. As the catheter crosses the lesion, the catheter itself introduces blockage, in addition to that caused by the lesion itself. The measured distal pressure would therefore he somewhat lower than it would be without the additional flow obstruction, which may exaggerate the measured pressure gradient across the lesion.
100061 Pressure drop can also be measured across a heart valve. When a heart valve is rcgurgitant, a less than optimal pressure drop is typically observed. Using a catheter to measure pressure drop is common across a heart valve. However, because of the catheter size, the heart valve may not seal well around the catheter. Leakage might also result from the presence of the catheter and may contribute to an inaccurate pressure drop reading. One example of where this could occur is in the mitral valve (e.g., mitral valve regurgitation).
100071 One method of measuring blood pressure in a patient is to use a pressure sensing guidewire. Such a device has a pressure sensor embedded within the guidewire itself. A pressure sensing guidewire could be used in the deployment of interventional devices such as angioplasty balloons or stents. Prior to the intervention, the pressure sensing guidcwire would be deployed across a stenotic lesion so the sensing element is on the distal side of the lesion and the distal blood pressure is recorded. The guidewire may then be retracted so the sensing clement is on the proximal side of the lesion. The pressure gradient across the stenosis and the resulting FFR value could then be calculated.
r00081 To use a guidewirc-based pressure sensor in certain applications, the guidewire must be repositioned so the sensing element of the guidcwire is correctly placed with respect to a stcrtotic lesion, for example. Blood pressure measurements for calculating FFR, for example, arc generally taken on both sides of a given stenosis, so the guidewire is typically retracted across the stenosis to make the upstream measurement. After retracting the guidewire to make the proximal pressure measurement (aortic pressure or upstream coronary pressure), the guidewire may again be repositioned downstream of the lesion, for example, if it is determined (e.g., based on the FFR calculation) that an interventional device should be deployed. In l5 cases where there are multiple lesions, the sensing element of a pressure sensing guidewire would need to be advanced and retracted across multiple lesions, and would potentially have to be advanced and repositioned again for each such lesion.
Advancing and maneuvering a pressure sensing guidewire though stcnotie lesions and the vasculature, for example, can be a difficult and/or time consuming task.
100091 Physician preference is another factor that may influence the choice of diagnostic tools or techniques used for certain applications. For example, sorne physicians may tend to become accustomed to using certain specific guidewires for certain applications. "Standee (e.g., commercially available) medical guidewires may vary in size, flexibility, and torque characteristics. A physician may prefer to use different guidewires for different tasks, for example, to access hard-to-reach anatomical areas, or when encountering bifurcations in arteries. Certain guidewires may therefore be better suited for specific tasks because of the torque and flexing characteristics, and a physician may display a strong preference for using a certain guidewire based on the specific task (or tasks) he or she is facing. A
pressure sensing guidcwire may have torque and flexing characteristics that are either unknown to the physician, or that arc unsuitable for a particular task, because such a guidewire is specifically constructed to have a pressure sensor incorporated as part of the
of less than about 0.75 may be a useful criterion on which to base certain therapy decisions.
Pijls, DeBnlyne et al., Measurement of Fractional Flow Reserve to Assess the Functional Severity of corona-Artery Stenoses, 334:1703-1708, New England Journal of Medicine, June 27, 1996. A physician might decide, for example, to perform an interventional procedure (e.g., angioplasty or stent placement) when the FFR for a given stenotic lesion is below 0.75, and may decide to forego such treatment for lesions where the FFR is above 0.75. Thus, the FFR measurement could J 0 become a decision point for guiding treatment decisions.
100051 One method of measuring the pressure gradient across a lesion is to use a small catheter connected to a blood pressure measurement sensor. The catheter would be passed over the guidewire which has already been placed across the lesion.
The catheter would bc advanced down the guidewire until the tip of thc catheter crosses the lesion. The blood pressure on the distal side of the lesion is recorded.
This pressure would be divided by the pressure value recorded in the aorta. A
disadvantage of using this method is that some error may be introduce(' due to the cross sectional size of the catheter. As the catheter crosses the lesion, the catheter itself introduces blockage, in addition to that caused by the lesion itself. The measured distal pressure would therefore he somewhat lower than it would be without the additional flow obstruction, which may exaggerate the measured pressure gradient across the lesion.
100061 Pressure drop can also be measured across a heart valve. When a heart valve is rcgurgitant, a less than optimal pressure drop is typically observed. Using a catheter to measure pressure drop is common across a heart valve. However, because of the catheter size, the heart valve may not seal well around the catheter. Leakage might also result from the presence of the catheter and may contribute to an inaccurate pressure drop reading. One example of where this could occur is in the mitral valve (e.g., mitral valve regurgitation).
100071 One method of measuring blood pressure in a patient is to use a pressure sensing guidewire. Such a device has a pressure sensor embedded within the guidewire itself. A pressure sensing guidewire could be used in the deployment of interventional devices such as angioplasty balloons or stents. Prior to the intervention, the pressure sensing guidcwire would be deployed across a stenotic lesion so the sensing element is on the distal side of the lesion and the distal blood pressure is recorded. The guidewire may then be retracted so the sensing clement is on the proximal side of the lesion. The pressure gradient across the stenosis and the resulting FFR value could then be calculated.
r00081 To use a guidewirc-based pressure sensor in certain applications, the guidewire must be repositioned so the sensing element of the guidcwire is correctly placed with respect to a stcrtotic lesion, for example. Blood pressure measurements for calculating FFR, for example, arc generally taken on both sides of a given stenosis, so the guidewire is typically retracted across the stenosis to make the upstream measurement. After retracting the guidewire to make the proximal pressure measurement (aortic pressure or upstream coronary pressure), the guidewire may again be repositioned downstream of the lesion, for example, if it is determined (e.g., based on the FFR calculation) that an interventional device should be deployed. In l5 cases where there are multiple lesions, the sensing element of a pressure sensing guidewire would need to be advanced and retracted across multiple lesions, and would potentially have to be advanced and repositioned again for each such lesion.
Advancing and maneuvering a pressure sensing guidewire though stcnotie lesions and the vasculature, for example, can be a difficult and/or time consuming task.
100091 Physician preference is another factor that may influence the choice of diagnostic tools or techniques used for certain applications. For example, sorne physicians may tend to become accustomed to using certain specific guidewires for certain applications. "Standee (e.g., commercially available) medical guidewires may vary in size, flexibility, and torque characteristics. A physician may prefer to use different guidewires for different tasks, for example, to access hard-to-reach anatomical areas, or when encountering bifurcations in arteries. Certain guidewires may therefore be better suited for specific tasks because of the torque and flexing characteristics, and a physician may display a strong preference for using a certain guidewire based on the specific task (or tasks) he or she is facing. A
pressure sensing guidcwire may have torque and flexing characteristics that are either unknown to the physician, or that arc unsuitable for a particular task, because such a guidewire is specifically constructed to have a pressure sensor incorporated as part of the
3 PCTfUS2009/056664 guidewire itself As a result, a physician may find it difficult to maneuver a pressure sensing guidewire into an anatomical location of interest, as compared to a "standard"
(e.g., non-pressure sensing) medical guidewire.
[0010] Having grown accustomed to the handling characteristics of a particular non -pressure sensing guidewire, a physician may be reluctant to employ a pressure sensing guidewire, which may increase the time and difficulty of positioning and repositioning the pressure sensing guidewire across a stenotic lesion, for example. In such cases, a physician may choose to forego the benefit of a diagnostic measurement, such as FFR, and simply choose to deploy some form of interventional therapy as a conservative approach to such decisions. If the diagnostic measurement techniques and thc associated devices were simple enough to use, more physicians would use them and thereby make better therapy decisions.
SUMMARY
[0011] Physiological sensor delivery devices and methods according to embodiments of the invention may bc used in diagnostic applications, such as cardiovascular procedures in coronary arteries, interventional radiology applications in peripheral arteries, and structural heart applications in heart valves.
[0012] An intravascular sensor delivery device according to some embodiments of the invention comprises a distal sleeve with a guidewire lumen for sliding over a medical guidewire, a sensor coupled to the distal sleeve, the sensor adapted to measure a physiological parameter of a patient and generate a signal representative of the physiological parameter. A proximal portion is coupled to the distal sleeve.
The proximal portion comprises a communication channel for communicating the signal from the sensor to a location outside of the patient (such as a display monitor, or another medical device, etc.). The proximal portion of the sensor delivery device is adapted to facilitate positioning of the sensor within a vascular structure of the patient.
[00131 A method of assessing the severity of a stenotic lesion in a blood vessel of a patient according to some embodiments of the invention comprises deploying an intravascular sensor delivery device over a guidewire to a position such that the sensor is distal to the lesion, and measuring a distal pressure. In some embodiments, thc method may next comprise using the sensor delivery device to move the sensor to
(e.g., non-pressure sensing) medical guidewire.
[0010] Having grown accustomed to the handling characteristics of a particular non -pressure sensing guidewire, a physician may be reluctant to employ a pressure sensing guidewire, which may increase the time and difficulty of positioning and repositioning the pressure sensing guidewire across a stenotic lesion, for example. In such cases, a physician may choose to forego the benefit of a diagnostic measurement, such as FFR, and simply choose to deploy some form of interventional therapy as a conservative approach to such decisions. If the diagnostic measurement techniques and thc associated devices were simple enough to use, more physicians would use them and thereby make better therapy decisions.
SUMMARY
[0011] Physiological sensor delivery devices and methods according to embodiments of the invention may bc used in diagnostic applications, such as cardiovascular procedures in coronary arteries, interventional radiology applications in peripheral arteries, and structural heart applications in heart valves.
[0012] An intravascular sensor delivery device according to some embodiments of the invention comprises a distal sleeve with a guidewire lumen for sliding over a medical guidewire, a sensor coupled to the distal sleeve, the sensor adapted to measure a physiological parameter of a patient and generate a signal representative of the physiological parameter. A proximal portion is coupled to the distal sleeve.
The proximal portion comprises a communication channel for communicating the signal from the sensor to a location outside of the patient (such as a display monitor, or another medical device, etc.). The proximal portion of the sensor delivery device is adapted to facilitate positioning of the sensor within a vascular structure of the patient.
[00131 A method of assessing the severity of a stenotic lesion in a blood vessel of a patient according to some embodiments of the invention comprises deploying an intravascular sensor delivery device over a guidewire to a position such that the sensor is distal to the lesion, and measuring a distal pressure. In some embodiments, thc method may next comprise using the sensor delivery device to move the sensor to
4 a position proximal of the lesion and measuring proximal (e.g., aortic) pressure, then calculating a ratio (or some other quantitative comparison) of the two pressure measurements. In some embodiments, the proximal pressure may be obtained from a separate pressure sensing apparatus (e.g., a pressure sensor connected to a fluid injection system), and the distal and proximal pressure measurements may be made substantially simultaneously (e.g., to reduce timing errors, etc.) before making a quantitative comparison of the two values.
BRIEF DESCRIPTION OF THE DRAWINGS
100141 FIG. 1 is a perspective view of a sensor delivery device according to an embodiment of the invention;
[00151 FIG. 2 is a conceptual perspective view of a sensor delivery device =for making physiological measurements according to an embodiment of thc invention;
100161 FIG. 3 is an conceptual plot of a patient's blood pressure as a function of time;
100171 FIG. 4(a) is a side view of a sensor delivery device according to an embodiment of the invention having one or more flow holes disposed along a side portion;
100181 FIG. 4(b) is a cross-sectional view of a sensor delivery device according to an embodiment having one or more flow holes;
100191 FIG. 5(a) is a cut-away side view of a sensor delivery device with a sensor housing according to one ernbodiment of the invention;
100201 FIG. 5(b) is a cut-away side view of a sensor delivery device with a sensor housing according to one embodiment of thc invention;
[00211 FIGS. 5(c) and 5(d) arc side views of a sensor delivery device with radiopaque marker band according to certain embodiments of the invention;
100221 FIG. 5(c) is a cut-away side view of a sensor delivery device with a strain relief spacer according to one embodiment of the invention;
BRIEF DESCRIPTION OF THE DRAWINGS
100141 FIG. 1 is a perspective view of a sensor delivery device according to an embodiment of the invention;
[00151 FIG. 2 is a conceptual perspective view of a sensor delivery device =for making physiological measurements according to an embodiment of thc invention;
100161 FIG. 3 is an conceptual plot of a patient's blood pressure as a function of time;
100171 FIG. 4(a) is a side view of a sensor delivery device according to an embodiment of the invention having one or more flow holes disposed along a side portion;
100181 FIG. 4(b) is a cross-sectional view of a sensor delivery device according to an embodiment having one or more flow holes;
100191 FIG. 5(a) is a cut-away side view of a sensor delivery device with a sensor housing according to one ernbodiment of the invention;
100201 FIG. 5(b) is a cut-away side view of a sensor delivery device with a sensor housing according to one embodiment of thc invention;
[00211 FIGS. 5(c) and 5(d) arc side views of a sensor delivery device with radiopaque marker band according to certain embodiments of the invention;
100221 FIG. 5(c) is a cut-away side view of a sensor delivery device with a strain relief spacer according to one embodiment of the invention;
5 [00231 FIGS. 6(a) ¨ 6(g) are enlarged side views of a distal transition of a sensor delivery device according to certain embodiments of the invention;
100241 FIGS. 7(a) and 7(b) are perspective views of a sensor delivery device having a second sensor disposed on a proximal sleeve according to an embodiment of the invention;
100251 FIG. 8 is a perspective view of a sensor delivery device having a fureation tube according to an embodiment of the invention:
100261 FIG. 9 is a cross-sectional side view of a sensor delivery device having a dual lumen configuration according to one embodiment of the invention;
100271 FIG. 10 is a side view of a sensor delivery device having an over-the-wire configuration according to one embodiment of the invention;
100281 FIG. 11 is a flow diagram showing a method of using a sensor delivery device according to certain embodiments of the invention;
100291 FIG. 12 is a perspective view of a fluid injection system that may bc used to interact with a sensor delivery device according to an embodiment of the invention;
100301 FIG. 13 is a perspective view of a fluid injection system that may be used to interact with a sensor delivery device according to an embodiment of the invention;
100311 FIG. 14 is a flow diagram of a method of using a sensor delivery device in conjunction with a fluid injection system according to certain embodiments of the invention;
100321 FIG, 15 is a flow diagram of a method of using a sensor delivery device according to an embodiment of the invention;
100331 FIG. 16 is a perspective view of a powered injection system adapted to be coupled to a physiological sensor delivery device according to certain embodiments of the invention; and
100241 FIGS. 7(a) and 7(b) are perspective views of a sensor delivery device having a second sensor disposed on a proximal sleeve according to an embodiment of the invention;
100251 FIG. 8 is a perspective view of a sensor delivery device having a fureation tube according to an embodiment of the invention:
100261 FIG. 9 is a cross-sectional side view of a sensor delivery device having a dual lumen configuration according to one embodiment of the invention;
100271 FIG. 10 is a side view of a sensor delivery device having an over-the-wire configuration according to one embodiment of the invention;
100281 FIG. 11 is a flow diagram showing a method of using a sensor delivery device according to certain embodiments of the invention;
100291 FIG. 12 is a perspective view of a fluid injection system that may bc used to interact with a sensor delivery device according to an embodiment of the invention;
100301 FIG. 13 is a perspective view of a fluid injection system that may be used to interact with a sensor delivery device according to an embodiment of the invention;
100311 FIG. 14 is a flow diagram of a method of using a sensor delivery device in conjunction with a fluid injection system according to certain embodiments of the invention;
100321 FIG, 15 is a flow diagram of a method of using a sensor delivery device according to an embodiment of the invention;
100331 FIG. 16 is a perspective view of a powered injection system adapted to be coupled to a physiological sensor delivery device according to certain embodiments of the invention; and
6 00341 FIG. 17 is an idealized view of a user interface screen containing information that may bc displayed to an operator, according to certain embodiments of the invention 100351 The following detailed description should be read with reference to the accompanying drawings, in which like numerals denote like elements. The drawings, which are not necessarily to scale, depict selected embodiments of the invention ¨
other possible embodiments may become readily apparent to those of ordinary skill in the art with the benefit of these teachings. Thus, the embodiments shown in the accompanying drawings and described below are provided for illustrative purposes, and are not intended to limit the scope of the invention as defined in the claims appended hereto.
10036j An example of a sensor delivery device according to certain embodiments of the invention is shown in FIG. 1. Thc sensor delivery device 10 of FIG. 1 includes a distal sleeve 20 having a guidewire lumen 22 for slidably receiving a medical guidewire 30. A sensor 40 is coupled to the distal sleeve 20, sensor 40 being capable of sensing and/or measuring a physiological parameter of a patient and generating a signal representative of the physiological parameter. Thus, the distal sleeve 20, and hence, the sensor 40, may be positioned within a patient (e.g., within an anatomical structure of a patient, such as within a vein, artery, or other blood vessel, or across a heart valve, for example) by causing the distal sleeve 20 to slide over the medical guidewire 30 to the desired position.
(00371 The sensor delivery device 10 of FIG. 1 also includes a proximal portion 50, which is coupled to the distal sleeve 20. The proximal portion 50 includes a communication channel 60 for communicating the signal from the sensor 40 to a location outside of the patient (e.g., to a processor, display, computer, monitor, or to another medical device). Communication channel 60 may comprise a fiber optic communication channel in certain preferred embodiments, such as where the sensor 40 is a fiber optic pressure sensor. Alternately, communication channel 60 may comprise an electrically conductive medium, such as one or more electrical conducting wires. Of course, many other forms of cormnunication media may be
other possible embodiments may become readily apparent to those of ordinary skill in the art with the benefit of these teachings. Thus, the embodiments shown in the accompanying drawings and described below are provided for illustrative purposes, and are not intended to limit the scope of the invention as defined in the claims appended hereto.
10036j An example of a sensor delivery device according to certain embodiments of the invention is shown in FIG. 1. Thc sensor delivery device 10 of FIG. 1 includes a distal sleeve 20 having a guidewire lumen 22 for slidably receiving a medical guidewire 30. A sensor 40 is coupled to the distal sleeve 20, sensor 40 being capable of sensing and/or measuring a physiological parameter of a patient and generating a signal representative of the physiological parameter. Thus, the distal sleeve 20, and hence, the sensor 40, may be positioned within a patient (e.g., within an anatomical structure of a patient, such as within a vein, artery, or other blood vessel, or across a heart valve, for example) by causing the distal sleeve 20 to slide over the medical guidewire 30 to the desired position.
(00371 The sensor delivery device 10 of FIG. 1 also includes a proximal portion 50, which is coupled to the distal sleeve 20. The proximal portion 50 includes a communication channel 60 for communicating the signal from the sensor 40 to a location outside of the patient (e.g., to a processor, display, computer, monitor, or to another medical device). Communication channel 60 may comprise a fiber optic communication channel in certain preferred embodiments, such as where the sensor 40 is a fiber optic pressure sensor. Alternately, communication channel 60 may comprise an electrically conductive medium, such as one or more electrical conducting wires. Of course, many other forms of cormnunication media may be
7 suitable for transmitting the signal generated by sensor 40 to a location outside of the patient. In some embodiments oldie invention, the communication channel 60 may comprise any of a variety of fluid and/or non-fluid communication media, such as a wireless communication link, or an infrared capability, or acoustic communications such as ultrasound, as possible examples.
I00381 The proximal portion 50 is also adapted to assist an operator (e.g., a physician or other medical staff) in positioning the distal sleeve 20 and the sensor 40 within an anatomical (e.g., vascular) structure of the patient. This is typically accomplished by an operator first inserting a "standard" medical guidewire 30 into a patient's vasculature and advancing it past an area of interest. The sensor delivery device 10 is then deployed by "threading" the distal sleeve 20 onto the guidewire 30 such that the lumen 22 slides over the guidewire 30, and advancing the distal sleeve 20 (and the associated sensor 40) by moving (e.g., pushing and/or pulling) the proximal portion 50 until sensor 40 is in the desired location.
10039J The device 10 and the guidewire 30 arc typically manipulated inside a guiding catheter 32, which has been placed in the anatomical (e.g., vascular) structure of interest. In certain preferred embodiments of the invention, the guidewire lumen 22 rnay be sized to slide over "standard sized medical guidewires. For example, a number of manufacturers make medical guidewircs that range in size from Icss than about 0.014 inches outer diameter to more than about 0.038 inches outer diameter, typically having a finite number of common sizes within this range. "Standard"
size medical guidewires might, for example, have outer diameters of 0.010, 0.014, 0.018, 0.021, 0.025, 0.028, 0.032, 0.035, and 0.038 inches. Thus, in certain preferred embodiments of the invention, the guidewire lumen 22 may be sized appropriately to slide over a particular standard size medical guidewire. A device according to preferred embodiments of the invention may therefore be made available in a range of sizes corresponding to standard medical guidewire sizes.
100401 One potential advantage of a sensor delivery device 10 according to embodiments of the invention is that it allows a physician to use the guidewire of their choice. Sensor delivery device 10 can be sized to be used with any guidewire.
The physician may, for example, choose a particular guidewire based on its unique flexing and torque characteristics for certain procedures. Delivery device 10 according to
I00381 The proximal portion 50 is also adapted to assist an operator (e.g., a physician or other medical staff) in positioning the distal sleeve 20 and the sensor 40 within an anatomical (e.g., vascular) structure of the patient. This is typically accomplished by an operator first inserting a "standard" medical guidewire 30 into a patient's vasculature and advancing it past an area of interest. The sensor delivery device 10 is then deployed by "threading" the distal sleeve 20 onto the guidewire 30 such that the lumen 22 slides over the guidewire 30, and advancing the distal sleeve 20 (and the associated sensor 40) by moving (e.g., pushing and/or pulling) the proximal portion 50 until sensor 40 is in the desired location.
10039J The device 10 and the guidewire 30 arc typically manipulated inside a guiding catheter 32, which has been placed in the anatomical (e.g., vascular) structure of interest. In certain preferred embodiments of the invention, the guidewire lumen 22 rnay be sized to slide over "standard sized medical guidewires. For example, a number of manufacturers make medical guidewircs that range in size from Icss than about 0.014 inches outer diameter to more than about 0.038 inches outer diameter, typically having a finite number of common sizes within this range. "Standard"
size medical guidewires might, for example, have outer diameters of 0.010, 0.014, 0.018, 0.021, 0.025, 0.028, 0.032, 0.035, and 0.038 inches. Thus, in certain preferred embodiments of the invention, the guidewire lumen 22 may be sized appropriately to slide over a particular standard size medical guidewire. A device according to preferred embodiments of the invention may therefore be made available in a range of sizes corresponding to standard medical guidewire sizes.
100401 One potential advantage of a sensor delivery device 10 according to embodiments of the invention is that it allows a physician to use the guidewire of their choice. Sensor delivery device 10 can be sized to be used with any guidewire.
The physician may, for example, choose a particular guidewire based on its unique flexing and torque characteristics for certain procedures. Delivery device 10 according to
8 various embodiments of the invention provides the physician with the ability to use whichever guidewire is deemed best suited for the particular application.
(00411 Another potential advantage of the sensor delivery device 10 is that it does not require repositioning of the guidewire in order to make sensor readings. Once the guidewirc has been positioned across a stenotic lesion, for example, the sensor delivery device 10 can be positioned (e.g., advanced and/or retracted) over the guidcwire and thc sensor 40 can therefore be advanced and retracted across lesions to make pressure readings, for exarnple, without moving the guidcwire. A
physician may also save time by riot having to reposition the guidewire across the lesion or lesions to make such measurements.
100421 In the example shown in FIG. 1, the device 10 is being deployed using guiding catheter 32, which has been placed within a vascular structure of interest (in this example, blood vessel 34, which could be, for example, a coronary artery of the patient). In certain embodiments of the invention, the size or "footprint (e.g., the width and/or the cross-sectional arca) of device 10 may allow it to fit within certain standard sized guiding catheters. For example, in certain diagnostic applications, it would be desirable to have device 10 deployed within a certain sized guiding catheter (e.g., smaller than about 4 or 5 French (FR)).
{00431 In certain embodiments of the invention, the distal sleeve 20 of the device may be substantially concentric with the guidewirc 30. The coupling of the proximal portion 50 to the distal sleeve 20 allows the guidewire 30 to separate from the rest of device I 0 (e.g., in what is sometimes referred to as a "monorail" catheter configuration); this would typically occur inside the guiding catheter 32. The guidewire 30 and device 10 would both exit the patient at the proximal end of the guiding catheter 32 as separate devices. Having the device 10 and guidewirc 30 separate allows the physician to independently control device 10 and guidewire 30, as necessary. It may also allow a physician to use a shorter guidcwirc for catheter exchange. For example, a monorail-type configuration may allow for the use of a guidewire that is approximately 170 to 200 cm long, whereas an "over-the-wire"
configuration might require the use of a much longer (e.g., up to 300 cm or more) guidewirc. Having the device 10 and guidewirc 30 separate (except at the distal sleeve 20) may also result in less friction (e.g., within the guiding catheter 32) than if the
(00411 Another potential advantage of the sensor delivery device 10 is that it does not require repositioning of the guidewire in order to make sensor readings. Once the guidewirc has been positioned across a stenotic lesion, for example, the sensor delivery device 10 can be positioned (e.g., advanced and/or retracted) over the guidcwire and thc sensor 40 can therefore be advanced and retracted across lesions to make pressure readings, for exarnple, without moving the guidcwire. A
physician may also save time by riot having to reposition the guidewire across the lesion or lesions to make such measurements.
100421 In the example shown in FIG. 1, the device 10 is being deployed using guiding catheter 32, which has been placed within a vascular structure of interest (in this example, blood vessel 34, which could be, for example, a coronary artery of the patient). In certain embodiments of the invention, the size or "footprint (e.g., the width and/or the cross-sectional arca) of device 10 may allow it to fit within certain standard sized guiding catheters. For example, in certain diagnostic applications, it would be desirable to have device 10 deployed within a certain sized guiding catheter (e.g., smaller than about 4 or 5 French (FR)).
{00431 In certain embodiments of the invention, the distal sleeve 20 of the device may be substantially concentric with the guidewirc 30. The coupling of the proximal portion 50 to the distal sleeve 20 allows the guidewire 30 to separate from the rest of device I 0 (e.g., in what is sometimes referred to as a "monorail" catheter configuration); this would typically occur inside the guiding catheter 32. The guidewire 30 and device 10 would both exit the patient at the proximal end of the guiding catheter 32 as separate devices. Having the device 10 and guidewirc 30 separate allows the physician to independently control device 10 and guidewire 30, as necessary. It may also allow a physician to use a shorter guidcwirc for catheter exchange. For example, a monorail-type configuration may allow for the use of a guidewire that is approximately 170 to 200 cm long, whereas an "over-the-wire"
configuration might require the use of a much longer (e.g., up to 300 cm or more) guidewirc. Having the device 10 and guidewirc 30 separate (except at the distal sleeve 20) may also result in less friction (e.g., within the guiding catheter 32) than if the
9 device 10 and guidewire 30 had to be moved together as a unit. In some embodiments, a hydrophilic coating may be applied to various portions of the device to further reduce the amount of friction encountered, for example, when advancing or retracting device 10.
[0044J One diagnostic application in which various embodiments of the invention may be well-suited is the measurement of Fractional Flow Reserve (FFR). As noted above, the FFR measurement quantifies the degree to which a stenotic lesion, for example, obstructs flow through a blood vessel. To calculate the FFR for a given stenosis, two blood pressure measurements are needed: one pressure reading is taken on the distal side of the stenosis (downstream side), the other pressure reading is taken on the proximal side of the stenosis (upstream side). The FFR is therefore a unitless ratio of the distal pressure to the proximal pressure. The pressure gradient across a stenotic lesion is an indicator of the severity of the stenosis. The more restrictive the stenosis is, thc more the pressure drop, and the lower the FFR.
[0045J To add clarity and context to the disclosure, several embodiments of the invention will now be described below in the context of making FFR
measurements.
However, it should be realized that there arc other applications in which physiological parameter measurements could be facilitated with the devices andior methods described herein.
100461 FIG. 2 is a perspective view of a sensor delivery device for rneasuring physiological parameter in a patient according to an embodiment of the invention.
The embodiment shown in FIG. 2 might, for example, be deployed to make an FFR
measurement in a blood vessel of a patient. FIG. 2 shows a sensor delivery device 210 being deployed in a blood vessel of a patient (e.g., coronary artery 234) across a stenosis (e.g., stenotic lesion 236). To make an FFR measurement, for example, first sensor 240 may be positioned to measure distal (downstream) blood pressure, Pd, at a location 231 downstream of a location of interest (e.g., stenotie lesion 236).
First sensor 240 may then be positioned to measure proximal (upstream) blood pressure, Pp, at a location 233 upstream of a location of interest (e.g., stenotie lesion 236). FFR
is simply calculated as the ratio of distal pressure to proximal pressure, or FFR = (Pd Pp). The use of the terms "downstream" and "upstream" arc with respect to the nomial direction of blood flow, "I:)," as shown in FIG. 2.
[0044J One diagnostic application in which various embodiments of the invention may be well-suited is the measurement of Fractional Flow Reserve (FFR). As noted above, the FFR measurement quantifies the degree to which a stenotic lesion, for example, obstructs flow through a blood vessel. To calculate the FFR for a given stenosis, two blood pressure measurements are needed: one pressure reading is taken on the distal side of the stenosis (downstream side), the other pressure reading is taken on the proximal side of the stenosis (upstream side). The FFR is therefore a unitless ratio of the distal pressure to the proximal pressure. The pressure gradient across a stenotic lesion is an indicator of the severity of the stenosis. The more restrictive the stenosis is, thc more the pressure drop, and the lower the FFR.
[0045J To add clarity and context to the disclosure, several embodiments of the invention will now be described below in the context of making FFR
measurements.
However, it should be realized that there arc other applications in which physiological parameter measurements could be facilitated with the devices andior methods described herein.
100461 FIG. 2 is a perspective view of a sensor delivery device for rneasuring physiological parameter in a patient according to an embodiment of the invention.
The embodiment shown in FIG. 2 might, for example, be deployed to make an FFR
measurement in a blood vessel of a patient. FIG. 2 shows a sensor delivery device 210 being deployed in a blood vessel of a patient (e.g., coronary artery 234) across a stenosis (e.g., stenotic lesion 236). To make an FFR measurement, for example, first sensor 240 may be positioned to measure distal (downstream) blood pressure, Pd, at a location 231 downstream of a location of interest (e.g., stenotie lesion 236).
First sensor 240 may then be positioned to measure proximal (upstream) blood pressure, Pp, at a location 233 upstream of a location of interest (e.g., stenotie lesion 236). FFR
is simply calculated as the ratio of distal pressure to proximal pressure, or FFR = (Pd Pp). The use of the terms "downstream" and "upstream" arc with respect to the nomial direction of blood flow, "I:)," as shown in FIG. 2.
10 WO 2010/030082 PeriUS2009/056664 10047j In FIG, 2, first sensor 240 is coupled to distal sleeve 220. In the embodiment shown in FIG. 2, first sensor 240 is coupled to an outer surface of distal sleeve 220.
The first sensor 240 is adapted to measure a physiological parameter of a patient, such as a blood parameter (e.g., blood pressure, temperature, pH, blood oxygen saturation levels, etc.), and generate a signal representative of the physiological parameter. In certain preferred embodiments of the invention, the first sensor 240 is a fiber optic pressure sensor adapted to measure blood pressure. An example of a fiber optic pressure sensor is a Fabry-Perot fiber optic pressure sensor, which is a commercially available sensor. Examples of Fabry-Perot fiber optic sensors are the "OPP-M"
MEMS-based fiber optic pressure sensor (400 micron size) manufactured by Opserts (Quebec, Canada), and the -FOP-MIV" sensor (515 micron size) manufactured by Fiso Technologies, Inc. (Quebec, Canada). In certain alternate embodiments, first sensor 240 may be a piezo-resistive pressure sensor (e.g., a MEMS piezo-resistive pressure sensor), and in other embodiments, first sensor 240 may be a capacitive pressure sensor (e.g., a MEMS capacitive pressure sensor). A pressure sensing range from about -50 mm fig to about +300 mm Hg (relative to atmospheric pressure) is desired for making most physiological measurements with sensor 240, for example.
100481 In embodiments of the invention using the Fabty-Penot fiber optic pressure sensor as the sensor 240, such a sensor works by having a reflective diaphragm that varies a cavity length measurement according to the pressure against the diaphragm.
Coherent light from a light source travels down the fiber and crosses a small cavity at the sensor end. The reflective diaphragm reflects a portion of the light signal back into the fiber. The reflected light travels back through the fiber to a detector at the light source end of the fiber. The two light waves, the source light and reflected light travel in opposite directions and interfere with each other. The amount of interference will vary depending on the cavity length. The cavity length will change as the diaphragm deflects under pressure. The amount of interference is registered by a fringe pattern detector.
100491 FIG. 2 shows proximal portion 250 coupled to the distal sleeve 220. The proximal portion 250 includes a communication channel 260 for communicating the physiological signal horn the sensor 240 to a location outside of the patient (e.g., to a processor, display, computer, monitor, or to another medical device). The proximal
The first sensor 240 is adapted to measure a physiological parameter of a patient, such as a blood parameter (e.g., blood pressure, temperature, pH, blood oxygen saturation levels, etc.), and generate a signal representative of the physiological parameter. In certain preferred embodiments of the invention, the first sensor 240 is a fiber optic pressure sensor adapted to measure blood pressure. An example of a fiber optic pressure sensor is a Fabry-Perot fiber optic pressure sensor, which is a commercially available sensor. Examples of Fabry-Perot fiber optic sensors are the "OPP-M"
MEMS-based fiber optic pressure sensor (400 micron size) manufactured by Opserts (Quebec, Canada), and the -FOP-MIV" sensor (515 micron size) manufactured by Fiso Technologies, Inc. (Quebec, Canada). In certain alternate embodiments, first sensor 240 may be a piezo-resistive pressure sensor (e.g., a MEMS piezo-resistive pressure sensor), and in other embodiments, first sensor 240 may be a capacitive pressure sensor (e.g., a MEMS capacitive pressure sensor). A pressure sensing range from about -50 mm fig to about +300 mm Hg (relative to atmospheric pressure) is desired for making most physiological measurements with sensor 240, for example.
100481 In embodiments of the invention using the Fabty-Penot fiber optic pressure sensor as the sensor 240, such a sensor works by having a reflective diaphragm that varies a cavity length measurement according to the pressure against the diaphragm.
Coherent light from a light source travels down the fiber and crosses a small cavity at the sensor end. The reflective diaphragm reflects a portion of the light signal back into the fiber. The reflected light travels back through the fiber to a detector at the light source end of the fiber. The two light waves, the source light and reflected light travel in opposite directions and interfere with each other. The amount of interference will vary depending on the cavity length. The cavity length will change as the diaphragm deflects under pressure. The amount of interference is registered by a fringe pattern detector.
100491 FIG. 2 shows proximal portion 250 coupled to the distal sleeve 220. The proximal portion 250 includes a communication channel 260 for communicating the physiological signal horn the sensor 240 to a location outside of the patient (e.g., to a processor, display, computer, monitor, or to another medical device). The proximal
11 WO 2010/1130832 PeT/US2009/056644 portion 250 rnay preferably be formed of a material of sufficient stiffness in order to assist an operator (e.g., a physician or other medical staff) in positioning the distal sleeve 220 and the sensor 240 within a anatomical (e.g., vascular) structure of the patient.
[00.501 One suitable material for the proximal portion 250 may be a stainless steel hypotube, for example. Depending on the application, the proximal portion 250 (sometimes also referred to as the "delivery tube") should typically be stiffer and more rigid than the distal sleeve 220 in order to provide a reasonable amount of control to push, pull and otherwise maneuver the device to a physiological location of interest within the patient. In interventional cardiology procedures, for example, at least a portion of the proximal portion 250 will be maneuvered within a guiding catheter positioned within the aortic artery. Thc proximal portion 250 in such an application should therefore bc flexible enough to accommodate the arch of the aorta, while being rigid enough to push and pull the device. Accordingly, suitable materials for proximal portion 250 may also include (in addition to the aforementioned stainless steel hypotube) materials such as nitinol, nylon, and plastic, for example, or composites of multiple materials.
100511 The communication channel 260 may be disposed along an outer surface of proximal portion 250, or may bc fomied within the proximal portion 250, as shown in FIG. 2. For example, communication channel 260 may comprise a communication lumen that extends longitudinally through proximal portion 250 in some embodiments. Communication channel 260 may comprise a fiber optic communication channel in certain embodiments, such as where thc sensor 240 is a fiber optic pressure sensor. Alternately, communication channel 260 may comprise an electrically conductive medium, such as electrical conducting wires, or other communication media suitable for transmitting the signal generated by sensor 240. In preferred embodiments of the invention, the communication channel 260 comprises a non-fluid communication medium. In the embodiment shown in FIG. 2, communication channel 260 (e.g., a fiber optic cable) extends distally beyond proximal portion 250 and is coupled to sensor 240. The communication channel in such an embodiment is at least partially housed within a communication lumen of the proximal portion 250 (e.g., a stainless steel hypotube).
[00.501 One suitable material for the proximal portion 250 may be a stainless steel hypotube, for example. Depending on the application, the proximal portion 250 (sometimes also referred to as the "delivery tube") should typically be stiffer and more rigid than the distal sleeve 220 in order to provide a reasonable amount of control to push, pull and otherwise maneuver the device to a physiological location of interest within the patient. In interventional cardiology procedures, for example, at least a portion of the proximal portion 250 will be maneuvered within a guiding catheter positioned within the aortic artery. Thc proximal portion 250 in such an application should therefore bc flexible enough to accommodate the arch of the aorta, while being rigid enough to push and pull the device. Accordingly, suitable materials for proximal portion 250 may also include (in addition to the aforementioned stainless steel hypotube) materials such as nitinol, nylon, and plastic, for example, or composites of multiple materials.
100511 The communication channel 260 may be disposed along an outer surface of proximal portion 250, or may bc fomied within the proximal portion 250, as shown in FIG. 2. For example, communication channel 260 may comprise a communication lumen that extends longitudinally through proximal portion 250 in some embodiments. Communication channel 260 may comprise a fiber optic communication channel in certain embodiments, such as where thc sensor 240 is a fiber optic pressure sensor. Alternately, communication channel 260 may comprise an electrically conductive medium, such as electrical conducting wires, or other communication media suitable for transmitting the signal generated by sensor 240. In preferred embodiments of the invention, the communication channel 260 comprises a non-fluid communication medium. In the embodiment shown in FIG. 2, communication channel 260 (e.g., a fiber optic cable) extends distally beyond proximal portion 250 and is coupled to sensor 240. The communication channel in such an embodiment is at least partially housed within a communication lumen of the proximal portion 250 (e.g., a stainless steel hypotube).
12 WO 2010/030882 Per/US2009/056664 100521 FIG. 2 also shows an optional embodiment of the invention in which a second sensor 242 may be coupled to the device 210. For example, a second sensor 242 may be coupled to proximal portion 250 such that the first and second sensor 240, 242 are spaced apart sufficiently (e.g., a fixed distance apart) to span a stenotic lesion. This embodiment may offer the ability to measure FFR without having to reposition device 210, since first sensor 240 could be placed distal of the stenotic lesion 236 to measure Pd, and second sensor 242 could be placed proximal of the stenotic lesion 236 to measure P. Second sensor 242 may have a communication channel 262, which could be housed within proximal portion 250, or could be disposed along an outside surface of proximal portion 250, as shown in FIG. 2, for example. Further, the ability to measure Pd and Pp substantially simultaneously may improve accuracy and/or reduce the effects of certain types of errors illustrated and described below with reference to F10. 3.
100531 It should be noted that certain embodiments could have more than 2 sen.sors, and that the spacing between adjacent sensors in such embodiments may be varied to provide a variable spacing capability. In certain alternate embodiments of the invention, one or more sensors could be disposed on the proximal portion 250 with no sensors disposed on the distal sleeve 220, for example, la some alternate embodiments, it may be desirable to have a plurality of sensors (two, or three, or four, or more sensors) spaced at known, fixed distances, disposed along the proximal portion 250. This could, for example, provide the ability to measure Pd and substantially simultaneously, regardless of lesion length, by selecting an appropriate pair of sensors (from among the plurality of sensors) placed across the lesion from which to obtain the Pd and Pp signals. Further, the sensors could have some form of radiopaque znarkings incorporated thereon (e.g., marker bands), which could provide a visual estimate of lesion size in conjunction with the measurement of physiological parameters (e.g., Pd and P).
100541 FIG. 3 graphically illustrates several possible sources of error in measuring blood pressure, particularly as thcy may affect the calculation of FFR, for example.
FIG. 3 is a conceptual plot of blood pressure, 340, as a function of time for a given patient, P(t). One potential error in calculating FFR is due to the fluctuations in blood pressure due to the systolic and diastolic phases of the cardiac cycle 342.
Unless Pd
100531 It should be noted that certain embodiments could have more than 2 sen.sors, and that the spacing between adjacent sensors in such embodiments may be varied to provide a variable spacing capability. In certain alternate embodiments of the invention, one or more sensors could be disposed on the proximal portion 250 with no sensors disposed on the distal sleeve 220, for example, la some alternate embodiments, it may be desirable to have a plurality of sensors (two, or three, or four, or more sensors) spaced at known, fixed distances, disposed along the proximal portion 250. This could, for example, provide the ability to measure Pd and substantially simultaneously, regardless of lesion length, by selecting an appropriate pair of sensors (from among the plurality of sensors) placed across the lesion from which to obtain the Pd and Pp signals. Further, the sensors could have some form of radiopaque znarkings incorporated thereon (e.g., marker bands), which could provide a visual estimate of lesion size in conjunction with the measurement of physiological parameters (e.g., Pd and P).
100541 FIG. 3 graphically illustrates several possible sources of error in measuring blood pressure, particularly as thcy may affect the calculation of FFR, for example.
FIG. 3 is a conceptual plot of blood pressure, 340, as a function of time for a given patient, P(t). One potential error in calculating FFR is due to the fluctuations in blood pressure due to the systolic and diastolic phases of the cardiac cycle 342.
Unless Pd
13 and Pp are measured at substantially the sarne phase of the cardiac cycle 342, there may be some amount of error introduced. Similarly, a more slowly varying source of error can also be introduced by the effect of the respiratory cycle (e.g., inspiration and expiration) on blood pressure, as illustrated at 344 in FIG. 3. A third source of error $ could be introduced by changes in the patient's posture, which could either raise or lower the overall pressure profile as indicated at 346 in FIG. 3. Embodiments of the invention which have the ability to measure Pd and Pp substantially simultaneously, such as the two-sensor embodiment shown in FIG. 2, may be able to minimize or eliminate the effects of such "timing errors" on the FFR calculation. Another method of addressing the effects of such "timing errors" will be discussed below in the context of using a contrast injection system in conjunction with a sensor delivery device, according to some embodiments of the invention.
100551 Referring again to FIG. 2, distal sleeve 220 may be substantially tubular, as shown, or may have any shape that allows distal sleeve 220 to slide over a medical guidewire 230 in a anatomical (e.g., vascular) structure of interest. In the context of measuring FFR in a coronary artery, for example, it may be desirable that distal sleeve 220 be substantially cylindrical in cross-section to minimize the total cross-sectional arca of the device. Distal sleeve 220 may be preferably formed of a flexible material in some embodiments to facilitate positioning and placement of the distal sleeve 220 (and sensor 240) over a guidewire 230 through narrow vascular structures such as coronary arteries. In certain preferred embodiments, the distal sleeve 220 comprises a flexible polyimide tube sized for placement in anatomical (e.g., vascular) structures of interest, such as in coronary arteries or peripheral arteries. In some embodiments, the distal sleeve 220 may comprise a flexible mierocoil tube. in some embodiments, flexibility may be achieved and/or enhanced by applying a series of cuts along the surface of the tube. For example, a plurality of cuts or notches along a length of the outer surface of distal sleeve 220 may be applied (e.g., by laser cutting techniques known to those of ordinary skill in this field). Such cuts or notches may bc substantially circumferentially directed, and may extend at least partially around the circumference of the distal sleeve. Successive cuts may be angularly offset from each other to provide flexibility in all directions according to some embodiments.
100551 Referring again to FIG. 2, distal sleeve 220 may be substantially tubular, as shown, or may have any shape that allows distal sleeve 220 to slide over a medical guidewire 230 in a anatomical (e.g., vascular) structure of interest. In the context of measuring FFR in a coronary artery, for example, it may be desirable that distal sleeve 220 be substantially cylindrical in cross-section to minimize the total cross-sectional arca of the device. Distal sleeve 220 may be preferably formed of a flexible material in some embodiments to facilitate positioning and placement of the distal sleeve 220 (and sensor 240) over a guidewire 230 through narrow vascular structures such as coronary arteries. In certain preferred embodiments, the distal sleeve 220 comprises a flexible polyimide tube sized for placement in anatomical (e.g., vascular) structures of interest, such as in coronary arteries or peripheral arteries. In some embodiments, the distal sleeve 220 may comprise a flexible mierocoil tube. in some embodiments, flexibility may be achieved and/or enhanced by applying a series of cuts along the surface of the tube. For example, a plurality of cuts or notches along a length of the outer surface of distal sleeve 220 may be applied (e.g., by laser cutting techniques known to those of ordinary skill in this field). Such cuts or notches may bc substantially circumferentially directed, and may extend at least partially around the circumference of the distal sleeve. Successive cuts may be angularly offset from each other to provide flexibility in all directions according to some embodiments.
14 10056J The length of distal sleeve 220 rnay vary. In embodiments to be used in coronary arteries, for example, distal sleeve 220 may be up to about 15 inches long, and in some preferred embodiments may be 11 inches long (e.g., to facilitate use deep within certain coronary arteries). In some embodiments, the distal sleeve 220 may also include a thin covering to provide additional structural support and/or improve handling characteristics of the device. Such a covering may comprise, for example, polyester (PET) shrink tubing that substantially covers the distal sleeve.
(0057J Distal sleeve 220 has a guidewire lumen 222 that is sized to slidably receive a guidewire 230 having an outer diameter between about 0.010 inches and 0.050 inches.
For making an FFR measurement in a coronary artery 234, for example, the guidewire 230 may preferably have an outer diameter of 0.014 inches, and guidewire lumen would therefore need to have an inner diameter slightly larger than this to facilitate slidable movement of thc distal sleeve 220 over the guidewire 230.
100581 FIG 4(a) shows an embodiment of the invention in which one or more flow holes 224 are disposed along a side portion of the distal sleeve 220 (e.g., along thc length of distal sleeve 220). Flow holes 224 could allow blood to flow into the guidewire lumen 222 if an operator were to pull back (e.g., withdraw) the guidewire 230 as shown in FIG. 4(a). Such an embodiment may provide an improvement in accuracy in measuring the pressure drop across a stenosis, since the pressure drop attributable to the device itself would be lessened by decreasing the effective cross-sectional arca of the device.
100591 FIG,4(b) is a cross.seetional view of an embodiment of the invention, illustrating the potential reduction in cross-sectional area that could be obtained by employing flow holes 224 in a side portion of distal sleeve 220. For example, by allowing blood to flow through flow holes 224 into guidewire lumen 222, the effective cross-sectional area of the device 210 is reduced by the area of guidewire lumen 222, and any error in blood pressure measurements caused by the flow obstruction of the device 210 itself would be accordingly reduced.
10060j FIG. 5(a) is a cut-away side view of a portion of the device 210 according to certain embodiments of the invention. FIG. 5(a) shows the distal sleeve 220 and first sensor 240 of an embodiment in which sensor 240 is provided with a certain degree of
(0057J Distal sleeve 220 has a guidewire lumen 222 that is sized to slidably receive a guidewire 230 having an outer diameter between about 0.010 inches and 0.050 inches.
For making an FFR measurement in a coronary artery 234, for example, the guidewire 230 may preferably have an outer diameter of 0.014 inches, and guidewire lumen would therefore need to have an inner diameter slightly larger than this to facilitate slidable movement of thc distal sleeve 220 over the guidewire 230.
100581 FIG 4(a) shows an embodiment of the invention in which one or more flow holes 224 are disposed along a side portion of the distal sleeve 220 (e.g., along thc length of distal sleeve 220). Flow holes 224 could allow blood to flow into the guidewire lumen 222 if an operator were to pull back (e.g., withdraw) the guidewire 230 as shown in FIG. 4(a). Such an embodiment may provide an improvement in accuracy in measuring the pressure drop across a stenosis, since the pressure drop attributable to the device itself would be lessened by decreasing the effective cross-sectional arca of the device.
100591 FIG,4(b) is a cross.seetional view of an embodiment of the invention, illustrating the potential reduction in cross-sectional area that could be obtained by employing flow holes 224 in a side portion of distal sleeve 220. For example, by allowing blood to flow through flow holes 224 into guidewire lumen 222, the effective cross-sectional area of the device 210 is reduced by the area of guidewire lumen 222, and any error in blood pressure measurements caused by the flow obstruction of the device 210 itself would be accordingly reduced.
10060j FIG. 5(a) is a cut-away side view of a portion of the device 210 according to certain embodiments of the invention. FIG. 5(a) shows the distal sleeve 220 and first sensor 240 of an embodiment in which sensor 240 is provided with a certain degree of
15 WO 2010/030/182 PCT/US2009/05666.1 protection by being at least partially covered by a sensor housing 270 disposed on distal sleeve 220. Sensor housing 270 may be substantially tubular, or may be semi-circular, or may be any other shape that provides suitable protection for sensor 240.
Sensor housing 270 may be constructed of tubing such as polyimide, which is capable of being fonried with a relatively thin wall thickness.
[00611 The sensor housing 270 may be constructed in several different ways, as described with reference to FIGS. 5(a) through 5(e). Fiber optic sensors, for example, may be somewhat fragile, and should typically be provided with some form of mechanical protection from stress and/or strain relief The sensing head of sensor 240 is generally attached to the communication channel 260 (e.g., a fiber optic cable) with an adhesive. The sensing head can be prone to being pulled away from (e.g., disconnected from) the fiber optic without much force because the bonding area is typically very small. FIGS, 5(a) through 5(e) illustrate several techniques that utilize a protective sensor housing 270 surrounding the sensor 240 to minimize or eliminate the effects of such stresses on the sensor 240.
100621 One material which may be used to construct the sensor housing 270 is a heavy metal that is x-ray visible, such as platinum. A sensor housing 270 formed of platinum may provide an x-ray marker band to facilitate the placement and positioning of the sensor 240. A platinum sensor housing 270 may be formed so it is generally thin, for example, approximately 0.001 inches in thickness. Such a thin-walled platinum sensor housing 270 may provide suitable protection to the sensor 240 from stresses that might otherwise cause it to detach from the communication channel 260.
100631 In some etnbodiments, sensor housing 270 may be shaped to facilitate movement and placement of the device in the anatomical (e.g., vascular) structure of the patient. For example, as shown in FIG. 5(a), the forward and rearward portions 274 of sensor housing 270 may be formed at an angle (e,g., cut at an angle) to present a smoother, tapered structure that is easier to navigate through anatomical (e.g., vascular) structures and passages in a patient (e.g., it allows the device 210 to slide through vascular passages such as arterial walls without catching or snagging).
Sensor housing 270 may be constructed of tubing such as polyimide, which is capable of being fonried with a relatively thin wall thickness.
[00611 The sensor housing 270 may be constructed in several different ways, as described with reference to FIGS. 5(a) through 5(e). Fiber optic sensors, for example, may be somewhat fragile, and should typically be provided with some form of mechanical protection from stress and/or strain relief The sensing head of sensor 240 is generally attached to the communication channel 260 (e.g., a fiber optic cable) with an adhesive. The sensing head can be prone to being pulled away from (e.g., disconnected from) the fiber optic without much force because the bonding area is typically very small. FIGS, 5(a) through 5(e) illustrate several techniques that utilize a protective sensor housing 270 surrounding the sensor 240 to minimize or eliminate the effects of such stresses on the sensor 240.
100621 One material which may be used to construct the sensor housing 270 is a heavy metal that is x-ray visible, such as platinum. A sensor housing 270 formed of platinum may provide an x-ray marker band to facilitate the placement and positioning of the sensor 240. A platinum sensor housing 270 may be formed so it is generally thin, for example, approximately 0.001 inches in thickness. Such a thin-walled platinum sensor housing 270 may provide suitable protection to the sensor 240 from stresses that might otherwise cause it to detach from the communication channel 260.
100631 In some etnbodiments, sensor housing 270 may be shaped to facilitate movement and placement of the device in the anatomical (e.g., vascular) structure of the patient. For example, as shown in FIG. 5(a), the forward and rearward portions 274 of sensor housing 270 may be formed at an angle (e,g., cut at an angle) to present a smoother, tapered structure that is easier to navigate through anatomical (e.g., vascular) structures and passages in a patient (e.g., it allows the device 210 to slide through vascular passages such as arterial walls without catching or snagging).
16 WO MO/030882 PCTJUS2009/056664' 100641ln sorne embodiments, sensor housing 270 may be formed as part of the process of forming distal sleeve 220. For example, a substantially cylindrical mandrel may be used to form a distal sleeve 220 made of a thermoset polymer (e.g., polyimide) by employing a dipping process. A slight modification of this manufacturing process could employ a "housing forming element" located alongside the mandrel at the distal end of the mandrel. A single dipping process could thereby form sensor housing 270 as an integral part of distal sleeve 220.
[00651 In some embodiments, an optional covering 226 may be applied over the sensor housing 270 and distal sleeve 220. Such a covering 226 may facilitate movement and positioning of the device 210 within a anatomical (e.g., vascular) structure of a patient. The covering 226 may also provide additional structural stability to the sensor 240, housing 270, and distal sleeve 220 arrangement.
An example of a class of materials that may be suitable for forming covering 226 are thermoplastics. Such materials may sometimes be referred to as thin-walled heat-shrink tubing, and include materials such as polyolefin, fluoropolymers (FYFFE), polyvinyl chloride (PVC), and polyester, specifically polyethylene terephthalate (PET). For simplicity, the term "PET tubing" will be used herein in reference to embodiments that incorporate such thin covering materials. The use of PET
tubing could be employed, for example, in embodiments with or without a housing 270.
100661 PET tubing is a heat shrink tube made from polyester that exhibits excellent tensile strength characteristics, while having a wall thickness as little as 0.0002 inches. PET tubing may be used in some embodiments of the invention to encapsulate the distal sleeve 220. This may include, for example, encapsulating the sensor housing 270 andior a portion of the communication channel 260 (e.g., the fiber optic cable), to the extent the communication channel 260 extends from the proximal portion 250. In some embodiments, the PET tubing may also extend to cover part of the proximal portion 250, for example, where it is coupled to the distal sleeve 220. In some embodiments, PET tubing may be used to hold a fiber optic communication channel 260 in place around the distal sleeve 220. After the PET tubing has been heat shrunk, one or more openings may be cut in the PET tubing, for example, to allow an exit port for the guidcwire 230.
[00651 In some embodiments, an optional covering 226 may be applied over the sensor housing 270 and distal sleeve 220. Such a covering 226 may facilitate movement and positioning of the device 210 within a anatomical (e.g., vascular) structure of a patient. The covering 226 may also provide additional structural stability to the sensor 240, housing 270, and distal sleeve 220 arrangement.
An example of a class of materials that may be suitable for forming covering 226 are thermoplastics. Such materials may sometimes be referred to as thin-walled heat-shrink tubing, and include materials such as polyolefin, fluoropolymers (FYFFE), polyvinyl chloride (PVC), and polyester, specifically polyethylene terephthalate (PET). For simplicity, the term "PET tubing" will be used herein in reference to embodiments that incorporate such thin covering materials. The use of PET
tubing could be employed, for example, in embodiments with or without a housing 270.
100661 PET tubing is a heat shrink tube made from polyester that exhibits excellent tensile strength characteristics, while having a wall thickness as little as 0.0002 inches. PET tubing may be used in some embodiments of the invention to encapsulate the distal sleeve 220. This may include, for example, encapsulating the sensor housing 270 andior a portion of the communication channel 260 (e.g., the fiber optic cable), to the extent the communication channel 260 extends from the proximal portion 250. In some embodiments, the PET tubing may also extend to cover part of the proximal portion 250, for example, where it is coupled to the distal sleeve 220. In some embodiments, PET tubing may be used to hold a fiber optic communication channel 260 in place around the distal sleeve 220. After the PET tubing has been heat shrunk, one or more openings may be cut in the PET tubing, for example, to allow an exit port for the guidcwire 230.
17 100671 FIG. 5(a) shows a fluid opening 272 formed in one of the portions 274 (e.g., the forward portion in this example) of the sensor housing 270. Fluid opening allows fluid (e.gõ blood) to enter the sensor housing 270 and come into fluid contact with sensor 240. In embodiments that incorporate a covering 226 (such as PET
tubing), fluid opening 272 may be formed in the coveting 226.
100681 FIG. 5(b) shows an embodiment of the invention where the fluid opening is formed in a side portion of the housing 270. This arrangement may provide a reduced likelihood of "clogging" within sensor housing 270, and/or a reduced likelihood of catching or snagging on any obstructions or bends encountered while positioning device 210, For example, plaque or calcium from arterial walls may enter the housing 270 as the device is moved through an artery; having the fluid opening 272 in a side portion of housing 270 may reduce this effect. In some embodiments, allowing the PET tubing covering 226 to remain intact at the distal end of the housing 270 may prevent foreign material from entering the housing 270 and possibly damaging the sensor 240, or affecting the accuracy of pressure measurements.
After the PET tubing coveting 226 has been heat shrunk over the device 210, holes can be punched through the covering 226 as needed to form fluid openings 272 to allow fluid access (e.g., blood flow) inside the sensor housing 270.
[00691 In some embodiments of the invention, the inside portion of the sensor housing 270 may be filled with a gel 278, such as a silicone dielectric gel.
Silicone dielectric gels are often used with solid state sensors to protect the sensor from the effects of exposure to a fluid medium, for example. If the sensor housing 270 is filled with a gel 278 in front of the sensor diaphragm 279, then foreign material would be less likely to penetrate inside the housing 270. The gel 278 may aLso offer added structural stability to the sensor 240, andior rnay enhance the pressure-sensing characteristics of the sensor 240. A gel 278 may be used in any of thc embodiments of sensor housing 270 illustrated in FIGS. 5(a) to 5(d) and their equivalents.
100701 In FIGS. 5(c) and 5(d), embodiments of the invention are shown which include an optional marker band. If the sensor housing 270 is made from polyimide tubing, for example, the device 210 may not show up as well under x-ray. An optional marker band 276 could be placed near the end of the distal sleeve 220. Marker band 276 may provide a visible indication of the location of the sensor 240 when viewed
tubing), fluid opening 272 may be formed in the coveting 226.
100681 FIG. 5(b) shows an embodiment of the invention where the fluid opening is formed in a side portion of the housing 270. This arrangement may provide a reduced likelihood of "clogging" within sensor housing 270, and/or a reduced likelihood of catching or snagging on any obstructions or bends encountered while positioning device 210, For example, plaque or calcium from arterial walls may enter the housing 270 as the device is moved through an artery; having the fluid opening 272 in a side portion of housing 270 may reduce this effect. In some embodiments, allowing the PET tubing covering 226 to remain intact at the distal end of the housing 270 may prevent foreign material from entering the housing 270 and possibly damaging the sensor 240, or affecting the accuracy of pressure measurements.
After the PET tubing coveting 226 has been heat shrunk over the device 210, holes can be punched through the covering 226 as needed to form fluid openings 272 to allow fluid access (e.g., blood flow) inside the sensor housing 270.
[00691 In some embodiments of the invention, the inside portion of the sensor housing 270 may be filled with a gel 278, such as a silicone dielectric gel.
Silicone dielectric gels are often used with solid state sensors to protect the sensor from the effects of exposure to a fluid medium, for example. If the sensor housing 270 is filled with a gel 278 in front of the sensor diaphragm 279, then foreign material would be less likely to penetrate inside the housing 270. The gel 278 may aLso offer added structural stability to the sensor 240, andior rnay enhance the pressure-sensing characteristics of the sensor 240. A gel 278 may be used in any of thc embodiments of sensor housing 270 illustrated in FIGS. 5(a) to 5(d) and their equivalents.
100701 In FIGS. 5(c) and 5(d), embodiments of the invention are shown which include an optional marker band. If the sensor housing 270 is made from polyimide tubing, for example, the device 210 may not show up as well under x-ray. An optional marker band 276 could be placed near the end of the distal sleeve 220. Marker band 276 may provide a visible indication of the location of the sensor 240 when viewed
18 WO 2010/030882 PCfiUS2009/056664 under x-ray. As shown in FIG. 5(c), the marker band 276 on the end of the distal sleeve 220 may provide some structural reinforcement to the end of the distal sleeve 220. In the alternative embodiment shown in FIG. 5(d), a marker band 276 on the distal sleeve 220 located proximal of the sensor housing 270 may reduce the likelihood of the marker band 276 becoming dislodged from the device 210. In some embodiments, it may be desirable to include a number of such mtu-ker bands spaced at known distances (e.g., every 10 mm along distal sleeve 220, for example), such that the marker bands could be used to provide visual estimates of length or distance (e.g., to measure lesion length).
100711 FIG. 5(e) shows an embodiment where a spacer 278 is used to provide strain relief at the connection between the sensor 240 and the communication channel 260.
This strain relief may be made of any suitable =Aerial, such as polyetheretherketone (PEEK), for example. In some embodiments, spacer 278 may also be formed so as to serve as a marker band 276, substantially as described above. Spacer 278 could be employed in embodiments with a sensor housing 270, or in embodiments without a sensor housing.
f00721 FIG. 6(a) shows an enlarged side view of a portion of the device 210 according to one embodiment of the invention. The delivery tube (proximal portion 250) and distal sleeve 220 are preferably coupled together using a flexible bond method (medical adhesive) to maintain flexibility of the device 210. la some preferred embodiments, for example, the proximal portion 250 will be bonded to an outer surface 221 of the distal sleeve 220 in a bonding area 223. Bonding area 223 is preferably disposed on distal sleeve 220 sufficiently proximal of the sensor 240 so that bonding area 223 is not within the vascular structure or passage of interest (e.g., it is not within the arterial vessel near a stcnosis), but would still be inside the guiding catheter 232. The joining or bonding arca 223 preferably maintains a degree of flexibility in order to accomrnodate bends such as that in the aortic arch. As previously noted, it may be desirable to minimize the width of the device 210 so that it can be passed through a relatively small guiding catheter 232, for example.
This goal may be achieved, at least in part, by causing the bonding area 223 to be as narrow as possible. In some embodiments, it is desirable to use the sensor delivery device 210 inside a diagnostic guiding catheter 232, which are generally 4 Fr.
100711 FIG. 5(e) shows an embodiment where a spacer 278 is used to provide strain relief at the connection between the sensor 240 and the communication channel 260.
This strain relief may be made of any suitable =Aerial, such as polyetheretherketone (PEEK), for example. In some embodiments, spacer 278 may also be formed so as to serve as a marker band 276, substantially as described above. Spacer 278 could be employed in embodiments with a sensor housing 270, or in embodiments without a sensor housing.
f00721 FIG. 6(a) shows an enlarged side view of a portion of the device 210 according to one embodiment of the invention. The delivery tube (proximal portion 250) and distal sleeve 220 are preferably coupled together using a flexible bond method (medical adhesive) to maintain flexibility of the device 210. la some preferred embodiments, for example, the proximal portion 250 will be bonded to an outer surface 221 of the distal sleeve 220 in a bonding area 223. Bonding area 223 is preferably disposed on distal sleeve 220 sufficiently proximal of the sensor 240 so that bonding area 223 is not within the vascular structure or passage of interest (e.g., it is not within the arterial vessel near a stcnosis), but would still be inside the guiding catheter 232. The joining or bonding arca 223 preferably maintains a degree of flexibility in order to accomrnodate bends such as that in the aortic arch. As previously noted, it may be desirable to minimize the width of the device 210 so that it can be passed through a relatively small guiding catheter 232, for example.
This goal may be achieved, at least in part, by causing the bonding area 223 to be as narrow as possible. In some embodiments, it is desirable to use the sensor delivery device 210 inside a diagnostic guiding catheter 232, which are generally 4 Fr.
19 10073j In some embodiments, the use of a distal transition 254 to couple the proximal portion 250 to the distal sleeve 220 may obtain a significant reduction in the width of the device 210. In certain preferred embodiments of the invention, the device will be able to pass through a 4 Fr guiding catheter 232. The embodiment of FIG, 6(a) has a proximal portion 250 that comprises a main section 252 and a distal transition 254. Distal transition 254 extends distally from main section 252 and is coupled to an outer surface 221 of distal sleeve 220 at bonding area 223. As shown in FIG. 6(a), the use of a distal transition 254 to couple the proximal portion 250 to the distal sleeve 220 may cause a reduction in the width of the device 210 as compared to a device 210 without the distal transition 254. This may be accomplished, for example, in embodiments where the distal transition 254 is smaller in cross-sectional area than main section 252. (Of course, the distal transition 254 is optional and may not be required in all embodiments of the invention; the embodiments shown in FIGS.
I, 2, and 4, for example, do not include a distal transition. Such embodiments may result in a simpler manufacturing process, for example.) 1.0074) In the embodiment shown in FIG. 6(a), distal transition 254 may be substantially coaxial and/or concentric with main section 252, and is smaller in diameter than main section 252. In some embodiments, distal transition 254 may be formed by inserting a hypotube inside the end of thc proximal portion 250, the hypotube being of somewhat smaller diameter than the proximal portion 250. The hypotube distal transition 254 and the proximal portion may then be soldered together, as shown at 256. The distal sleeve 220, which may comprise a thin walled tube formed of a material such as polyimide, may then be bonded to the smaller diameter distal transition 254. Alternately, the distal sleeve 220 could be fomied from a flat wire wound microcoil with PET tubing heat shrunk over the mierocoil. An embodiment using a stainless steel mierocoil for the distal sleeve 220 might provide a lower coefficient of friction (than polyimidc, for example) to reduce the sliding friction. flowever, such a mierocoil embodiment would probably benefit from the use of a PET tubing covering 226 to provide reinforcement and/or a smooth surface.
PET
tubing may be used to form covering 226, as shown in FIG. 6(a), and substantially as described above. Once the PET tubing covering 226 has been heat shrunk in the area of distal transition 254, for example, covering 226 may have one or more openings 227 forrned in the PET tubing, for example, to create an exit port 227 for the
I, 2, and 4, for example, do not include a distal transition. Such embodiments may result in a simpler manufacturing process, for example.) 1.0074) In the embodiment shown in FIG. 6(a), distal transition 254 may be substantially coaxial and/or concentric with main section 252, and is smaller in diameter than main section 252. In some embodiments, distal transition 254 may be formed by inserting a hypotube inside the end of thc proximal portion 250, the hypotube being of somewhat smaller diameter than the proximal portion 250. The hypotube distal transition 254 and the proximal portion may then be soldered together, as shown at 256. The distal sleeve 220, which may comprise a thin walled tube formed of a material such as polyimide, may then be bonded to the smaller diameter distal transition 254. Alternately, the distal sleeve 220 could be fomied from a flat wire wound microcoil with PET tubing heat shrunk over the mierocoil. An embodiment using a stainless steel mierocoil for the distal sleeve 220 might provide a lower coefficient of friction (than polyimidc, for example) to reduce the sliding friction. flowever, such a mierocoil embodiment would probably benefit from the use of a PET tubing covering 226 to provide reinforcement and/or a smooth surface.
PET
tubing may be used to form covering 226, as shown in FIG. 6(a), and substantially as described above. Once the PET tubing covering 226 has been heat shrunk in the area of distal transition 254, for example, covering 226 may have one or more openings 227 forrned in the PET tubing, for example, to create an exit port 227 for the
20 WO 2010/030882 PCTAIS2009/05666,1 guidewire 230, as shown. Note that, although only shown in FIG. 6(a), the embodiments shown in FIGS. 6(a), 6(b), and 6(c) may all include an optional covering 226 (e.g., PET tubing), according to certain embodiments of the invention.
100751 FIG. 6(b) shows an embodiment of the invention in which the longitudinal axis of distal transition 254 is offset radially some distance "R" from the longitudinal axis of main section 252 to provide a further potential reduction in the width of device 210, for example, to minimize the footprint of device 210 and allow the use of a relatively small guiding catheter. FIG. 6(c) shows an embodiment where the radial offset "R" is in an opposite direction from the offset R. shown in FIG. 6(b).
This arrangement may provide more clearance for guidewire 230 as it exits distal sleeve 220 in the area near distal transition 254.
100761 FIGS. 6(a) and 6(b) also illustrate techniques that may be employed to form the distal transition 254. For example, the distal transition 254 may bc formed by welding or soldering a tubular member to the main section 252 as shown at 256.
As shown, the tubular member 254 may extend into the end of main section 252, and may include a communication channel 260 (e.g., an extension of communication channel 260 within main section 252). Alternately, the distal transition 254 may be formed by "swaging a distal end of the main section 252, as shown at 256, "Swaging," as that term is used herein, encompasses a number of manufacturing processes that reduce the diameter of a workpiece, for example, by forcing the workpicce (or a portion thereof) through a confining die, or by hammering a round workpiece into a smaller diameter workpieee (e.g., rotary swaging or radial forging, for example).
100771 Other methods of forming the distal transition 254 may include grinding (e.g., to reduce the outer diameter of a single piece from that of main section 252 to that of distal transition 254), or the use of adhesives or glue (e.g., epoxy, ultraviolet adhesives, cyanoacrylates, etc.), or thermoforming, and/or other techniques known to those of ordinary skill in this area. FIGS. 6(d) and 6(6) show exemplary embodiments that may be fumed by grinding or other comparable techniques, for example.
Further, distal transition 254 need not extend into the main section 252 and could instead be held in an abutting relationship to main section 252 using certain of the aforementioned techniques.
100751 FIG. 6(b) shows an embodiment of the invention in which the longitudinal axis of distal transition 254 is offset radially some distance "R" from the longitudinal axis of main section 252 to provide a further potential reduction in the width of device 210, for example, to minimize the footprint of device 210 and allow the use of a relatively small guiding catheter. FIG. 6(c) shows an embodiment where the radial offset "R" is in an opposite direction from the offset R. shown in FIG. 6(b).
This arrangement may provide more clearance for guidewire 230 as it exits distal sleeve 220 in the area near distal transition 254.
100761 FIGS. 6(a) and 6(b) also illustrate techniques that may be employed to form the distal transition 254. For example, the distal transition 254 may bc formed by welding or soldering a tubular member to the main section 252 as shown at 256.
As shown, the tubular member 254 may extend into the end of main section 252, and may include a communication channel 260 (e.g., an extension of communication channel 260 within main section 252). Alternately, the distal transition 254 may be formed by "swaging a distal end of the main section 252, as shown at 256, "Swaging," as that term is used herein, encompasses a number of manufacturing processes that reduce the diameter of a workpiece, for example, by forcing the workpicce (or a portion thereof) through a confining die, or by hammering a round workpiece into a smaller diameter workpieee (e.g., rotary swaging or radial forging, for example).
100771 Other methods of forming the distal transition 254 may include grinding (e.g., to reduce the outer diameter of a single piece from that of main section 252 to that of distal transition 254), or the use of adhesives or glue (e.g., epoxy, ultraviolet adhesives, cyanoacrylates, etc.), or thermoforming, and/or other techniques known to those of ordinary skill in this area. FIGS. 6(d) and 6(6) show exemplary embodiments that may be fumed by grinding or other comparable techniques, for example.
Further, distal transition 254 need not extend into the main section 252 and could instead be held in an abutting relationship to main section 252 using certain of the aforementioned techniques.
21 WO 2010/030682 PCTILT82002t0$6644 100781 FIGS. 6(a) and 6(b) happen to show embodiments of the invention in which a distal transition 254 is employed to "setback" the main section 252 from the distal sleeve 220 a distance "S" as shown. This may, for example, be advantageous in creating additional "clearance" for the guidewire 230 as it exits the distal sleeve 220.
However, the setback is not a requirement, and embodiments of the invention may be employed with a zero setback, as shown in FIG. 6(c) (e.g., S,=0).
10079] FIG. 7(a) shows one possible embodiment of the invention in which a second sensor 242 is coupled to a proximal sleeve 280, which thereby allows the first and second sensors 240, 242 to be spaced apart a variable distance, 'V," as shown.
Proximal sleeve 280 in such an embodiment is adapted to be moved longitudinally (e.g., advanced and/or retracted) by an operator by sliding over proximal portion 250 to achieve the desired spacing, "V," as shown.
10080] FIG. 7(b) shows an alternate embodiment in which a multilumen shaft 290 (e.g., formed of a polymer) includes a guidewire lumen 292, a sensor lumen 294 for an extendible/retractable first sensor 240 disposed on a distal end of an extendible/retractable sensor shall 296, the sensor shaft 296 being slidabty received within sensor lumen 294, and a second sensor 242 coupled to an outer portion of the multilumen shaft 290. The first and second sensors 240, 242 may be spaced a variable distance apart (e.g., across a stenotic lesion of other anatomical location of interest in a patient) by slidably moving the sensor shaft 296 with respect to the multilurnen shaft 290 (c,g., by moving sensor shaft 296 within sensor lumen 294).
10081] FIG. 8 shows a device 210 according to an embodiment of the invention in which a proximal end of proximal portion 250 interconnects with a fiber optic furcation tube 290 (e.g., in embodiments of the invention employing a fiber optic sensor). A fiber optic furcation tube 290 provides an extension of thc fiber optic communication channel 260 (from the sensor 240 through the proximal portion 250), to an optional connector 294, such as an "SC fiber optic connector. (An SC
connector is a fiber optic connector with a push-pull latching mechanism which provides quick insertion and removal while also ensuring a positive connection. It also follows certain industry standards, allowing interconnection with a variety of fiber optic devices which follow the same standards.) Furcation tube 290 may, for example, be provided with SC connector 294 to allow the device 210 to send a signal
However, the setback is not a requirement, and embodiments of the invention may be employed with a zero setback, as shown in FIG. 6(c) (e.g., S,=0).
10079] FIG. 7(a) shows one possible embodiment of the invention in which a second sensor 242 is coupled to a proximal sleeve 280, which thereby allows the first and second sensors 240, 242 to be spaced apart a variable distance, 'V," as shown.
Proximal sleeve 280 in such an embodiment is adapted to be moved longitudinally (e.g., advanced and/or retracted) by an operator by sliding over proximal portion 250 to achieve the desired spacing, "V," as shown.
10080] FIG. 7(b) shows an alternate embodiment in which a multilumen shaft 290 (e.g., formed of a polymer) includes a guidewire lumen 292, a sensor lumen 294 for an extendible/retractable first sensor 240 disposed on a distal end of an extendible/retractable sensor shall 296, the sensor shaft 296 being slidabty received within sensor lumen 294, and a second sensor 242 coupled to an outer portion of the multilumen shaft 290. The first and second sensors 240, 242 may be spaced a variable distance apart (e.g., across a stenotic lesion of other anatomical location of interest in a patient) by slidably moving the sensor shaft 296 with respect to the multilurnen shaft 290 (c,g., by moving sensor shaft 296 within sensor lumen 294).
10081] FIG. 8 shows a device 210 according to an embodiment of the invention in which a proximal end of proximal portion 250 interconnects with a fiber optic furcation tube 290 (e.g., in embodiments of the invention employing a fiber optic sensor). A fiber optic furcation tube 290 provides an extension of thc fiber optic communication channel 260 (from the sensor 240 through the proximal portion 250), to an optional connector 294, such as an "SC fiber optic connector. (An SC
connector is a fiber optic connector with a push-pull latching mechanism which provides quick insertion and removal while also ensuring a positive connection. It also follows certain industry standards, allowing interconnection with a variety of fiber optic devices which follow the same standards.) Furcation tube 290 may, for example, be provided with SC connector 294 to allow the device 210 to send a signal
22 W02010/030882 PeT/VS3009/0$6664 from sensor 240, for example, to other devices, monitors, fluid injection devices, display and control units, etc. Fureation tube 290 may comprise a Kevtar fiber reinforced tube (e.g., for strength) according to some embodiments. In some alternate embodiments, furcation tube 290 could be formed of coaxial tubing.
100821 The length of fureation tube 290 may be chosen to extend from the device 210 in the sterile field (e.g., where the patient is) to a location outside of the patient, such as a medical fluid injector, or to a standalone display device, or to some other processing or computing equipment 296 positioned some distance from the patient.
The SC connector 294 is adapted to interconnect with an injector (or other signal processing unit) appropriately configured. If signal pmeessing is done within the injector, then the injector display could be utilized to display pressure waveforms and/or to calculate and display FFR values.
100831 An alternate embodiment of the invention would be to construct a distal portion 300 of the sensor delivery device 210 using a dual lumen configuration. An example of such an embodiment is illustrated in FIG. 9. One lumen of the distal portion 300 would accommodate the fiber optic communication channel 260 from the sensor 240 (and from sensor housing 270, in some embodiments). The other lumen (e.g., guidel,vire lumen 222) would be adapted to slide over the guidewire 230 as shown. The guidewire 230 in such an embodiment would exit from the dual lumen distal portion 300 a certain distance (e.g., about 10-12 inches) back from (e.g., proximal to) the sensor 240 through an opening 320 in the device 210. In some embodiments, a stiffening wire 310 could be placed in the remaining proximal portion of the lumen 222 (that is, the portion of the guidewire lumen 222 in the proximal portion 250 of device 210). The stiffness of the stiffening wire 310 could be varied, for example, to aid a physician in deploying and positioning the device 210 through a catheter and into a particular anatomical (e.g., vascular) structure of interest. The stiffening wire 310 could be part of the dual-lumen device 210, or could be an optional, removable item selected by a physician to obtain the desired amount of stiffness according to some embodiments.
100841 Another alternate embodiment of the invention would be an entirely over-the-wire (OTW) device, substantially us shown in FIG. 10. FIG. 10 illustrates an embodiment of the invention in which both the distal sleeve 220 and the proximal
100821 The length of fureation tube 290 may be chosen to extend from the device 210 in the sterile field (e.g., where the patient is) to a location outside of the patient, such as a medical fluid injector, or to a standalone display device, or to some other processing or computing equipment 296 positioned some distance from the patient.
The SC connector 294 is adapted to interconnect with an injector (or other signal processing unit) appropriately configured. If signal pmeessing is done within the injector, then the injector display could be utilized to display pressure waveforms and/or to calculate and display FFR values.
100831 An alternate embodiment of the invention would be to construct a distal portion 300 of the sensor delivery device 210 using a dual lumen configuration. An example of such an embodiment is illustrated in FIG. 9. One lumen of the distal portion 300 would accommodate the fiber optic communication channel 260 from the sensor 240 (and from sensor housing 270, in some embodiments). The other lumen (e.g., guidel,vire lumen 222) would be adapted to slide over the guidewire 230 as shown. The guidewire 230 in such an embodiment would exit from the dual lumen distal portion 300 a certain distance (e.g., about 10-12 inches) back from (e.g., proximal to) the sensor 240 through an opening 320 in the device 210. In some embodiments, a stiffening wire 310 could be placed in the remaining proximal portion of the lumen 222 (that is, the portion of the guidewire lumen 222 in the proximal portion 250 of device 210). The stiffness of the stiffening wire 310 could be varied, for example, to aid a physician in deploying and positioning the device 210 through a catheter and into a particular anatomical (e.g., vascular) structure of interest. The stiffening wire 310 could be part of the dual-lumen device 210, or could be an optional, removable item selected by a physician to obtain the desired amount of stiffness according to some embodiments.
100841 Another alternate embodiment of the invention would be an entirely over-the-wire (OTW) device, substantially us shown in FIG. 10. FIG. 10 illustrates an embodiment of the invention in which both the distal sleeve 220 and the proximal
23 portion 250 of sensor delivery device 210 are adapted to slide over a guidewire 230, The guidewire 230 in such an embodiment would not exit from or separate from the device 210 at some point along the length of device 210. Instead, the entire length of the proximal portion 250 of device 210 would slide over the guidewire 230 within a guiding catheter (not shown). The design of the device =may incorporate two different sizes of tubes, for example, to form the distal sleeve 220 and proximal portion 250.
For example, a smaller diameter thin-walled tube could fonn the distal sleeve 220, where the sensor 240 resides (optionally, within a sensor housing 270) Back some distance from the location of sensor 240 on the distal sleeve 220, the smaller diameter tube of the distal sleeve 220 would transition into a larger diameter portion (e.g., proximal portion 250), with sufficient clearance between the inner wall of both tubes and the guidewire. Such clearance may provide less friction and sliding resistance while positioning the sensor 240, for example. The larger diameter tube of the proximal portion 250 could be made, for example, from a material with u low coefficient of friction to lower the sliding force. The sensor 240 (and sensor housing 270, where applicable) could be of similar construction to that described above with respect to FIGS. 5(a) ¨ 5(d).
100851 FIG. 10 is an example of an embodiment of the invention that illustrates the over-the-wire concept. The larger diameter tubing of the proximal portion 250 could be formed of a, single lumen tube or a dual lumen tube. With a single lumen tube, the communication channel 260 (e.g., fiber optic) could be disposed on an outer surface of the proximal portion 250, for example, and could extend toward a connector at a proximal end of the device 210. In embodiments with a dual lumen tube forming the proximal portion 250, the communication channel 260 could extend toward a connector at a proxirnal end of the device 210 within the second lumen. This could, for example, provide added protection for the communication channel 260 (e.g., fiber optic).
100861 FIG. I I is a flow diagram showing a method of using a sensor delivery device according to certain embodiments of the invention. In a preferred embodiment of the invention, for example, the method may be used to assess thc severity of a stenotie lesion in a patient's vasculature. Step 1105 comprises placing a guidewire in a patient to a location of interest. in some embodiments, this may be a diagnostic guidewire,
For example, a smaller diameter thin-walled tube could fonn the distal sleeve 220, where the sensor 240 resides (optionally, within a sensor housing 270) Back some distance from the location of sensor 240 on the distal sleeve 220, the smaller diameter tube of the distal sleeve 220 would transition into a larger diameter portion (e.g., proximal portion 250), with sufficient clearance between the inner wall of both tubes and the guidewire. Such clearance may provide less friction and sliding resistance while positioning the sensor 240, for example. The larger diameter tube of the proximal portion 250 could be made, for example, from a material with u low coefficient of friction to lower the sliding force. The sensor 240 (and sensor housing 270, where applicable) could be of similar construction to that described above with respect to FIGS. 5(a) ¨ 5(d).
100851 FIG. 10 is an example of an embodiment of the invention that illustrates the over-the-wire concept. The larger diameter tubing of the proximal portion 250 could be formed of a, single lumen tube or a dual lumen tube. With a single lumen tube, the communication channel 260 (e.g., fiber optic) could be disposed on an outer surface of the proximal portion 250, for example, and could extend toward a connector at a proximal end of the device 210. In embodiments with a dual lumen tube forming the proximal portion 250, the communication channel 260 could extend toward a connector at a proxirnal end of the device 210 within the second lumen. This could, for example, provide added protection for the communication channel 260 (e.g., fiber optic).
100861 FIG. I I is a flow diagram showing a method of using a sensor delivery device according to certain embodiments of the invention. In a preferred embodiment of the invention, for example, the method may be used to assess thc severity of a stenotie lesion in a patient's vasculature. Step 1105 comprises placing a guidewire in a patient to a location of interest. in some embodiments, this may be a diagnostic guidewire,
24 and a guiding catheter may also be inserted into the patient in conjunction with the guidewire. Step 1110 comprises deploying a sensor delivery device over the guidewire such that the sensor is positioned downstream of the location of interest (e.g., downstream of a stenotic lesion). In some embodiments, the sensor delivery device will have a sensor mounted to a distal sleeve that slides over the guidewire, and a proximal portion that is used to advance the distal sleeve over the guidewire without having to move the guidewire. Step I 115 comprises using the sensor of the sensor delivery device to rneasure a physiological parameter of interest at the location of interest. In some embodiments, the physiological parameter is blood pressure downstream of a stenotic lesion, Pd. Step 1120 comprises measuring a reference value of the physiological parameter of interest. In some embodiments, this step comprises measuring blood pressure upstream of a stenotic lesion, P. This could be done, for example, with a separate blood pressure monitoring apparatus, according to some embodiments, or could bc done by repositioning the sensor &lively device to a location upstream of the stenotic lesion and making a second pressure measurement with the sensor of the device. Step 1125 may be an optional step which comprises comparing the physiological parameter of interest measured at the location of interest to the reference value measured in step 1120. In some embodiments, this may comprise calculating a ratio of the two measured VaitICS. In one preferred embodiment of the invention, step 1125 comprises calculating FFR as the ratio of downstream to upstream blood pressures, Pd/ P. Step 1130 may be an optional step which comprises providing an indication of the result obtained in step 1125.
For example, step 1130 may comprise providing a visual indication of the calculated FFR
value, or may provide other visual cues (e.g., providing a color-coded indication of the severity of a stenotic lesion, such as a red indicator for FFR values less than 0.75, and a green indicator for FFR values equal to or greater than 0.75, as possible examples).
[00871 It may be desirable, as mentioned above with respect to FIG. 8, to have the sensor delivery device 210 interact with other devices and/or display equipment. For example, a fureation tube 290 and a connector 294 may be used to send the signal (e.g., the measured physiological parameter signal) from sensor NO to processing device 296. Processing device 296 could be, for example, a standalone display monitor to show signal waveforms and/or numerical values of the physiological
For example, step 1130 may comprise providing a visual indication of the calculated FFR
value, or may provide other visual cues (e.g., providing a color-coded indication of the severity of a stenotic lesion, such as a red indicator for FFR values less than 0.75, and a green indicator for FFR values equal to or greater than 0.75, as possible examples).
[00871 It may be desirable, as mentioned above with respect to FIG. 8, to have the sensor delivery device 210 interact with other devices and/or display equipment. For example, a fureation tube 290 and a connector 294 may be used to send the signal (e.g., the measured physiological parameter signal) from sensor NO to processing device 296. Processing device 296 could be, for example, a standalone display monitor to show signal waveforms and/or numerical values of the physiological
25 WO 2010/030$82 PerUS-2000/056664 parameter signal from sensor 240. Processing device 296 could include data recording capabilities in some embodiments. In certain preferred embodiments of the invention, processing device 296 could comprise a medical fluid injection system, such as a powered fluid injector used to inject contrast media and/or saline during certain imaging procedures (e.g., angiography, computed tomography, MRT, ultrasound, ctc.). FIGS. 12 and 13 illustrate exemplary powered injection systems which may be used with a sensor delivery device according to various embodiments oldie invention.
[00881 FIG. 12 is a perspective view of one embodiment of a powered injection system 1200 that may be used to perform various functions and, when operable, may be coupled to a physiological sensor delivery device, such as the various embodiments of a sensor delivery, device described above. 'fhc powered injection systern 1200 shown in FIG, 12 may be used to inject medical fluid, such as contrast media or saline, into a patient within the sterile field during a medical procedure (such as during an angiographic or CI procedure). A physiological sensor delivery device may be coupled to the system 1200 and used within the sterile field during a patient procedure, according to one embodiment. The system 1200 includes various components, such as a control panel 1202, a hand-controller connection 1204, a hand controller 1212, a fluid reservoir 1206, tubing 1208, a pump 1210, a pressure transducer 1218, a fluid reservoir 1214, an injection syringe 1216, high pressure injection tubing 1222, a valve 1220, an air detector 1224, and a stopcock 1226. In one embodiment, described in more detail below, the fluid reservoir 1206 comprises a container such as, for example, a bag or bottle of diluent (such as saline), thc fluid reservoir 1214 comprises a container such as, for example, a bag or bottle of contrast media, and thc pump 1210 comprises a peristaltic pump. In other embodiments, the pump 1210 may comprise other forms of pumping devices, such as a syringe, a gear pump, or other form of displacement pump. In some embodiments, the injection syringe 1216 (along with its associated plunger), which is a pumping device, may be replaced with another form of pumping device that delivers high-pressure fluid injections to a patient. An individual pumping device is capable of operating or functioning in different, or multiple, operational modes. For example, a pumping device may be operable to pump fluid when actuated, or driven, to move in a first
[00881 FIG. 12 is a perspective view of one embodiment of a powered injection system 1200 that may be used to perform various functions and, when operable, may be coupled to a physiological sensor delivery device, such as the various embodiments of a sensor delivery, device described above. 'fhc powered injection systern 1200 shown in FIG, 12 may be used to inject medical fluid, such as contrast media or saline, into a patient within the sterile field during a medical procedure (such as during an angiographic or CI procedure). A physiological sensor delivery device may be coupled to the system 1200 and used within the sterile field during a patient procedure, according to one embodiment. The system 1200 includes various components, such as a control panel 1202, a hand-controller connection 1204, a hand controller 1212, a fluid reservoir 1206, tubing 1208, a pump 1210, a pressure transducer 1218, a fluid reservoir 1214, an injection syringe 1216, high pressure injection tubing 1222, a valve 1220, an air detector 1224, and a stopcock 1226. In one embodiment, described in more detail below, the fluid reservoir 1206 comprises a container such as, for example, a bag or bottle of diluent (such as saline), thc fluid reservoir 1214 comprises a container such as, for example, a bag or bottle of contrast media, and thc pump 1210 comprises a peristaltic pump. In other embodiments, the pump 1210 may comprise other forms of pumping devices, such as a syringe, a gear pump, or other form of displacement pump. In some embodiments, the injection syringe 1216 (along with its associated plunger), which is a pumping device, may be replaced with another form of pumping device that delivers high-pressure fluid injections to a patient. An individual pumping device is capable of operating or functioning in different, or multiple, operational modes. For example, a pumping device may be operable to pump fluid when actuated, or driven, to move in a first
26 direction (e.g., forward), while it may also be operable to move in a second direction (e.g., an opposite direction, backward) to carry out certain functions.
10089] 'rho system 1200 of HQ. 12 also shows a hand controller 1212 und an air detector 1224. An operator tnay use the hand controller 1212 to manually control injection of saline and/or contrast media. The operator may push a first buttott (not shown) on the hand control 1212 to inject saline, and may push a second button (not shown) to inject contrast, for example. In one embodiment, the operator may push on the contrast button to deliver contrast at a variable flow rate. The harder the operator pushes on the button, the greater the flow rate of contrast media delivered to the patient. Other controllers, such as foot pedal controllers, may also be used.
The air detector 1224 is able to detect potential air bubbles or columns within the high-pressure tubing 1222. In one embodiment, the air detector 1224 is an ultrasonic or acoustic-based detector. In other embodiments, the air detector 1224 may use infrared or other detection means (such as optical). If the air detector 1224 detects the presence of air in the high-pressure tubing 1222, it generates a signal that is used to warn the operator andior halt an injection procedure.
[00901 An operator may use the control panel 1202 to view and/or select various parameters and/or protocols to be used during a given procedure. The control panel 1202 may be used to display information to an operator about the status of the equipment and/or the patient. The pump 1210 may be used to pump saline from the bag into the patient via the saline tubing 1208, the valve 1220, and the high-pressure tubing 1222. In one embodiment, the valve 1220 comprises a spring-based spool valve, as is known in the art. In one embodiment, the valve 1220 comprises an elastornerie-based valve.
[00911 In one embodiment, the syringe 1216 is used to draw contrast from the reservoir 1214 into the syringe 1216, and to inject contrast from the syringe 1216 into the patient via the valve 1220 and high-pressure tubing 1222. In one embodiment, the syringe 1216 is a self-purging syringe that has one port for filling of contrast and purging of air, and a second port for injection of contrast.
[00921 The valve 1220 may be used to control coupling between input ports to the valve 1220 and an output port. In one embodiment, the valve includes two input ports, WO 2010/030882 PCT/US2009105666.1 one which is coupled to the contrast fluid line and another which is coupled to the saline fluid line. The saline fluid line also includes a pressure transducer 1218 for providing a signal representative of patient blood pressure, for example.
100931 The stopcock 1226 regulates the flow of fluids to the patient. In one embodiment, the valve 1220 allows either the saline line or the contrast line to be coupled to the patient (high-pressure tubing) line 1222. When the syringe 1216 is used to inject contrast media, for example, the valve 1220 may allow the contrast media to flow to the patient line 1222 while blocking the flow of saline to the patient line 1222.
Valve 1220 may operate such that the pressure transducer 1218 may also be blocked or isolated from the patient line 1222 during high-pressure injections, for example, to protect the transducer 1218 from high injection pressures that may accompany a contrast injection. When there is no injection of contrast from the syringe 1216, the valve 1220 may operate to block the contrast line from the patient line 1222, while opening the fluid connection between the saline line (tubing) 1208 and the patient line 1222. In this state, the pump 1210 is capable of injecting saline into the patient, and the pressure transducer 1218 is also capable of monitoring hemodynamic signals coming from the patient via the patient line 1222 and generating representative signals based upon the measured pressures.
f 0094j As noted above, the system 1200 of Fla 12 may bc adapted to be coupled to a physiological sensor delivery device according to certain embodiments of the invention. System 1200 may, for example, be adapted to receive the physiological signal generated by the sensor 240 of device 210. In embodiments where the physiological signal from device 210 is a pressure signal measured downstream of a stenotie lesion (e.g., Pd"), system 1200 may facilitate calculation of FFR, for example, since Pp may already be provided by pressure transducer 1218 of system 1200. A
visual or graphical display of the calculated FFR value could be presented to an operator via control panel 1202, for example. Since instantaneous values of Pi, and Pd are available in such an arrangement, the timing effects and associated errors noted above with respect to FIG. 3 would not pose a problem - simultaneous measurement of Pp and Pd would reduce or eliminate such errors. In addition, time averaging or other signal processing could be employed by system 1200 to produce mathematical variants of the FFR calculation (e.g., mean, max, min, etc.). Alternately, a time-varying display or plot of the calculated FFR value could be displayed as a waveform (e.g., as a function of time).
100951 FIG. 13 is a perspective view of another embodiment of a powered injection system 1300 that may be used to perform various functions and, when operable, may be coupled to a physiological sensor delivery device, such as the embodiments described above. The powered injection system 1300 shown in FIG. 13 may be used to inject medical fluid, such as contrast media or saline, into a patient within the sterile field during a medical procedure (such as during an angiographic or cr procedure). A physiological sensor delivery device may be coupled to the system 1300 and used within the sterile field during a patient procedure, according to one embodiment.
100961 The system 1300 of FIG. 13 is a dual-syringe system that includes a control panel 1302 and two motor/actuator assemblies 1303a and 1303b. Each motor drives one of the linear actuators in the assemblies 1303a, 1303b. Each linear actuator drives a plunger done syringe 1308a or 1308b. An individual plunger moves within the syringe barrel of thc syringe 1308a or 1308b in either a forward or rearward direction.
When moving in it forward direction, the plunger injects liquid into the patient line or purges air out of the syringe and into a liquid container (e.g., bottle). When moving in a rearward direction, the plunger fills liquid into the syringe 1308a, 1308b from a liquid container. Fla 13 shows examples of two such liquid containers 1304 and 1306. in one embodiment, the container 1304 is a bag or bottle containing contrast agent, and the container 1306 is a bag or bottle containing diluent, such as saline. In other embodiments, the syringes 1308a, 13808b (along with associated plungers), which are each pumping devices, may either separately or together comprise another form of pumping device that is capable of injecting fluids at appropriate flow rates/pressures/etc. , such as, for example, a peristaltic pump or another form of displacement pump. An individual pumping device is capable of operating or .functioning in different, or multiple, operational modes. For example, a pumping device may be operable to pump fluid when actuated, or driven, to move in a first direction (e.g., forward), while it may also be operable to move in a second direction (e.g., an opposite direction, backward) to carry out certain functions.
Multiple sets of pinch valve/air detect assemblies are shown both FIG. 13. One pinch valve/air detect assembly 1310a is coupled between the liquid container 1306 and a syringe input port of the syringe 1308a, and a second pinch valve/air detect assembly 1312a is coupled between a syringe output port of the syringe 1308a and the patient connection.
A third pinch valve/air detect assembly 1310b is coupled between the liquid container and a syringe input port of the syringe I 308b, and a fourth pinch valve/air detect assembly I312b is coupled betvvecn a syringe output port of the syringe 1308b and thc patient connection. In the embodiment shown in FIG. 13, each syringe I308a, 1308b is a dual-port syringe. Fluid flows and is drawn into the syringe 1308a or 1308b from a container via the syringe input port, and fluid flows out of and is injected from the syringe 1308a or 1308b via the syringe output port.
100971 Each pinch valve is a pinch valve/air detect assembly 1310a, I310b, 1312a, 1312b may be opened or closed by the system 1300 to control the fluid connections leading to or away from each of the syringes 1308a, 1308b. The air detect sensors in the assemblies 1310a, 1310b, 1312a, 1312b may be optical, acoustic, or other form of sensor. These sensors help detect air that may be present in the fluid connections leading to or away from the syringes 1308a, 1308b. When one or more of these sensors generates a signal indicating that air may be present in a fluid line, the system 1300 may Warn the user or terminate an injection procedure. The use of multiple pinch valves within the system 1300 allows the system 1300 automatically, or through user interaction, selectively control the flow of fluid into or out of the syringes 1308a, I 308b by opening or closing fluid tubing. In one embodiment, the system 1300 controls each of the pinch valves. The use of multiple air-detect sensors helps improve the overall safety of the system 1300 by detecting possibly air (e.g., columns, bubbles) within fluid (in the tubing) leading to or away from the syringes 1308a, 1308b. Signals from the air detectors are sent to and processed by the system 1300, such that the system 1300 may, for example, provide a warning, or terminate an injection procedure, if air is detected. In the example of FIG. 13, the fluid tubing first flows through a pinch valve and then flows through an air detector within the assemblies 1310a, 1310b, 1312a, I312b. In other embodiments, other configurations, ordering, and the like may be used for the pinch valves and air detectors within these assemblies. Moreover, other types of valves may be substituted for the pinch valves.
WO 2010/0.308102 PCINS2009/036664 00981 An operator may use the control panel 1302 to initialize, or setup, the injection system 1300 for one or more injection procedures, and may further use the control panel 1302 to configure one or more parameters (e.g., flow rate, volume of fluid to be delivered, pressure limit, rise time) of an individual injection procedure.
The operator may also use the panel 1302 to pause, resume, or end an injection procedure and begin a new procedure. The control panel also displays various injection-related information to the operator, such as flow rate, volume, pressure, rise time, procedure type, fluid information, and patient inforrnation. In one embodiment, the control panel 1302 may be connected to a patient table, while being electrically coupled to the main injector of the system 1300. In this embodiment, the operator may manually move the control panel 1302 to a desirable location, while still having access to all functionality provided by the panel I 302.
100991 The system of FIG. 13 also includes a valve 1314 coupled to both output lines coming from the syringes 1308a and 1308b. Each syringe output provides fluid injectcd through tubing that passes through a pinch valve/air detect assembly 1312a or 1312b and that then leads to an input of the valve 1314. In one embodiment, one fluid line to the valve 1314 also includes a pressure transducer. The valve output port of the valve 13 14 is coupled to high-pressure tubing line, which is used to direct fluid to the patient. In one embodiment, the valve 1314 is made of a flexible material, such as an elastomerie material. The valve 1314 allows one of the fluid lines (e.g., the contrast line or the saline line) to be coupled to the patient (high-pressure tubing) line. When saline and contrast arc contained within the syringes 1308a and 1308b, respectively, the valve 1314 allows the contrast media to flow from the syringe 1308b to the patient line (assuming the pinch valve in the assembly 1312b is open and ihere has been no ttir detected), but blocks the flow of saline from the syringe I308a to the patient linc.
The pressure transducer coupled to the saline line (according to one embodiment) is also blocked from the patient line, thereby protecting the transducer from high injection pressures that may accompany a contrast injection. When there is no injection of contrast from the syringe 1308b, the valve 1314 blocks the contrast line from the patient line, but allows a connection between the saline line from the syringe 1306 to thc patient line. The syringe 1308a is capable of injecting saline into the patient (assuming the pinch valve in the assembly l 312a is open and there has been no air detected), and the pressure transducer is also capable of monitoring hemodynamic signals corning from the patient via the patient line, and generating representative electronic signals based upon the measured pressures that can be processed by the system 1300.
1001001 In one embodiment, a secondary control panel (not shown) pinvides subset of functions provided by the main panel 1302. This secondary control panel (also referred to herein as the "small" control panel) may be coupled to the injector within the system 1300. In one scenario, the operator may use the small panel to manage injector setup. The small panel may display guided setup instructions that aid in this process. The small panel may also display certain error and troubleshooting information to assist the operator. For example, the small panel may warn the operator of low contrast or saline fluid levels in the liquid reservoirs and/or syringes.
1001011 As with the system 1200 of FIG. 12, system 1300 of FIG. 13 may be adapted to be coupled to a physiological sensor delivery device according to certain embodiments of the invention. System 1300 may, for example, be adapted to receive the physiological signal generated by the sensor 240 of device 210. Processing of thc physiological signaî from sensor 240 (and/or from additional sensors of the sensor delivery device 210, if applicable) may be performed within the injection system 1200 or 1300, for example. Signal conditioning and/or processing may, for example, be performed by a circuit board or card that may be an add-on feature to system 1200 or 1300. Such a signal conditioning board or card may process a ="raw " signal from sensor 240 and convert the signal into a standard analog and/or digital signal, which can be used by processors of the injector system, according to some embodiments.
The processed signal may enable injector system 1200 or 1300 to display the signal data (e.g., as pressure waveforms), and/or perform algorithms and/or calculations and display the results.
1001021 In embodiments where the physiological signal from device 210 is a pressure signal measured downstream of a stenotic lesion (e.g., Pa), system 1300 may facilitate calculation of FFR, for example, since PI, is already provided by the pressure transducer of system 1300. A visual or graphical display of the calculated FFR
value, for example, could be presented to an operator via control panel 1302, for example, or via a small control panel (not shown) having a subset of the functions provided by control panel 1302. Since instantaneous values of Pp and Pd are available in such an arrangement, the timing effects noted above with respect to FIG. 3 would not pose a problem. In addition, time averaging or other signal processing could bc employed by system 1300 to produce mathematical variants of the FFR calculation (e.g., mean, max, min, etc.).
[001031 FIG. 14 is a flow diagram of a method that rnay be performed according to one embodiment of the invention. The methods described herein may be perforrned in varying degrees of automation, for example, by having instructions stored in a computer-readable mediurn and/or performed by a computer or processor associated with a powered injection system (such as the ones described above with respect to FIGS. 12 and 13, or other comparable fluid injection systems). The method of FIG. 14 may, for example, be used to assess the severity of a fluid flow restriction in a patient according to some embodiments of the invention. This method may be performed using various powered injection systems, such as the system 1200 shown in FIG. 12, or the system 1300 shown in FIG. 13. The ordering of the actions shown in FIG. 14 is for exemplary purposes only. In one embodiment, a powered injection system may be capable of performing some of the steps of the method shown in FIG.
14 automatically, or alternately, after the operator has requested that the method be commenced through manual activation on the control panel (or secondary panel, if available).
[001041 Step 1405 in FIG. 14 comprises placing a guidewire in a patient to a location of interest, such as a stenotic lesion, or across a heart valve, for example. In some embodiments, this may be a diagnostic guidewire, and a guiding catheter may also be inserted into the patient in conjunction with the guidewire. Step 1410 comprises deploying a sensor delivery device over the guidewire such that the sensor is positioned upstream of the location of interest (e.g., upstream of a stenotic lesion, or on the high pressure side of a valve). In some embodiments, the sensor delivery device will have a sensor mounted to a distal sleeve that slides over the guidewire, and a proximal portion that is used by an operator to advance the distal sleeve over the guidewire to the desired location without having to move the guidewire. Step comprises using the sensor of the sensor delivery device to measure a value of the physiological parameter upstream of the location of interest. In some embodiments, the physiological parameter is blood pressure, and the pressure measured by the sensor upstream of a stenotic lesion is the proximal pressure, Pp.
1001051 Step 1420 in FIG. 14 comprises "normalizing" the Pp measurement made in step 1415 to the Pp measurement obtained from an independent source.
"Normalizing" the Pp measurement refers to the fact that an independent source (e.g., a fluid sensor for monitoring patient blood pressure during a procedure) will be used to obtain the Pp value that will be used for later comparisons or calculations with the Pd value (e.g., the downstream pressure) measured with the sensor of the sensor delivery device. The normalizing step basically ensures that the Pp value measured with the sensor equals the Pp value measured using the independent source so that no error is introduced (or that any error is minimized) when a subsequent downstream pressure measurement (e.g., Pd) is made. An adjustment, if needed, could be made to either Pp value, although it may often be simpler to adjust the sensor-based Pp value to match the independent source's Pp value.
1001061 Step 1425 comprises deploying the sensor delivery device over the guidewire such that the sensor is downstream of the location of interest (e.g., downstream of the stenotic lesion). Step 1430 comprises using the sensor of the sensor delivery device to measure a downstream value of the physiological parameter.
In some embodiments, this step comprises measuring blood pressure downstream of the stenotic lesion, P. Step 1435 comprises comparing the measured value downstream of the location of interest (e.g., Pd, downstream blood pressure) to a value measured upstream of the location of interest using the independent source (e.g., P).
In some embodiments, the comparison made in step 1435 may comprise calculating a ratio of the two measured values. In one preferred embodiment of the invention, step 1435 comprises calculating FFR as the ratio of downstream to upstream blood pressures, Pd/ P. Step 1440, which may be an optional step, comprises providing an indication of the result of the comparison made in step 1435. For example, step 1440 may comprise providing an indication of thc calculated FFR value (e.g., numerical or graphical display or plot), and/or other cues may be provided to an operator.
A color-coded indication of the severity of a stenotic lesion may be provided, for example, a RED indicator for FFR values less than 0.75, and/or a GREEN indicator for FFR
values equal to or greater than 0.75. Other examples of indicators are possible, WO 2010/03002 periuS2009/056664 including non-visual indicators ¨ an audible indication, an alarm sound for example, could alert an operator of an FFR value that is less than 0.75, which may prompt the operator to make a therapy decision.
1001071 FIG. 15 is a flow diagram of a method that may be performed according to an embodiment of the invention. The method of FIG. 15 may, for example, be used to assess the severity of a fluid flow restriction in a patient according to some embodiments of the invention. The method of FIG. 15 employs a sensor &lively device 210 having a first and second sensor 240, 242, such as the devices 210 shown in FIGS. 2 and 7. This method may also be performed in conjunction with various powered injection systems, such as the system 1200 shown in FIG, 12, or thc system 1300 shown in FIG. 13. The ordering of thc actions shown in FIG. 15 is for exemplary purposes only.
1001081 Step 1505 in FIG. 15 comprises placing a guidewire in a patient to a location of interest, such as a stenotic lesion, or across a heart valve, for example. In some embodiments, thc guidewire may bc a diagnostic guidewire, and a guiding catheter may also be inserted into the patient in conjunction with the guidewire. Step 1510 comprises deploying a sensor delivery device over the guidewire such that a first sensor of the sensor delivery device is positioned upstream of the location of interest, and a second sensor of the sensor delivery device is positioned downstream of the location of interest. In an embodiment such as that described above with respect to FIG. 7, an optional step may next be performed wherein a proximal sleeve 280 is moved by an operator relative to the rest of device 210 in order to vary the distance, V, between first sensor 240 and second sensor 242. la an embodiment such as that described above with respect to FIG. 2, it should be noted that more than two sensors could be mounted along device 210, and that the spacing between adjacent sensors could vary as well, according to some embodiments oldie invention. Step 1515 comprises using the first sensor to measure an upstream value of the physiological parameter, and using the second sensor to measure a downstream value of the physiological parameter.
001091 Step 1535 comprises comparing the measured value downstream of the location of interest (e.g., Pd, downstream blood pressure) to the value measured upstream of the location of interest (e.g., Pp). In some embodiments, the comparison WO 2010/030882 PC1111S2009/05666.1 made in step 1535 may comprise calculating a ratio of the two measured values.
In one preferred embodiment of the invention, step l 535 comprises calculating FFR as the ratio of downstream to upstream blood pressures, Pd/ Pp. Step 1540, which may be an optional step, comprises providing an indication of the result of the comparison made in step 1535. For example, step 1540 may comprise providing an indication of the calculated FFR value (e.g., numerical or graphical display or plot), andlor other cues may be provided to an operator. A color-coded indication of the severity of a stenotic lesion may be provided, for example, a RED indicator for FFR values less than 0.75, andior a GREEN indicator for FFR values equal to or greater than 0.75.
Other examples of indicators are possible, including non-visual indicators ¨
an audible indication, an alarm sound for example, could alert an operator of an FFR
value that is less than 0.75, which may prompt the operator to make a therapy decision.
1001101 Although not shown in FIGS. 11, 14, and 15, any of these methods could be performed with an embodiment of device 210 having flow holes 224, such as the device of FIGS_ 4(a) and 4(b). Using such a device, the methods may optionally include a step wherein an operator retracts the guidewire 230 to allow fluid flow (e.g., blood flow) through flow holes 224 into the guidewire lumen 222 of the distal sleeve 220. Performing this optional step prior to measuring downstream pressure, Pd, may reduce the amount of flow restriction caused by the device 210 itself, and may thereby reduce the measurement error.
1001111 In some embodiments, a method may include basing a therapy decision on the calculated FFR value, e.g., if the calculated FFR is less than 0.75, an interventional therapy is recommended and/or performed. In some embodiments, an interventional therapy device may be deployed by withdrawing sensor delivery device 210, and using the same guidewirc 230 to deploy the interventional therapy device.
100n21 FIG. 16 is a perspective view of a powered injection system adapted to be coupled to a physiological sensor delivery device according to certain embodiments of the invention. FIG. 16 shows a sensor delivery device 210 connected to a powered injection system 1630 via furcation tube 290 and connector 294.
Injection system 1630 is adapted to receive a physiological measurement signal (e.g., blood pressure) from device 210 via input port 1650. In preferred embodiments, the signal is an optical signal, and connector 294 is an SC fiber optic connector adapted to mate with port 1650 to receive thc optical signal.
[00113) As shown in FIG. 16, system1630 has 2 fluid containers 1632, 1634, which are adapted to deliver fluid through lines 1633 and 1635. Fluid in line (e.g., contrast solution) may be delivered at significantly higher pressures than fluid in line 1635 (e.g., saline solution), for example. Valve 1620 may be used to control coupling between input ports to the valve 1620 and to an output port which ultimately leads to a patient via patient line 1622. In one embodiment, valve 1620 includes two input ports, one which is coupled to a contrast fluid line 1633 and another which is coupled to a saline fluid line 1635. The saline fluid line is also coupled to a pressure transducer 1618 for providing a signal representative of patient blood pressure, for example. The signal from pressure transducer 1618 may be communicated to system 1630 via communication path 1640 and connector 1642, or via other equivalent means (e.g., infrared, optical, etc.).
[001141 In one embodiment, the valve 1620 allows either the saline line or the contrast line to be coupled to the patient (high-pressure tubing) line 1622.
When the system 1630 is injecting contrast media, for example, the valve 1620 may allow the contrast media to flow to the patient line 1622 while blocking the flow of saline to the patient line 1622. Valve 1620 may operate such that the pressure transducer 1618 may also be blocked or isolated from the patient line 1622 during high-pressure injections, for example, to protect the transducer 1618 from high injection pressures that may accompany a contrast injection. When there is no injection of contrast from the system 1630, the valve 1620 may operate to block the contrast line from the patient line 1622, while opening the fluid connection between the saline line (tubing) and the patient line 1622. In this state, the system 1630 may be capable of injecting saline into the patient, while the pressure transducer 1618 is capable of monitoring hemodynarnic signals coming from the patient via the patient line 1622, and generating representative signals based upon the measured pressures.
[001.1 51 FIG. 16 shows control panel 1602 connected to injection system 1630 via communication path 1660. An operator may interact with system 1630 via control panel 1602 (or via a secondary panel, if available) to review and/or modify injection parameters, for example. In a preferred embodiment of the invention, system 1630 is adapted to receive pressure signals simultaneously from pressure transducer 16) 8 and from device 210, representative of downstream and upstream pressures (e.g., Pd, Fp), respectively. Thus, in a preferred embodiment, system 1630 receives Pd and Pp signals substantially simultaneously, compares the two signals (e.g., calculates FFR
Pd Pi,), and provides an indication of the result of the comparison to an operator via a display screen 1670 of control panel 1602. As noted above, the indication attic result of the comparison may take a number of different forms, including numerical, graphical, time plots, etc. The indication may be of the pass/fail variety, for example, indicating one color-coded pattern (e.g., a RED icon) for an FFR value below a certain value (e.g., 0.75), and/or a different color-coded pattern (e.g., a GREEN icon) for an FFR value at or above a certain value (e.g., 0.75). The indication may also be an audible alarrn according to some embodiments of the invention, 1001161 FIG. 17 is an idealized view of information that may be displayed (e.g., via an interactive graphical user interface, or "GUI interface") to an operator, according to certain embodiments of the invention. FIG. 17 shows a GUI screen that may be displayed either via a control panel that is unique to the sensor delivery device 210, or via a control panel of a device adapted for use with device 210, such as the powered fluid injection systems described above with respect to FIGS. 12, 13, and 16.
(The GUI interface could be implemented in software such that a user might see a very similar screen regardless of whether a stand-alone display device or an integrated injector system was being used, according to various embodiments of the invention.) 1001171 In FIG. 17, screen 1702 is adapted to display data in various forms (e.g., waveform data, numerical data, calculated values, patient information, device status information, etc.). For example, in a preferred embodiment of the invention useful for making FFR measurements, blood pressure waveforms may be displayed as a function of time for both proximal pressure, Pp(t) 1704, and distal pressure, Pd(t) 1706. In some embodiments, systolic and diastolic blood pressure measurements may be superimposed on the time plot for the proximal (e.g., aortic) pressure waveform, as shown at 1708 and 1710, respectively, and/or may be calculated as average values and displayed substantially as shown at 1712. Similarly, average values for proximal pressure 1704 and distal pressure 1706 may be calculated (e.g., these could be time-weighted averages, moving averages, etc.) and displayed as shown at 1714 and 1716, WO 20taiuJuan EICTAIR,00010$4664 respectively. A calculation of FFR based on proximal pressure 1704 and distal pressure 1706 may also be calculated and displayed as shown at 1718, for example (e.g.. FFR equals Pp/Pd, and the values used for Pe and Pd could be averages or other forms of statistical or numerical representation), according to some embodiments of the invention. Further, some embodiments may include a feature to alert an operator to an FFR value that lies outside of a normal range (e.g., less than 0.75) to indicate, for example, that some other action should be taken (e.g., select and perform an interventional therapy). This could be a visual cue (such as a colored light., as shown at 1720), or could be an audible cue (such as an alarm sound, for example).
j001181 The screen 1702 of FIG. 17 shows various additional features which may be (optionally or alternately) incorporated in various embodiments. Status area 1722, for example, may provide information about the patient, date/time, the site within a particular patient, the status of the sensor, and an indication of whether the sensor signal has been "normalized" to another pressure monitoring signal. A
normalization button 1724 may be included in some embodiments, and could be used, for example, to normalize the pressure signal from a sensor of sensor delivery device 210. Normalization might be done during a procedure in which an FFR
measurement is desired (e.g., to assess the severity of a stenos's). When a sensor of sensor delivery device 210 is positioned upstream of the stenosis, the measured pressure using the sensor should be equal to the proximal pressure measured using normal blood pressure monitoring equipment (e.g., via the pressure transducer 1618 of the injection system shown in FIG. 16, for example). In one embodiment, an operator would position the sensor 240 of sensor delivery device 210 upstream of a location of interest and press the normalization button 1724 of screen 1702, which could then automatically adjust or calibrate the pressure signal from sensor 240 to match the proximal pressure measured using normal blood pressure monitoring equipment.
001191 The screen 1702 of FIG. 17 may also include navigational features, in some embodiments, which may allow an operator to view and record information that may be of interest. For example, a cursor button 1726 may allow an operator to position a marker or cursor 1727 to a point of interest on the waveforms 1704, 1706, which could provide instantaneous measured values of P(t) 1704 and Pa(t) 1706 at a selected point in time. In some embodiments, an operator may elect to save the cursored data by pressing a "save" button 1728, which could save the highlighted data for review at a later point in time. A review button 1730 may bc provided for this purpose in some embodiments, allowing a user to compare previous historical measurements to current ones and use this information to make diagnostic and therapeutic decisions. In some embodiments, it may be desirable to include a `µzoom"
feature, for example, to analyze the data. For example, an operator may wish to zoom in (e.g., via the + arrow of zoom 1732) to look more closely at certain data, or may instead wish to zoom out (e.g., via the ¨ arrow of zoom 1732) to evaluate overall trends, for example.
1001201 A Physiological Sensor Delivery Device has been described in connection with exemplary embodiments and exemplary preferred embodiments and implementations, as examples only. It will bc understood by those having ordinary skill in the pertinent art that modifications to any of the embodiments or preferred embodiments may be easily made without materially departing from the scope of the appended claims.
10089] 'rho system 1200 of HQ. 12 also shows a hand controller 1212 und an air detector 1224. An operator tnay use the hand controller 1212 to manually control injection of saline and/or contrast media. The operator may push a first buttott (not shown) on the hand control 1212 to inject saline, and may push a second button (not shown) to inject contrast, for example. In one embodiment, the operator may push on the contrast button to deliver contrast at a variable flow rate. The harder the operator pushes on the button, the greater the flow rate of contrast media delivered to the patient. Other controllers, such as foot pedal controllers, may also be used.
The air detector 1224 is able to detect potential air bubbles or columns within the high-pressure tubing 1222. In one embodiment, the air detector 1224 is an ultrasonic or acoustic-based detector. In other embodiments, the air detector 1224 may use infrared or other detection means (such as optical). If the air detector 1224 detects the presence of air in the high-pressure tubing 1222, it generates a signal that is used to warn the operator andior halt an injection procedure.
[00901 An operator may use the control panel 1202 to view and/or select various parameters and/or protocols to be used during a given procedure. The control panel 1202 may be used to display information to an operator about the status of the equipment and/or the patient. The pump 1210 may be used to pump saline from the bag into the patient via the saline tubing 1208, the valve 1220, and the high-pressure tubing 1222. In one embodiment, the valve 1220 comprises a spring-based spool valve, as is known in the art. In one embodiment, the valve 1220 comprises an elastornerie-based valve.
[00911 In one embodiment, the syringe 1216 is used to draw contrast from the reservoir 1214 into the syringe 1216, and to inject contrast from the syringe 1216 into the patient via the valve 1220 and high-pressure tubing 1222. In one embodiment, the syringe 1216 is a self-purging syringe that has one port for filling of contrast and purging of air, and a second port for injection of contrast.
[00921 The valve 1220 may be used to control coupling between input ports to the valve 1220 and an output port. In one embodiment, the valve includes two input ports, WO 2010/030882 PCT/US2009105666.1 one which is coupled to the contrast fluid line and another which is coupled to the saline fluid line. The saline fluid line also includes a pressure transducer 1218 for providing a signal representative of patient blood pressure, for example.
100931 The stopcock 1226 regulates the flow of fluids to the patient. In one embodiment, the valve 1220 allows either the saline line or the contrast line to be coupled to the patient (high-pressure tubing) line 1222. When the syringe 1216 is used to inject contrast media, for example, the valve 1220 may allow the contrast media to flow to the patient line 1222 while blocking the flow of saline to the patient line 1222.
Valve 1220 may operate such that the pressure transducer 1218 may also be blocked or isolated from the patient line 1222 during high-pressure injections, for example, to protect the transducer 1218 from high injection pressures that may accompany a contrast injection. When there is no injection of contrast from the syringe 1216, the valve 1220 may operate to block the contrast line from the patient line 1222, while opening the fluid connection between the saline line (tubing) 1208 and the patient line 1222. In this state, the pump 1210 is capable of injecting saline into the patient, and the pressure transducer 1218 is also capable of monitoring hemodynamic signals coming from the patient via the patient line 1222 and generating representative signals based upon the measured pressures.
f 0094j As noted above, the system 1200 of Fla 12 may bc adapted to be coupled to a physiological sensor delivery device according to certain embodiments of the invention. System 1200 may, for example, be adapted to receive the physiological signal generated by the sensor 240 of device 210. In embodiments where the physiological signal from device 210 is a pressure signal measured downstream of a stenotie lesion (e.g., Pd"), system 1200 may facilitate calculation of FFR, for example, since Pp may already be provided by pressure transducer 1218 of system 1200. A
visual or graphical display of the calculated FFR value could be presented to an operator via control panel 1202, for example. Since instantaneous values of Pi, and Pd are available in such an arrangement, the timing effects and associated errors noted above with respect to FIG. 3 would not pose a problem - simultaneous measurement of Pp and Pd would reduce or eliminate such errors. In addition, time averaging or other signal processing could be employed by system 1200 to produce mathematical variants of the FFR calculation (e.g., mean, max, min, etc.). Alternately, a time-varying display or plot of the calculated FFR value could be displayed as a waveform (e.g., as a function of time).
100951 FIG. 13 is a perspective view of another embodiment of a powered injection system 1300 that may be used to perform various functions and, when operable, may be coupled to a physiological sensor delivery device, such as the embodiments described above. The powered injection system 1300 shown in FIG. 13 may be used to inject medical fluid, such as contrast media or saline, into a patient within the sterile field during a medical procedure (such as during an angiographic or cr procedure). A physiological sensor delivery device may be coupled to the system 1300 and used within the sterile field during a patient procedure, according to one embodiment.
100961 The system 1300 of FIG. 13 is a dual-syringe system that includes a control panel 1302 and two motor/actuator assemblies 1303a and 1303b. Each motor drives one of the linear actuators in the assemblies 1303a, 1303b. Each linear actuator drives a plunger done syringe 1308a or 1308b. An individual plunger moves within the syringe barrel of thc syringe 1308a or 1308b in either a forward or rearward direction.
When moving in it forward direction, the plunger injects liquid into the patient line or purges air out of the syringe and into a liquid container (e.g., bottle). When moving in a rearward direction, the plunger fills liquid into the syringe 1308a, 1308b from a liquid container. Fla 13 shows examples of two such liquid containers 1304 and 1306. in one embodiment, the container 1304 is a bag or bottle containing contrast agent, and the container 1306 is a bag or bottle containing diluent, such as saline. In other embodiments, the syringes 1308a, 13808b (along with associated plungers), which are each pumping devices, may either separately or together comprise another form of pumping device that is capable of injecting fluids at appropriate flow rates/pressures/etc. , such as, for example, a peristaltic pump or another form of displacement pump. An individual pumping device is capable of operating or .functioning in different, or multiple, operational modes. For example, a pumping device may be operable to pump fluid when actuated, or driven, to move in a first direction (e.g., forward), while it may also be operable to move in a second direction (e.g., an opposite direction, backward) to carry out certain functions.
Multiple sets of pinch valve/air detect assemblies are shown both FIG. 13. One pinch valve/air detect assembly 1310a is coupled between the liquid container 1306 and a syringe input port of the syringe 1308a, and a second pinch valve/air detect assembly 1312a is coupled between a syringe output port of the syringe 1308a and the patient connection.
A third pinch valve/air detect assembly 1310b is coupled between the liquid container and a syringe input port of the syringe I 308b, and a fourth pinch valve/air detect assembly I312b is coupled betvvecn a syringe output port of the syringe 1308b and thc patient connection. In the embodiment shown in FIG. 13, each syringe I308a, 1308b is a dual-port syringe. Fluid flows and is drawn into the syringe 1308a or 1308b from a container via the syringe input port, and fluid flows out of and is injected from the syringe 1308a or 1308b via the syringe output port.
100971 Each pinch valve is a pinch valve/air detect assembly 1310a, I310b, 1312a, 1312b may be opened or closed by the system 1300 to control the fluid connections leading to or away from each of the syringes 1308a, 1308b. The air detect sensors in the assemblies 1310a, 1310b, 1312a, 1312b may be optical, acoustic, or other form of sensor. These sensors help detect air that may be present in the fluid connections leading to or away from the syringes 1308a, 1308b. When one or more of these sensors generates a signal indicating that air may be present in a fluid line, the system 1300 may Warn the user or terminate an injection procedure. The use of multiple pinch valves within the system 1300 allows the system 1300 automatically, or through user interaction, selectively control the flow of fluid into or out of the syringes 1308a, I 308b by opening or closing fluid tubing. In one embodiment, the system 1300 controls each of the pinch valves. The use of multiple air-detect sensors helps improve the overall safety of the system 1300 by detecting possibly air (e.g., columns, bubbles) within fluid (in the tubing) leading to or away from the syringes 1308a, 1308b. Signals from the air detectors are sent to and processed by the system 1300, such that the system 1300 may, for example, provide a warning, or terminate an injection procedure, if air is detected. In the example of FIG. 13, the fluid tubing first flows through a pinch valve and then flows through an air detector within the assemblies 1310a, 1310b, 1312a, I312b. In other embodiments, other configurations, ordering, and the like may be used for the pinch valves and air detectors within these assemblies. Moreover, other types of valves may be substituted for the pinch valves.
WO 2010/0.308102 PCINS2009/036664 00981 An operator may use the control panel 1302 to initialize, or setup, the injection system 1300 for one or more injection procedures, and may further use the control panel 1302 to configure one or more parameters (e.g., flow rate, volume of fluid to be delivered, pressure limit, rise time) of an individual injection procedure.
The operator may also use the panel 1302 to pause, resume, or end an injection procedure and begin a new procedure. The control panel also displays various injection-related information to the operator, such as flow rate, volume, pressure, rise time, procedure type, fluid information, and patient inforrnation. In one embodiment, the control panel 1302 may be connected to a patient table, while being electrically coupled to the main injector of the system 1300. In this embodiment, the operator may manually move the control panel 1302 to a desirable location, while still having access to all functionality provided by the panel I 302.
100991 The system of FIG. 13 also includes a valve 1314 coupled to both output lines coming from the syringes 1308a and 1308b. Each syringe output provides fluid injectcd through tubing that passes through a pinch valve/air detect assembly 1312a or 1312b and that then leads to an input of the valve 1314. In one embodiment, one fluid line to the valve 1314 also includes a pressure transducer. The valve output port of the valve 13 14 is coupled to high-pressure tubing line, which is used to direct fluid to the patient. In one embodiment, the valve 1314 is made of a flexible material, such as an elastomerie material. The valve 1314 allows one of the fluid lines (e.g., the contrast line or the saline line) to be coupled to the patient (high-pressure tubing) line. When saline and contrast arc contained within the syringes 1308a and 1308b, respectively, the valve 1314 allows the contrast media to flow from the syringe 1308b to the patient line (assuming the pinch valve in the assembly 1312b is open and ihere has been no ttir detected), but blocks the flow of saline from the syringe I308a to the patient linc.
The pressure transducer coupled to the saline line (according to one embodiment) is also blocked from the patient line, thereby protecting the transducer from high injection pressures that may accompany a contrast injection. When there is no injection of contrast from the syringe 1308b, the valve 1314 blocks the contrast line from the patient line, but allows a connection between the saline line from the syringe 1306 to thc patient line. The syringe 1308a is capable of injecting saline into the patient (assuming the pinch valve in the assembly l 312a is open and there has been no air detected), and the pressure transducer is also capable of monitoring hemodynamic signals corning from the patient via the patient line, and generating representative electronic signals based upon the measured pressures that can be processed by the system 1300.
1001001 In one embodiment, a secondary control panel (not shown) pinvides subset of functions provided by the main panel 1302. This secondary control panel (also referred to herein as the "small" control panel) may be coupled to the injector within the system 1300. In one scenario, the operator may use the small panel to manage injector setup. The small panel may display guided setup instructions that aid in this process. The small panel may also display certain error and troubleshooting information to assist the operator. For example, the small panel may warn the operator of low contrast or saline fluid levels in the liquid reservoirs and/or syringes.
1001011 As with the system 1200 of FIG. 12, system 1300 of FIG. 13 may be adapted to be coupled to a physiological sensor delivery device according to certain embodiments of the invention. System 1300 may, for example, be adapted to receive the physiological signal generated by the sensor 240 of device 210. Processing of thc physiological signaî from sensor 240 (and/or from additional sensors of the sensor delivery device 210, if applicable) may be performed within the injection system 1200 or 1300, for example. Signal conditioning and/or processing may, for example, be performed by a circuit board or card that may be an add-on feature to system 1200 or 1300. Such a signal conditioning board or card may process a ="raw " signal from sensor 240 and convert the signal into a standard analog and/or digital signal, which can be used by processors of the injector system, according to some embodiments.
The processed signal may enable injector system 1200 or 1300 to display the signal data (e.g., as pressure waveforms), and/or perform algorithms and/or calculations and display the results.
1001021 In embodiments where the physiological signal from device 210 is a pressure signal measured downstream of a stenotic lesion (e.g., Pa), system 1300 may facilitate calculation of FFR, for example, since PI, is already provided by the pressure transducer of system 1300. A visual or graphical display of the calculated FFR
value, for example, could be presented to an operator via control panel 1302, for example, or via a small control panel (not shown) having a subset of the functions provided by control panel 1302. Since instantaneous values of Pp and Pd are available in such an arrangement, the timing effects noted above with respect to FIG. 3 would not pose a problem. In addition, time averaging or other signal processing could bc employed by system 1300 to produce mathematical variants of the FFR calculation (e.g., mean, max, min, etc.).
[001031 FIG. 14 is a flow diagram of a method that rnay be performed according to one embodiment of the invention. The methods described herein may be perforrned in varying degrees of automation, for example, by having instructions stored in a computer-readable mediurn and/or performed by a computer or processor associated with a powered injection system (such as the ones described above with respect to FIGS. 12 and 13, or other comparable fluid injection systems). The method of FIG. 14 may, for example, be used to assess the severity of a fluid flow restriction in a patient according to some embodiments of the invention. This method may be performed using various powered injection systems, such as the system 1200 shown in FIG. 12, or the system 1300 shown in FIG. 13. The ordering of the actions shown in FIG. 14 is for exemplary purposes only. In one embodiment, a powered injection system may be capable of performing some of the steps of the method shown in FIG.
14 automatically, or alternately, after the operator has requested that the method be commenced through manual activation on the control panel (or secondary panel, if available).
[001041 Step 1405 in FIG. 14 comprises placing a guidewire in a patient to a location of interest, such as a stenotic lesion, or across a heart valve, for example. In some embodiments, this may be a diagnostic guidewire, and a guiding catheter may also be inserted into the patient in conjunction with the guidewire. Step 1410 comprises deploying a sensor delivery device over the guidewire such that the sensor is positioned upstream of the location of interest (e.g., upstream of a stenotic lesion, or on the high pressure side of a valve). In some embodiments, the sensor delivery device will have a sensor mounted to a distal sleeve that slides over the guidewire, and a proximal portion that is used by an operator to advance the distal sleeve over the guidewire to the desired location without having to move the guidewire. Step comprises using the sensor of the sensor delivery device to measure a value of the physiological parameter upstream of the location of interest. In some embodiments, the physiological parameter is blood pressure, and the pressure measured by the sensor upstream of a stenotic lesion is the proximal pressure, Pp.
1001051 Step 1420 in FIG. 14 comprises "normalizing" the Pp measurement made in step 1415 to the Pp measurement obtained from an independent source.
"Normalizing" the Pp measurement refers to the fact that an independent source (e.g., a fluid sensor for monitoring patient blood pressure during a procedure) will be used to obtain the Pp value that will be used for later comparisons or calculations with the Pd value (e.g., the downstream pressure) measured with the sensor of the sensor delivery device. The normalizing step basically ensures that the Pp value measured with the sensor equals the Pp value measured using the independent source so that no error is introduced (or that any error is minimized) when a subsequent downstream pressure measurement (e.g., Pd) is made. An adjustment, if needed, could be made to either Pp value, although it may often be simpler to adjust the sensor-based Pp value to match the independent source's Pp value.
1001061 Step 1425 comprises deploying the sensor delivery device over the guidewire such that the sensor is downstream of the location of interest (e.g., downstream of the stenotic lesion). Step 1430 comprises using the sensor of the sensor delivery device to measure a downstream value of the physiological parameter.
In some embodiments, this step comprises measuring blood pressure downstream of the stenotic lesion, P. Step 1435 comprises comparing the measured value downstream of the location of interest (e.g., Pd, downstream blood pressure) to a value measured upstream of the location of interest using the independent source (e.g., P).
In some embodiments, the comparison made in step 1435 may comprise calculating a ratio of the two measured values. In one preferred embodiment of the invention, step 1435 comprises calculating FFR as the ratio of downstream to upstream blood pressures, Pd/ P. Step 1440, which may be an optional step, comprises providing an indication of the result of the comparison made in step 1435. For example, step 1440 may comprise providing an indication of thc calculated FFR value (e.g., numerical or graphical display or plot), and/or other cues may be provided to an operator.
A color-coded indication of the severity of a stenotic lesion may be provided, for example, a RED indicator for FFR values less than 0.75, and/or a GREEN indicator for FFR
values equal to or greater than 0.75. Other examples of indicators are possible, WO 2010/03002 periuS2009/056664 including non-visual indicators ¨ an audible indication, an alarm sound for example, could alert an operator of an FFR value that is less than 0.75, which may prompt the operator to make a therapy decision.
1001071 FIG. 15 is a flow diagram of a method that may be performed according to an embodiment of the invention. The method of FIG. 15 may, for example, be used to assess the severity of a fluid flow restriction in a patient according to some embodiments of the invention. The method of FIG. 15 employs a sensor &lively device 210 having a first and second sensor 240, 242, such as the devices 210 shown in FIGS. 2 and 7. This method may also be performed in conjunction with various powered injection systems, such as the system 1200 shown in FIG, 12, or thc system 1300 shown in FIG. 13. The ordering of thc actions shown in FIG. 15 is for exemplary purposes only.
1001081 Step 1505 in FIG. 15 comprises placing a guidewire in a patient to a location of interest, such as a stenotic lesion, or across a heart valve, for example. In some embodiments, thc guidewire may bc a diagnostic guidewire, and a guiding catheter may also be inserted into the patient in conjunction with the guidewire. Step 1510 comprises deploying a sensor delivery device over the guidewire such that a first sensor of the sensor delivery device is positioned upstream of the location of interest, and a second sensor of the sensor delivery device is positioned downstream of the location of interest. In an embodiment such as that described above with respect to FIG. 7, an optional step may next be performed wherein a proximal sleeve 280 is moved by an operator relative to the rest of device 210 in order to vary the distance, V, between first sensor 240 and second sensor 242. la an embodiment such as that described above with respect to FIG. 2, it should be noted that more than two sensors could be mounted along device 210, and that the spacing between adjacent sensors could vary as well, according to some embodiments oldie invention. Step 1515 comprises using the first sensor to measure an upstream value of the physiological parameter, and using the second sensor to measure a downstream value of the physiological parameter.
001091 Step 1535 comprises comparing the measured value downstream of the location of interest (e.g., Pd, downstream blood pressure) to the value measured upstream of the location of interest (e.g., Pp). In some embodiments, the comparison WO 2010/030882 PC1111S2009/05666.1 made in step 1535 may comprise calculating a ratio of the two measured values.
In one preferred embodiment of the invention, step l 535 comprises calculating FFR as the ratio of downstream to upstream blood pressures, Pd/ Pp. Step 1540, which may be an optional step, comprises providing an indication of the result of the comparison made in step 1535. For example, step 1540 may comprise providing an indication of the calculated FFR value (e.g., numerical or graphical display or plot), andlor other cues may be provided to an operator. A color-coded indication of the severity of a stenotic lesion may be provided, for example, a RED indicator for FFR values less than 0.75, andior a GREEN indicator for FFR values equal to or greater than 0.75.
Other examples of indicators are possible, including non-visual indicators ¨
an audible indication, an alarm sound for example, could alert an operator of an FFR
value that is less than 0.75, which may prompt the operator to make a therapy decision.
1001101 Although not shown in FIGS. 11, 14, and 15, any of these methods could be performed with an embodiment of device 210 having flow holes 224, such as the device of FIGS_ 4(a) and 4(b). Using such a device, the methods may optionally include a step wherein an operator retracts the guidewire 230 to allow fluid flow (e.g., blood flow) through flow holes 224 into the guidewire lumen 222 of the distal sleeve 220. Performing this optional step prior to measuring downstream pressure, Pd, may reduce the amount of flow restriction caused by the device 210 itself, and may thereby reduce the measurement error.
1001111 In some embodiments, a method may include basing a therapy decision on the calculated FFR value, e.g., if the calculated FFR is less than 0.75, an interventional therapy is recommended and/or performed. In some embodiments, an interventional therapy device may be deployed by withdrawing sensor delivery device 210, and using the same guidewirc 230 to deploy the interventional therapy device.
100n21 FIG. 16 is a perspective view of a powered injection system adapted to be coupled to a physiological sensor delivery device according to certain embodiments of the invention. FIG. 16 shows a sensor delivery device 210 connected to a powered injection system 1630 via furcation tube 290 and connector 294.
Injection system 1630 is adapted to receive a physiological measurement signal (e.g., blood pressure) from device 210 via input port 1650. In preferred embodiments, the signal is an optical signal, and connector 294 is an SC fiber optic connector adapted to mate with port 1650 to receive thc optical signal.
[00113) As shown in FIG. 16, system1630 has 2 fluid containers 1632, 1634, which are adapted to deliver fluid through lines 1633 and 1635. Fluid in line (e.g., contrast solution) may be delivered at significantly higher pressures than fluid in line 1635 (e.g., saline solution), for example. Valve 1620 may be used to control coupling between input ports to the valve 1620 and to an output port which ultimately leads to a patient via patient line 1622. In one embodiment, valve 1620 includes two input ports, one which is coupled to a contrast fluid line 1633 and another which is coupled to a saline fluid line 1635. The saline fluid line is also coupled to a pressure transducer 1618 for providing a signal representative of patient blood pressure, for example. The signal from pressure transducer 1618 may be communicated to system 1630 via communication path 1640 and connector 1642, or via other equivalent means (e.g., infrared, optical, etc.).
[001141 In one embodiment, the valve 1620 allows either the saline line or the contrast line to be coupled to the patient (high-pressure tubing) line 1622.
When the system 1630 is injecting contrast media, for example, the valve 1620 may allow the contrast media to flow to the patient line 1622 while blocking the flow of saline to the patient line 1622. Valve 1620 may operate such that the pressure transducer 1618 may also be blocked or isolated from the patient line 1622 during high-pressure injections, for example, to protect the transducer 1618 from high injection pressures that may accompany a contrast injection. When there is no injection of contrast from the system 1630, the valve 1620 may operate to block the contrast line from the patient line 1622, while opening the fluid connection between the saline line (tubing) and the patient line 1622. In this state, the system 1630 may be capable of injecting saline into the patient, while the pressure transducer 1618 is capable of monitoring hemodynarnic signals coming from the patient via the patient line 1622, and generating representative signals based upon the measured pressures.
[001.1 51 FIG. 16 shows control panel 1602 connected to injection system 1630 via communication path 1660. An operator may interact with system 1630 via control panel 1602 (or via a secondary panel, if available) to review and/or modify injection parameters, for example. In a preferred embodiment of the invention, system 1630 is adapted to receive pressure signals simultaneously from pressure transducer 16) 8 and from device 210, representative of downstream and upstream pressures (e.g., Pd, Fp), respectively. Thus, in a preferred embodiment, system 1630 receives Pd and Pp signals substantially simultaneously, compares the two signals (e.g., calculates FFR
Pd Pi,), and provides an indication of the result of the comparison to an operator via a display screen 1670 of control panel 1602. As noted above, the indication attic result of the comparison may take a number of different forms, including numerical, graphical, time plots, etc. The indication may be of the pass/fail variety, for example, indicating one color-coded pattern (e.g., a RED icon) for an FFR value below a certain value (e.g., 0.75), and/or a different color-coded pattern (e.g., a GREEN icon) for an FFR value at or above a certain value (e.g., 0.75). The indication may also be an audible alarrn according to some embodiments of the invention, 1001161 FIG. 17 is an idealized view of information that may be displayed (e.g., via an interactive graphical user interface, or "GUI interface") to an operator, according to certain embodiments of the invention. FIG. 17 shows a GUI screen that may be displayed either via a control panel that is unique to the sensor delivery device 210, or via a control panel of a device adapted for use with device 210, such as the powered fluid injection systems described above with respect to FIGS. 12, 13, and 16.
(The GUI interface could be implemented in software such that a user might see a very similar screen regardless of whether a stand-alone display device or an integrated injector system was being used, according to various embodiments of the invention.) 1001171 In FIG. 17, screen 1702 is adapted to display data in various forms (e.g., waveform data, numerical data, calculated values, patient information, device status information, etc.). For example, in a preferred embodiment of the invention useful for making FFR measurements, blood pressure waveforms may be displayed as a function of time for both proximal pressure, Pp(t) 1704, and distal pressure, Pd(t) 1706. In some embodiments, systolic and diastolic blood pressure measurements may be superimposed on the time plot for the proximal (e.g., aortic) pressure waveform, as shown at 1708 and 1710, respectively, and/or may be calculated as average values and displayed substantially as shown at 1712. Similarly, average values for proximal pressure 1704 and distal pressure 1706 may be calculated (e.g., these could be time-weighted averages, moving averages, etc.) and displayed as shown at 1714 and 1716, WO 20taiuJuan EICTAIR,00010$4664 respectively. A calculation of FFR based on proximal pressure 1704 and distal pressure 1706 may also be calculated and displayed as shown at 1718, for example (e.g.. FFR equals Pp/Pd, and the values used for Pe and Pd could be averages or other forms of statistical or numerical representation), according to some embodiments of the invention. Further, some embodiments may include a feature to alert an operator to an FFR value that lies outside of a normal range (e.g., less than 0.75) to indicate, for example, that some other action should be taken (e.g., select and perform an interventional therapy). This could be a visual cue (such as a colored light., as shown at 1720), or could be an audible cue (such as an alarm sound, for example).
j001181 The screen 1702 of FIG. 17 shows various additional features which may be (optionally or alternately) incorporated in various embodiments. Status area 1722, for example, may provide information about the patient, date/time, the site within a particular patient, the status of the sensor, and an indication of whether the sensor signal has been "normalized" to another pressure monitoring signal. A
normalization button 1724 may be included in some embodiments, and could be used, for example, to normalize the pressure signal from a sensor of sensor delivery device 210. Normalization might be done during a procedure in which an FFR
measurement is desired (e.g., to assess the severity of a stenos's). When a sensor of sensor delivery device 210 is positioned upstream of the stenosis, the measured pressure using the sensor should be equal to the proximal pressure measured using normal blood pressure monitoring equipment (e.g., via the pressure transducer 1618 of the injection system shown in FIG. 16, for example). In one embodiment, an operator would position the sensor 240 of sensor delivery device 210 upstream of a location of interest and press the normalization button 1724 of screen 1702, which could then automatically adjust or calibrate the pressure signal from sensor 240 to match the proximal pressure measured using normal blood pressure monitoring equipment.
001191 The screen 1702 of FIG. 17 may also include navigational features, in some embodiments, which may allow an operator to view and record information that may be of interest. For example, a cursor button 1726 may allow an operator to position a marker or cursor 1727 to a point of interest on the waveforms 1704, 1706, which could provide instantaneous measured values of P(t) 1704 and Pa(t) 1706 at a selected point in time. In some embodiments, an operator may elect to save the cursored data by pressing a "save" button 1728, which could save the highlighted data for review at a later point in time. A review button 1730 may bc provided for this purpose in some embodiments, allowing a user to compare previous historical measurements to current ones and use this information to make diagnostic and therapeutic decisions. In some embodiments, it may be desirable to include a `µzoom"
feature, for example, to analyze the data. For example, an operator may wish to zoom in (e.g., via the + arrow of zoom 1732) to look more closely at certain data, or may instead wish to zoom out (e.g., via the ¨ arrow of zoom 1732) to evaluate overall trends, for example.
1001201 A Physiological Sensor Delivery Device has been described in connection with exemplary embodiments and exemplary preferred embodiments and implementations, as examples only. It will bc understood by those having ordinary skill in the pertinent art that modifications to any of the embodiments or preferred embodiments may be easily made without materially departing from the scope of the appended claims.
Claims (20)
PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. A method of determining Fractional Flow Reserve (FFR) in a patient, the method comprising:
measuring, with a hemodynamic transducer or a sensor coupled to an intravascular sensor delivery device, a first blood pressure upstream of a location of interest in the patient during a phase of a cardiac cycle, measuring, with the sensor, , a second blood pressure downstream of a location of interest in the patient in substantially the same phase of the cardiac cycle in which the first blood pressure was measured, and calculating, with a processor, FFR as a ratio of the first blood pressure to the second blood pressure, wherein the intravascular sensor delivery device comprises a distal sleeve having a guidewire lumen configured to slide over and receive a separate medical guidewire, a proximal portion extending proximally from the distal sleeve, and a communication channel configured to communicate a signal from the sensor to a location outside of the patient.
measuring, with a hemodynamic transducer or a sensor coupled to an intravascular sensor delivery device, a first blood pressure upstream of a location of interest in the patient during a phase of a cardiac cycle, measuring, with the sensor, , a second blood pressure downstream of a location of interest in the patient in substantially the same phase of the cardiac cycle in which the first blood pressure was measured, and calculating, with a processor, FFR as a ratio of the first blood pressure to the second blood pressure, wherein the intravascular sensor delivery device comprises a distal sleeve having a guidewire lumen configured to slide over and receive a separate medical guidewire, a proximal portion extending proximally from the distal sleeve, and a communication channel configured to communicate a signal from the sensor to a location outside of the patient.
2. The method of claim 1, wherein the first blood pressure is measured with the hemodynamic transducer.
3. The method of claim 1, wherein the first blood pressure is measured with the sensor.
4. The method of claim 1, wherein the sensor is carried by the distal sleeve.
5. The method of claim 1, wherein the sensor is carried by the proximal portion.
6. The method of claim 1, wherein sensor comprises a first sensor and a second sensor, the first blood pressure is measured by the first sensor so as to generate a first signal and the second blood pressure is measured by a second sensor so as to generate a second signal.
7. The method of claim 6, wherein the first sensor is carried by the distal sleeve and the second sensor is carried by the proximal portion.
8. The method of claim 6, wherein the second sensor is mounted a fixed distance from the first sensor.
9. The method of claim 1, further including providing a fluid injector system having the processor, the processor adapted to receive a first signal representative of the first blood pressure and a second signal representative of the second blood pressure and calculate the FFR based on the first and second signal.
10. The method of claim 1, wherein the first blood pressure and second blood pressure are measured substantially simultaneously.
11. A fluid injection system comprising:
fluid tubing adapted to provide fluid communication between the injection system and a patient;
a control panel; and a processor;
wherein the processor is adapted to receive:
a) a first signal representative of a first blood pressure measured upstream of a location of interest in the patient during a phase of a cardiac cycle, the first signal being generated by a hemodynamic transducer in select fluid communication with the fluid tubing or a sensor coupled to an intravascular sensor delivery device, and b) a second signal representative of a second blood pressure measured downstream of a location of interest in the patient in substantially the same phase of the cardiac cycle as the first signal, the second signal being generated by the sensor, wherein the control panel is adapted to display information derived from the first and second signals, and wherein the intravascular sensor delivery device comprises a distal sleeve having a guidewire lumen configured to slide over and receive a separate medical guidewire, a proximal portion extending proximally from the distal sleeve, and a communication channel configured to communicate a signal from the sensor to a location outside of the patient.
fluid tubing adapted to provide fluid communication between the injection system and a patient;
a control panel; and a processor;
wherein the processor is adapted to receive:
a) a first signal representative of a first blood pressure measured upstream of a location of interest in the patient during a phase of a cardiac cycle, the first signal being generated by a hemodynamic transducer in select fluid communication with the fluid tubing or a sensor coupled to an intravascular sensor delivery device, and b) a second signal representative of a second blood pressure measured downstream of a location of interest in the patient in substantially the same phase of the cardiac cycle as the first signal, the second signal being generated by the sensor, wherein the control panel is adapted to display information derived from the first and second signals, and wherein the intravascular sensor delivery device comprises a distal sleeve having a guidewire lumen configured to slide over and receive a separate medical guidewire, a proximal portion extending proximally from the distal sleeve, and a communication channel configured to communicate a signal from the sensor to a location outside of the patient.
12. The system of claim 11, wherein the processor is adapted to calculate fractional flow reserve (FFR) based on a ratio of the first signal to the second signal, and wherein the control panel is adapted to display information related to the calculated FFR.
13. The system of claim12, wherein the control panel provides an indication of whether the FFR is below a threshold value.
14. The system of claim13, wherein the threshold value is about 0.75.
15. The system of claim11, wherein the hemodynamic transducer generates the first signal in response to a fluid pressure signal communicated through the fluid tubing.
16. The system of claim11, wherein the first blood pressure and the second blood pressure are measured substantially simultaneously.
17. The method of claim 1, wherein the proximal portion comprises a main section and a distal transition, the distal transition extending distally from the main section and being fixedly coupled to an outer surface of the distal sleeve.
18. The method of claim17, wherein the distal transition has a smaller cross-sectional area than the main section.
19. The system of claim 11, wherein the proximal portion comprises a main section and a distal transition, the distal transition extending distally from the main section and being fixedly coupled to an outer surface of the distal sleeve.
20. The system of claim 19, wherein the distal transition has a smaller cross-sectional area than the main section.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2939764A CA2939764C (en) | 2008-09-11 | 2009-09-11 | Physiological sensor delivery device and method |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9621608P | 2008-09-11 | 2008-09-11 | |
US61/096,216 | 2008-09-11 | ||
CA2762123A CA2762123C (en) | 2008-09-11 | 2009-09-11 | Physiological sensor delivery device and method |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2762123A Division CA2762123C (en) | 2008-09-11 | 2009-09-11 | Physiological sensor delivery device and method |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2939764A Division CA2939764C (en) | 2008-09-11 | 2009-09-11 | Physiological sensor delivery device and method |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2803747A1 CA2803747A1 (en) | 2010-03-18 |
CA2803747C true CA2803747C (en) | 2016-10-25 |
Family
ID=42005495
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2734698A Active CA2734698C (en) | 2008-09-11 | 2009-09-11 | Physiological sensor delivery device and method |
CA2762123A Active CA2762123C (en) | 2008-09-11 | 2009-09-11 | Physiological sensor delivery device and method |
CA2939764A Active CA2939764C (en) | 2008-09-11 | 2009-09-11 | Physiological sensor delivery device and method |
CA2803747A Active CA2803747C (en) | 2008-09-11 | 2009-09-11 | Physiological sensor delivery device and method |
Family Applications Before (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2734698A Active CA2734698C (en) | 2008-09-11 | 2009-09-11 | Physiological sensor delivery device and method |
CA2762123A Active CA2762123C (en) | 2008-09-11 | 2009-09-11 | Physiological sensor delivery device and method |
CA2939764A Active CA2939764C (en) | 2008-09-11 | 2009-09-11 | Physiological sensor delivery device and method |
Country Status (13)
Country | Link |
---|---|
US (12) | US8298156B2 (en) |
EP (1) | EP2334227B1 (en) |
JP (2) | JP5746969B2 (en) |
KR (2) | KR101754570B1 (en) |
CN (1) | CN102202562B (en) |
AU (3) | AU2009291623B2 (en) |
BR (1) | BRPI0918563B8 (en) |
CA (4) | CA2734698C (en) |
ES (1) | ES2913941T3 (en) |
IL (2) | IL211659A (en) |
PL (1) | PL2334227T3 (en) |
RU (1) | RU2478338C2 (en) |
WO (1) | WO2010030882A1 (en) |
Families Citing this family (258)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9867530B2 (en) | 2006-08-14 | 2018-01-16 | Volcano Corporation | Telescopic side port catheter device with imaging system and method for accessing side branch occlusions |
US9596993B2 (en) | 2007-07-12 | 2017-03-21 | Volcano Corporation | Automatic calibration systems and methods of use |
WO2009009802A1 (en) | 2007-07-12 | 2009-01-15 | Volcano Corporation | Oct-ivus catheter for concurrent luminal imaging |
JP5524835B2 (en) | 2007-07-12 | 2014-06-18 | ヴォルカノ コーポレイション | In vivo imaging catheter |
PL2334227T3 (en) | 2008-09-11 | 2022-09-12 | Acist Medical Systems, Inc. | Physiological sensor delivery device and fluid injection system |
EP2901966B1 (en) | 2008-09-29 | 2016-06-29 | Edwards Lifesciences CardiAQ LLC | Heart valve |
WO2010040009A1 (en) | 2008-10-01 | 2010-04-08 | Cardiaq Valve Technologies, Inc. | Delivery system for vascular implant |
JP5789195B2 (en) | 2008-12-08 | 2015-10-07 | シリコンバレー メディカル インスツルメンツ インコーポレイテッド | Catheter system for image guidance |
WO2010100654A2 (en) * | 2009-01-30 | 2010-09-10 | Panduranga Revankar Krishna Prasad | A device to directly monitor intra ocular pressure by a person based on pattern and colour changes |
EP2408356B1 (en) * | 2009-03-17 | 2018-05-23 | Opsens Inc. | Eccentric pressure catheter with guidewire compatibility |
US8414644B2 (en) | 2009-04-15 | 2013-04-09 | Cardiaq Valve Technologies, Inc. | Vascular implant and delivery system |
SE534637C2 (en) * | 2009-09-15 | 2011-11-01 | St Jude Medical Systems Ab | Quick change guide unit with pressure sensor |
US8771289B2 (en) * | 2009-12-21 | 2014-07-08 | Acist Medical Systems, Inc. | Thrombus removal device and system |
US8478384B2 (en) | 2010-01-19 | 2013-07-02 | Lightlab Imaging, Inc. | Intravascular optical coherence tomography system with pressure monitoring interface and accessories |
AU2014200116B2 (en) * | 2010-01-19 | 2015-09-03 | Lightlab Imaging, Inc. | Intravascular optical coherence tomography system with pressure monitoring interface and accessories |
GB2479340A (en) * | 2010-03-10 | 2011-10-12 | Imp Innovations Ltd | Method and apparatus for the measurement of a fluid flow restriction in a vessel |
US8579964B2 (en) | 2010-05-05 | 2013-11-12 | Neovasc Inc. | Transcatheter mitral valve prosthesis |
WO2011161212A1 (en) * | 2010-06-23 | 2011-12-29 | P2-Science Aps | Combined flow directed intraarterial microcatheter for the infusion of hyperemic agent and concomitant pressure measurements for diagnostic purposes |
US20110319738A1 (en) * | 2010-06-29 | 2011-12-29 | Abbott Diabetes Care Inc. | Medical Devices and Insertion Systems and Methods |
JP5866371B2 (en) * | 2010-11-09 | 2016-02-17 | オプセンス インコーポレイテッド | Guide wire with internal pressure sensor |
US11141063B2 (en) | 2010-12-23 | 2021-10-12 | Philips Image Guided Therapy Corporation | Integrated system architectures and methods of use |
US9775982B2 (en) | 2010-12-29 | 2017-10-03 | Medtronic, Inc. | Implantable medical device fixation |
US10112045B2 (en) | 2010-12-29 | 2018-10-30 | Medtronic, Inc. | Implantable medical device fixation |
US11040140B2 (en) * | 2010-12-31 | 2021-06-22 | Philips Image Guided Therapy Corporation | Deep vein thrombosis therapeutic methods |
US20120330145A1 (en) * | 2010-12-31 | 2012-12-27 | Volcano Corporation | Pulmonary Embolism Therapeutic Methods and Associated Devices and Systems |
GB201100136D0 (en) * | 2011-01-06 | 2011-02-23 | Davies Helen C S | Apparatus and method of characterising a narrowing in a filled tube |
GB201100137D0 (en) | 2011-01-06 | 2011-02-23 | Davies Helen C S | Apparatus and method of assessing a narrowing in a fluid tube |
US9107639B2 (en) * | 2011-03-15 | 2015-08-18 | Medicinsk Bildteknik Sverige Ab | System for synchronously visualizing a representation of first and second input data |
US9308087B2 (en) | 2011-04-28 | 2016-04-12 | Neovasc Tiara Inc. | Sequentially deployed transcatheter mitral valve prosthesis |
US9554897B2 (en) | 2011-04-28 | 2017-01-31 | Neovasc Tiara Inc. | Methods and apparatus for engaging a valve prosthesis with tissue |
WO2012155040A1 (en) | 2011-05-11 | 2012-11-15 | Acist Medical Systems, Inc. | Intravascular sensing method and system |
AU2012262258B2 (en) * | 2011-05-31 | 2015-11-26 | Lightlab Imaging, Inc. | Multimodal imaging system, apparatus, and methods |
US9532722B2 (en) | 2011-06-21 | 2017-01-03 | Masimo Corporation | Patient monitoring system |
US9986919B2 (en) | 2011-06-21 | 2018-06-05 | Masimo Corporation | Patient monitoring system |
US9314584B1 (en) * | 2011-06-27 | 2016-04-19 | Bayer Healthcare Llc | Method and apparatus for fractional flow reserve measurements |
RU2014110702A (en) | 2011-08-20 | 2015-09-27 | Волкано Корпорэйшн | DEVICES, SYSTEMS AND METHODS OF VISUAL DISPLAY OF A VESSEL AND EVALUATION OF TREATMENT OPTIONS |
US9339348B2 (en) * | 2011-08-20 | 2016-05-17 | Imperial Colege of Science, Technology and Medicine | Devices, systems, and methods for assessing a vessel |
US10888232B2 (en) * | 2011-08-20 | 2021-01-12 | Philips Image Guided Therapy Corporation | Devices, systems, and methods for assessing a vessel |
WO2013033592A1 (en) | 2011-08-31 | 2013-03-07 | Volcano Corporation | Optical-electrical rotary joint and methods of use |
US20130066197A1 (en) * | 2011-09-13 | 2013-03-14 | Celine Pruvot | System and method for blood vessel stenosis visualization and navigation |
US9854981B2 (en) | 2011-10-14 | 2018-01-02 | Acist Medical Systems, Inc. | Device and methods for measuring and treating an anatomical structure |
SE537177C2 (en) * | 2011-10-28 | 2015-02-24 | St Jude Medical Systems Ab | Medical system for determining the Fractional Flow Reserve (FFR) value |
US20140243688A1 (en) | 2011-10-28 | 2014-08-28 | Three Rivers Cardiovascular Systems Inc. | Fluid temperature and flow sensor apparatus and system for cardiovascular and other medical applications |
US10463259B2 (en) * | 2011-10-28 | 2019-11-05 | Three Rivers Cardiovascular Systems Inc. | System and apparatus comprising a multi-sensor catheter for right heart and pulmonary artery catheterization |
US20130109980A1 (en) * | 2011-11-01 | 2013-05-02 | Tat-Jin Teo | Systems and methods for a wireless vascular pressure measurement device |
WO2013109815A1 (en) * | 2012-01-19 | 2013-07-25 | Volcano Corporation | Interface devices, systems, and methods for use with intravascular pressure monitoring devices |
US9084539B2 (en) * | 2012-02-02 | 2015-07-21 | Volcano Corporation | Wireless pressure wire system with integrated power |
US9717421B2 (en) | 2012-03-26 | 2017-08-01 | Medtronic, Inc. | Implantable medical device delivery catheter with tether |
US10485435B2 (en) | 2012-03-26 | 2019-11-26 | Medtronic, Inc. | Pass-through implantable medical device delivery catheter with removeable distal tip |
US9220906B2 (en) | 2012-03-26 | 2015-12-29 | Medtronic, Inc. | Tethered implantable medical device deployment |
US9854982B2 (en) | 2012-03-26 | 2018-01-02 | Medtronic, Inc. | Implantable medical device deployment within a vessel |
US9339197B2 (en) | 2012-03-26 | 2016-05-17 | Medtronic, Inc. | Intravascular implantable medical device introduction |
US9833625B2 (en) | 2012-03-26 | 2017-12-05 | Medtronic, Inc. | Implantable medical device delivery with inner and outer sheaths |
JP6139510B2 (en) | 2012-03-29 | 2017-05-31 | テルモ株式会社 | Diagnostic imaging apparatus and probe |
US20130274618A1 (en) * | 2012-04-17 | 2013-10-17 | Boston Scientific Scimed, Inc. | Guidewire system for use in transcatheter aortic valve implantation procedures |
JP6173438B2 (en) | 2012-05-14 | 2017-08-02 | コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. | Determination of coronary flow reserve ratio (FFR) for stenosis of blood vessels |
US9549679B2 (en) * | 2012-05-14 | 2017-01-24 | Acist Medical Systems, Inc. | Multiple transducer delivery device and method |
WO2013177577A2 (en) | 2012-05-25 | 2013-11-28 | Eberle Michael J | Optical fiber pressure sensor |
US9345573B2 (en) | 2012-05-30 | 2016-05-24 | Neovasc Tiara Inc. | Methods and apparatus for loading a prosthesis onto a delivery system |
EP2858553A1 (en) * | 2012-06-08 | 2015-04-15 | Koninklijke Philips N.V. | Distributed sensing device for referencing of physiological features |
US20140005558A1 (en) * | 2012-06-29 | 2014-01-02 | Boston Scientific Scimed, Inc. | Pressure sensing guidewire |
US8926520B2 (en) * | 2012-07-20 | 2015-01-06 | Endophys Holdings, Llc | Transducer interface system and method |
US9241641B2 (en) * | 2012-07-20 | 2016-01-26 | Acist Medical Systems, Inc. | Fiber optic sensor assembly for sensor delivery device |
WO2014025255A1 (en) * | 2012-08-06 | 2014-02-13 | Wellinq Medical B.V. | Pressure sensor catheter and associated method |
WO2014027692A1 (en) * | 2012-08-16 | 2014-02-20 | 株式会社東芝 | Image-processing device, diagnostic medical image apparatus and blood pressure monitor |
EP2887863B1 (en) | 2012-08-27 | 2019-11-27 | Boston Scientific Scimed, Inc. | Pressure-sensing medical device system |
WO2014036477A1 (en) | 2012-08-31 | 2014-03-06 | Volcano Corporation | Pressure sensing intravascular devices with reduced drift and associated systems and methods |
EP3571998B1 (en) | 2012-09-25 | 2021-02-17 | The Johns Hopkins University | A method for estimating flow rates, pressure gradients, coronary flow reserve, and fractional flow reserve from patient specific computed tomography angiogram-based contrast distribution data |
US9265473B2 (en) | 2012-09-25 | 2016-02-23 | The Johns Hopkins University | Method for estimating flow rates and pressure gradients in arterial networks from patient specific computed tomography angiogram-based contrast distribution data |
US9286673B2 (en) | 2012-10-05 | 2016-03-15 | Volcano Corporation | Systems for correcting distortions in a medical image and methods of use thereof |
US10070827B2 (en) | 2012-10-05 | 2018-09-11 | Volcano Corporation | Automatic image playback |
US9307926B2 (en) | 2012-10-05 | 2016-04-12 | Volcano Corporation | Automatic stent detection |
US11272845B2 (en) | 2012-10-05 | 2022-03-15 | Philips Image Guided Therapy Corporation | System and method for instant and automatic border detection |
JP2015532536A (en) | 2012-10-05 | 2015-11-09 | デイビッド ウェルフォード, | System and method for amplifying light |
US9324141B2 (en) | 2012-10-05 | 2016-04-26 | Volcano Corporation | Removal of A-scan streaking artifact |
US9367965B2 (en) | 2012-10-05 | 2016-06-14 | Volcano Corporation | Systems and methods for generating images of tissue |
US9292918B2 (en) | 2012-10-05 | 2016-03-22 | Volcano Corporation | Methods and systems for transforming luminal images |
US10568586B2 (en) | 2012-10-05 | 2020-02-25 | Volcano Corporation | Systems for indicating parameters in an imaging data set and methods of use |
US9858668B2 (en) | 2012-10-05 | 2018-01-02 | Volcano Corporation | Guidewire artifact removal in images |
US9840734B2 (en) | 2012-10-22 | 2017-12-12 | Raindance Technologies, Inc. | Methods for analyzing DNA |
WO2014084377A1 (en) | 2012-11-29 | 2014-06-05 | 株式会社 東芝 | Circulatory function examination device and x-ray diagnostic device |
US9175944B2 (en) * | 2012-12-10 | 2015-11-03 | The Johns Hopkins University | Durable single mode fiber probe with optimized reference reflectivity |
US10674966B2 (en) * | 2012-12-11 | 2020-06-09 | Covidien Lp | Systems for diagnosing and/or treating medical conditions |
WO2014093170A1 (en) * | 2012-12-12 | 2014-06-19 | Edwards Lifesciences Corporation | System and method for detecting occlusions in a blood access device |
WO2014093121A1 (en) * | 2012-12-12 | 2014-06-19 | Edwards Lifesciences Corporation | Analyte sensing system and method for controlling presentation of information |
US9717422B2 (en) * | 2012-12-12 | 2017-08-01 | Volcano Corporation | Sheath with optically interrogatable sensors |
WO2014093374A1 (en) | 2012-12-13 | 2014-06-19 | Volcano Corporation | Devices, systems, and methods for targeted cannulation |
US20140180030A1 (en) * | 2012-12-20 | 2014-06-26 | Volcano Corporation | Intravascular blood pressure and velocity wire |
US10939826B2 (en) | 2012-12-20 | 2021-03-09 | Philips Image Guided Therapy Corporation | Aspirating and removing biological material |
US10942022B2 (en) | 2012-12-20 | 2021-03-09 | Philips Image Guided Therapy Corporation | Manual calibration of imaging system |
CA2895502A1 (en) | 2012-12-20 | 2014-06-26 | Jeremy Stigall | Smooth transition catheters |
US11406498B2 (en) | 2012-12-20 | 2022-08-09 | Philips Image Guided Therapy Corporation | Implant delivery system and implants |
EP2934310A4 (en) | 2012-12-20 | 2016-10-12 | Nathaniel J Kemp | Optical coherence tomography system that is reconfigurable between different imaging modes |
JP2016506276A (en) | 2012-12-20 | 2016-03-03 | ジェレミー スティガール, | Locate the intravascular image |
WO2014099760A1 (en) | 2012-12-21 | 2014-06-26 | Mai Jerome | Ultrasound imaging with variable line density |
US10993694B2 (en) | 2012-12-21 | 2021-05-04 | Philips Image Guided Therapy Corporation | Rotational ultrasound imaging catheter with extended catheter body telescope |
US10413317B2 (en) | 2012-12-21 | 2019-09-17 | Volcano Corporation | System and method for catheter steering and operation |
US10058284B2 (en) | 2012-12-21 | 2018-08-28 | Volcano Corporation | Simultaneous imaging, monitoring, and therapy |
EP4042936A1 (en) | 2012-12-21 | 2022-08-17 | Philips Image Guided Therapy Corporation | Wireless interface devices, and systems for use with intravascular pressure monitoring devices |
US9383263B2 (en) | 2012-12-21 | 2016-07-05 | Volcano Corporation | Systems and methods for narrowing a wavelength emission of light |
US9486143B2 (en) | 2012-12-21 | 2016-11-08 | Volcano Corporation | Intravascular forward imaging device |
CA2895940A1 (en) | 2012-12-21 | 2014-06-26 | Andrew Hancock | System and method for multipath processing of image signals |
US10191220B2 (en) | 2012-12-21 | 2019-01-29 | Volcano Corporation | Power-efficient optical circuit |
US9612105B2 (en) | 2012-12-21 | 2017-04-04 | Volcano Corporation | Polarization sensitive optical coherence tomography system |
EP2934305B1 (en) * | 2012-12-21 | 2018-02-21 | Volcano Corporation | System for multi-site intravascular measurement |
EP2934304B1 (en) * | 2012-12-21 | 2021-10-13 | Philips Image Guided Therapy Corporation | Multi-sensor devices |
EP2936426B1 (en) | 2012-12-21 | 2021-10-13 | Jason Spencer | System and method for graphical processing of medical data |
JP6445982B2 (en) | 2012-12-31 | 2018-12-26 | ボルケーノ コーポレイション | Apparatus, system, and method for tube evaluation |
WO2014105785A1 (en) * | 2012-12-31 | 2014-07-03 | Volcano Corporation | In-wall hypotube sensor mount for sensored guidewire |
US9757591B2 (en) | 2013-02-11 | 2017-09-12 | Bayer Healthcare Llc | Methods and systems for monitoring an automated infusion system |
KR101453918B1 (en) * | 2013-03-05 | 2014-11-03 | 주식회사 덴티스 | A device for measuring a blood pressure and a control method the same |
US10226597B2 (en) | 2013-03-07 | 2019-03-12 | Volcano Corporation | Guidewire with centering mechanism |
WO2014138555A1 (en) | 2013-03-07 | 2014-09-12 | Bernhard Sturm | Multimodal segmentation in intravascular images |
US10583002B2 (en) | 2013-03-11 | 2020-03-10 | Neovasc Tiara Inc. | Prosthetic valve with anti-pivoting mechanism |
US11154313B2 (en) | 2013-03-12 | 2021-10-26 | The Volcano Corporation | Vibrating guidewire torquer and methods of use |
US10638939B2 (en) | 2013-03-12 | 2020-05-05 | Philips Image Guided Therapy Corporation | Systems and methods for diagnosing coronary microvascular disease |
US9301687B2 (en) | 2013-03-13 | 2016-04-05 | Volcano Corporation | System and method for OCT depth calibration |
US11026591B2 (en) * | 2013-03-13 | 2021-06-08 | Philips Image Guided Therapy Corporation | Intravascular pressure sensor calibration |
EP2967488B1 (en) | 2013-03-13 | 2021-06-16 | Jinhyoung Park | System for producing an image from a rotational intravascular ultrasound device |
US10292677B2 (en) | 2013-03-14 | 2019-05-21 | Volcano Corporation | Endoluminal filter having enhanced echogenic properties |
US10219887B2 (en) | 2013-03-14 | 2019-03-05 | Volcano Corporation | Filters with echogenic characteristics |
WO2014152365A2 (en) | 2013-03-14 | 2014-09-25 | Volcano Corporation | Filters with echogenic characteristics |
US9681951B2 (en) | 2013-03-14 | 2017-06-20 | Edwards Lifesciences Cardiaq Llc | Prosthesis with outer skirt and anchors |
US20160022153A1 (en) | 2013-03-15 | 2016-01-28 | Volcano Corporation | Interface Devices, Systems, And Methods For Use With Intravascular Pressure Monitoring Devices |
US10246322B2 (en) * | 2013-03-15 | 2019-04-02 | Versana Micro Inc. | Distributed sensor system |
WO2014151841A1 (en) * | 2013-03-15 | 2014-09-25 | Volcano Corporation | Universal patient interface module and associated devices, systems, and methods |
CN105209102B (en) | 2013-03-15 | 2018-10-02 | 波士顿科学国际有限公司 | Pressure-sensing seal wire |
WO2014143816A1 (en) * | 2013-03-15 | 2014-09-18 | Volcano Corporation | Devices, systems, and methods for preservation of arteriovenous access sites |
US9572665B2 (en) | 2013-04-04 | 2017-02-21 | Neovasc Tiara Inc. | Methods and apparatus for delivering a prosthetic valve to a beating heart |
AU2014268473A1 (en) | 2013-05-22 | 2015-12-24 | Boston Scientific Scimed, Inc. | Pressure sensing guidewire systems including an optical connector cable |
AU2014284381B2 (en) * | 2013-07-01 | 2019-04-18 | Zurich Medical Corporation | Apparatus and method for intravascular measurements |
US10835183B2 (en) | 2013-07-01 | 2020-11-17 | Zurich Medical Corporation | Apparatus and method for intravascular measurements |
EP3021740B1 (en) * | 2013-07-18 | 2020-12-30 | Endophys Holdings, LLC | Blood pressure analysis system and method |
EP3021758A4 (en) | 2013-07-19 | 2017-03-15 | Volcano Corporation | Devices, systems, and methods for assessment of vessels |
EP3024381B1 (en) | 2013-07-26 | 2019-06-19 | Boston Scientific Scimed, Inc. | Ffr sensor head design that minimizes stress induced pressure offsets |
WO2015020911A2 (en) | 2013-08-05 | 2015-02-12 | Cercacor Laboratories, Inc. | Blood pressure monitor with valve-chamber assembly |
CN105636508B (en) | 2013-08-14 | 2019-09-27 | 波士顿科学国际有限公司 | Medical instrument system including tapered core fibre |
JP6453883B2 (en) * | 2013-08-21 | 2019-01-16 | コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. | Segmentation device for interactive segmentation of blood vessels in angiographic image data |
EP3054889B1 (en) * | 2013-09-30 | 2020-06-24 | Koninklijke Philips N.V. | Multipurpose lumen design for optical shape sensing |
US10327645B2 (en) | 2013-10-04 | 2019-06-25 | Vascular Imaging Corporation | Imaging techniques using an imaging guidewire |
US9775523B2 (en) | 2013-10-14 | 2017-10-03 | Boston Scientific Scimed, Inc. | Pressure sensing guidewire and methods for calculating fractional flow reserve |
CN105682554A (en) * | 2013-10-25 | 2016-06-15 | 火山公司 | Devices, systems, and methods for vessel assessment |
JP6231221B2 (en) * | 2013-10-25 | 2017-11-15 | ケファリオス ソシエテ・パル・アクスィオン・サンプリフィエKephalios S.A.S. | Adjustable annuloplasty ring and system |
WO2015061725A1 (en) * | 2013-10-25 | 2015-04-30 | Boston Scientific Scimed, Inc. | Catheter systems and methods for determining blood flow rates with optical sensing |
EP2865326A1 (en) * | 2013-10-25 | 2015-04-29 | Sinvent AS | In-vivo pressure monitoring system |
US9877660B2 (en) | 2013-11-14 | 2018-01-30 | Medtronic Vascular Galway | Systems and methods for determining fractional flow reserve without adenosine or other pharmalogical agent |
US10130269B2 (en) * | 2013-11-14 | 2018-11-20 | Medtronic Vascular, Inc | Dual lumen catheter for providing a vascular pressure measurement |
JP2016538048A (en) * | 2013-11-15 | 2016-12-08 | アシスト・メディカル・システムズ,インコーポレイテッド | Multi-sensor affected area evaluation apparatus and method |
US10537255B2 (en) | 2013-11-21 | 2020-01-21 | Phyzhon Health Inc. | Optical fiber pressure sensor |
WO2015085220A1 (en) * | 2013-12-06 | 2015-06-11 | Volcano Corporation | Device, system, and method for assessing intravascular pressure |
US11006840B2 (en) | 2013-12-06 | 2021-05-18 | Philips Image Guided Therapy Corporation | Device, system, and method for assessing intravascular pressure |
EP3082585A4 (en) * | 2013-12-19 | 2016-12-28 | Volcano Corp | Device, system, and method for assessing intravascular pressure |
WO2015099845A1 (en) * | 2013-12-23 | 2015-07-02 | Guided Interventions, Inc. | System for detection of fluid pressure using a pressure sensing capacitive sensor |
US9713456B2 (en) | 2013-12-30 | 2017-07-25 | Acist Medical Systems, Inc. | Position sensing in intravascular imaging |
US9913585B2 (en) | 2014-01-15 | 2018-03-13 | Medtronic Vascular, Inc. | Catheter for providing vascular pressure measurements |
US9539090B2 (en) | 2014-01-16 | 2017-01-10 | Cook Medical Technologies Llc | Transaortic valve access device |
EP3136955A1 (en) * | 2014-01-16 | 2017-03-08 | Volcano Corporation | Devices, systems, and methods for assessing a vessel |
US9974443B2 (en) | 2014-02-20 | 2018-05-22 | Koninklijke Philips N.V. | Devices, systems, and methods and associated display screens for assessment of vessels |
EP3116382B1 (en) * | 2014-03-11 | 2022-05-04 | The Johns Hopkins University | A method for estimating flow rates and pressure gradients in arterial networks from patient specific computed tomography angiogram-based contrast distribution data |
WO2015142623A1 (en) * | 2014-03-18 | 2015-09-24 | Boston Scientific Scimed, Inc. | Pressure sensing guidewires |
US20150272449A1 (en) * | 2014-03-26 | 2015-10-01 | Volcano Corporation | Hybrid Intravascular Pressure Measurement Devices and Associated Systems and Methods |
EP3125751B1 (en) * | 2014-04-04 | 2021-07-14 | St. Jude Medical Systems AB | Intravascular pressure and flow data diagnostic system |
US9429713B2 (en) | 2014-04-17 | 2016-08-30 | Boston Scientific Scimed, Inc. | Self-cleaning optical connector |
WO2015164250A1 (en) | 2014-04-21 | 2015-10-29 | Koninklijke Philips N.V. | Intravascular devices, systems, and methods having separate sections with engaged core components |
US11311271B2 (en) | 2014-04-23 | 2022-04-26 | Philips Image Guided Therapy Corporation | Catheter with integrated controller for imaging and pressure sensing |
US10729500B2 (en) | 2014-05-01 | 2020-08-04 | St. Jude Medical, Cardiology Division, Inc. | Depicting force |
USD761313S1 (en) * | 2014-05-01 | 2016-07-12 | St. Jude Medical, Cardiology Division, Inc. | Display screen with a transitional graphical user interface |
USD761808S1 (en) | 2014-05-01 | 2016-07-19 | St. Jude Medical, Cardiology Division, Inc. | Display screen with transitional graphical user interface |
CN106456073B (en) | 2014-05-02 | 2020-10-30 | 皇家飞利浦有限公司 | Devices, systems, and methods for assessing intravascular pressure |
USD794068S1 (en) * | 2014-05-07 | 2017-08-08 | Roche Diabetes Care, Inc. | Display screen with continuous glucose monitor icon |
CN103932694A (en) * | 2014-05-07 | 2014-07-23 | 霍云龙 | Method and device for accurately diagnosing FFR |
US10391227B2 (en) * | 2014-05-15 | 2019-08-27 | Novalung Gmbh | Medico-technical measuring device and measuring method |
US10463306B2 (en) | 2014-05-15 | 2019-11-05 | Novalung Gmbh | Medical measuring system and method for production of the measuring system |
CN106659393B (en) | 2014-06-04 | 2021-02-19 | 波士顿科学国际有限公司 | Pressure sensing guidewire system with reduced pressure excursions |
US10244951B2 (en) | 2014-06-10 | 2019-04-02 | Acist Medical Systems, Inc. | Physiological sensor delivery device and method |
US10973418B2 (en) | 2014-06-16 | 2021-04-13 | Medtronic Vascular, Inc. | Microcatheter sensor design for minimizing profile and impact of wire strain on sensor |
US10201284B2 (en) | 2014-06-16 | 2019-02-12 | Medtronic Vascular Inc. | Pressure measuring catheter having reduced error from bending stresses |
US11330989B2 (en) | 2014-06-16 | 2022-05-17 | Medtronic Vascular, Inc. | Microcatheter sensor design for mounting sensor to minimize induced strain |
US10098702B2 (en) | 2014-07-11 | 2018-10-16 | Volcano Corporation | Devices, systems, and methods for treatment of vessels |
US10722175B2 (en) | 2014-07-13 | 2020-07-28 | Hemocath Ltd. | System and apparatus comprising a multisensor guidewire for use in interventional cardiology |
US10849511B2 (en) | 2014-07-14 | 2020-12-01 | Philips Image Guided Therapy Corporation | Devices, systems, and methods for assessment of vessels |
WO2016008809A1 (en) | 2014-07-15 | 2016-01-21 | Koninklijke Philips N.V. | Devices, systems, and methods and associated display screens for assessment of vessels with multiple sensing components |
CN106714675B (en) * | 2014-08-01 | 2020-03-20 | 波士顿科学国际有限公司 | Pressure sensing guidewire |
EP3185764B1 (en) | 2014-08-27 | 2019-03-13 | St Jude Medical Systems Ab | System for evaluating a cardiac system by determining minimum ratio pd/pa (distal pressure / arterial pressure) |
US11311200B1 (en) | 2014-08-27 | 2022-04-26 | Lightlab Imaging, Inc. | Systems and methods to measure physiological flow in coronary arteries |
JP6596078B2 (en) * | 2014-09-11 | 2019-10-23 | コーニンクレッカ フィリップス エヌ ヴェ | Bedside controller and related devices, systems and methods for assessing blood vessels |
AU2015319822B2 (en) * | 2014-09-28 | 2020-07-23 | Potrero Medical, Inc. | Systems, devices and methods for sensing physiologic data and draining and analyzing bodily fluids |
US10080872B2 (en) * | 2014-11-04 | 2018-09-25 | Abbott Cardiovascular Systems Inc. | System and method for FFR guidewire recovery |
DE102014116221B4 (en) * | 2014-11-06 | 2019-05-23 | Ferton Holding S.A. | Monitoring system and method of monitoring |
US10258240B1 (en) | 2014-11-24 | 2019-04-16 | Vascular Imaging Corporation | Optical fiber pressure sensor |
US9795307B2 (en) | 2014-12-05 | 2017-10-24 | Boston Scientific Scimed, Inc. | Pressure sensing guidewires |
US10194812B2 (en) | 2014-12-12 | 2019-02-05 | Medtronic Vascular, Inc. | System and method of integrating a fractional flow reserve device with a conventional hemodynamic monitoring system |
EP4241820A1 (en) * | 2015-01-23 | 2023-09-13 | Terumo Kabushiki Kaisha | Guide wire |
CN107735138A (en) * | 2015-04-15 | 2018-02-23 | 桑福德保健公司 | Pulmonary embolism device |
RU2613086C2 (en) * | 2015-05-08 | 2017-03-15 | Общество с ограниченной ответственностью "М-ЛАЙН" (ООО "М-ЛАЙН") | Device for long-term remote invasive monitoring of state and critical changes of cardiovascular system for patients with comorbidity |
JP6917976B2 (en) * | 2015-07-17 | 2021-08-11 | コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. | Devices, systems, and methods for assessing vessels |
JP6397156B2 (en) * | 2015-08-03 | 2018-09-26 | メディリア アクチェンゲゼルシャフト | Sensor bend catheter |
CN117653061A (en) * | 2015-09-04 | 2024-03-08 | 波士顿科学国际有限公司 | Pressure sensing guide wire |
US10067112B2 (en) | 2015-09-30 | 2018-09-04 | Battelle Memorial Institute | Autonomous sensor fish to support advanced hydropower development |
EP3159026A1 (en) | 2015-10-23 | 2017-04-26 | novalung GmbH | Intermediate element for a medical extracorporeal fluid conduit, medical extracorporeal fluid system and method for measuring a gas contained in a fluid guided in a medical extracorporeal fluid system of the human or animal body |
US10722690B2 (en) | 2015-12-28 | 2020-07-28 | Boston Scientific Scimed, Inc. | Medical devices with antithrombogenic coatings |
US10376678B2 (en) | 2016-01-08 | 2019-08-13 | Makaha Medical, Llc. | Systems and methods for controlling reperfusion in a vessel |
US10602984B2 (en) | 2016-01-29 | 2020-03-31 | Acist Medical Systems, Inc. | Medicant-releasing intravascular components and methods |
WO2017136746A1 (en) | 2016-02-03 | 2017-08-10 | Cormetrics Llc | Modular sensing guidewire |
JP6669898B2 (en) | 2016-02-23 | 2020-03-18 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Pressure sensing guidewire system with optical connector cable |
US10595818B2 (en) | 2016-03-19 | 2020-03-24 | Makaha Medical, Llc. | Medical systems and methods for density assessment using ultrasound |
US11076808B2 (en) * | 2016-03-26 | 2021-08-03 | Makaha Medical, LLC | Flexible medical device with marker band and sensor |
JP2017176719A (en) * | 2016-03-31 | 2017-10-05 | 日本ゼオン株式会社 | catheter |
US10667698B2 (en) * | 2016-05-12 | 2020-06-02 | Masayoshi Yoshida | Methods for estimating post-PCI fractional flow reserve |
US11109833B2 (en) | 2016-05-19 | 2021-09-07 | Acist Medical Systems, Inc. | Position sensing in intravascular processes |
CN109561878B (en) | 2016-05-19 | 2021-11-23 | 阿西斯特医疗系统有限公司 | Position sensing in intravascular procedures |
US20190246918A1 (en) * | 2016-07-14 | 2019-08-15 | Koninklijke Philips N.V. | Apparatus, system and method for feedback on quality of property measurement in a vessel |
WO2018022919A1 (en) * | 2016-07-28 | 2018-02-01 | Evalve, Inc. | Systems and methods for intra-procedural cardiac pressure monitoring |
US11272850B2 (en) * | 2016-08-09 | 2022-03-15 | Medtronic Vascular, Inc. | Catheter and method for calculating fractional flow reserve |
US11272847B2 (en) | 2016-10-14 | 2022-03-15 | Hemocath Ltd. | System and apparatus comprising a multi-sensor catheter for right heart and pulmonary artery catheterization |
AU2017350759B2 (en) * | 2016-10-27 | 2019-10-17 | Cardiac Pacemakers, Inc. | Implantable medical device with pressure sensor |
US10722125B2 (en) * | 2016-10-31 | 2020-07-28 | Livemetric (Medical) S.A. | Blood pressure signal acquisition using a pressure sensor array |
CN106618490B (en) * | 2016-11-11 | 2023-08-15 | 武汉理工大学 | In-vivo real-time monitoring integrated system for pressure and temperature of human body minimally invasive type |
WO2018134330A2 (en) * | 2017-01-19 | 2018-07-26 | HighDim GmbH | Devices and methods for determining heart function of a living subject |
JP6812815B2 (en) * | 2017-01-31 | 2021-01-13 | 株式会社島津製作所 | X-ray imaging device and X-ray image analysis method |
US11330994B2 (en) | 2017-03-08 | 2022-05-17 | Medtronic Vascular, Inc. | Reduced profile FFR catheter |
EP3602394A1 (en) * | 2017-03-24 | 2020-02-05 | Pie Medical Imaging BV | Method and system for assessing vessel obstruction based on machine learning |
US10646122B2 (en) | 2017-04-28 | 2020-05-12 | Medtronic Vascular, Inc. | FFR catheter with covered distal pressure sensor and method of manufacture |
US11517734B2 (en) * | 2017-06-21 | 2022-12-06 | Kristin Rossodivito | System and method for detecting air embolisms in lines for hemodynamic monitoring |
AU2018311951B2 (en) | 2017-08-03 | 2020-10-15 | Boston Scientific Scimed, Inc. | Systems for assessing fractional flow reserve |
US11219741B2 (en) * | 2017-08-09 | 2022-01-11 | Medtronic Vascular, Inc. | Collapsible catheter and method for calculating fractional flow reserve |
US11235124B2 (en) | 2017-08-09 | 2022-02-01 | Medtronic Vascular, Inc. | Collapsible catheter and method for calculating fractional flow reserve |
ES2906773T3 (en) * | 2017-10-03 | 2022-04-20 | Sanford Health | Bilateral catheter system |
EP3706621A1 (en) * | 2017-11-08 | 2020-09-16 | Murata Manufacturing Co., Ltd. | Rapid exchange catheter system for fractional flow reserve measurement |
DE102018201314A1 (en) * | 2018-01-29 | 2019-08-01 | Siemens Healthcare Gmbh | Method for normalizing magnetic resonance images |
US11311196B2 (en) | 2018-02-23 | 2022-04-26 | Boston Scientific Scimed, Inc. | Methods for assessing a vessel with sequential physiological measurements |
WO2019183432A1 (en) | 2018-03-23 | 2019-09-26 | Boston Scientific Scimed, Inc. | Medical device with pressure sensor |
JP2021520260A (en) * | 2018-04-03 | 2021-08-19 | オプセンス インコーポレイテッドOpsens, Inc. | Pressure-based vascular assessment system and method |
JP7138189B2 (en) | 2018-04-06 | 2022-09-15 | ボストン サイエンティフィック サイムド,インコーポレイテッド | Medical device with pressure sensor |
JP7102544B2 (en) | 2018-04-18 | 2022-07-19 | ボストン サイエンティフィック サイムド,インコーポレイテッド | Evaluation method of blood vessels by sequential physiological measurement |
ES2915828T3 (en) * | 2018-04-20 | 2022-06-27 | Acist Medical Sys Inc | Evaluation of a glass |
CN109060203A (en) * | 2018-08-06 | 2018-12-21 | 上海大学 | Intrinsical Fabry-Perot pull sensing device and its manufacturing method based on Modulation Based on Optical Fiber Fused Taper |
US11185244B2 (en) | 2018-08-13 | 2021-11-30 | Medtronic Vascular, Inc. | FFR catheter with suspended pressure sensor |
CN109259752A (en) * | 2018-09-25 | 2019-01-25 | 山东大学 | FFR sensor structure based on fiber F-P cavity principle |
US10874850B2 (en) | 2018-09-28 | 2020-12-29 | Medtronic, Inc. | Impedance-based verification for delivery of implantable medical devices |
JP7166125B2 (en) * | 2018-09-28 | 2022-11-07 | フクダ電子株式会社 | medical electronics |
CN109520654A (en) * | 2018-10-30 | 2019-03-26 | 上海大学 | Intrinsical Fabry-Perot strain gauge and its manufacturing method based on Modulation Based on Optical Fiber Fused Taper |
EP3873564A1 (en) | 2018-10-31 | 2021-09-08 | ACIST Medical Systems, Inc. | Fluid pressure sensor protection |
AU2020237188A1 (en) * | 2019-03-11 | 2021-10-28 | Athos PATSALIDES | Endovascular electroencephalography (EEG) and electrocorticography (ECoG) devices, systems and methods |
US11331475B2 (en) | 2019-05-07 | 2022-05-17 | Medtronic, Inc. | Tether assemblies for medical device delivery systems |
CN113795188A (en) * | 2019-05-13 | 2021-12-14 | 二十-二十治疗有限责任公司 | Systems, devices, and methods for optical interrogation of implantable intraocular pressure sensors |
USD926199S1 (en) | 2019-05-17 | 2021-07-27 | Opsens, Inc. | Display screen or portion thereof with graphical user interface |
CN110269594A (en) * | 2019-06-18 | 2019-09-24 | 济南市第四人民医院 | A kind of coronary flow reserve fraction measurement system |
WO2020263780A1 (en) * | 2019-06-24 | 2020-12-30 | Orbusneich Medical Pte. Ltd. | Multi-lumen catheter |
KR102446493B1 (en) * | 2019-08-12 | 2022-09-26 | 한국수자원공사 | Method and device for predicting drought based on probability distribution |
WO2021046365A1 (en) * | 2019-09-06 | 2021-03-11 | Adventist Health System/Sunbelt, Inc. | Advanced dialysis catheter with pressure sensor |
CN111973864B (en) * | 2020-08-31 | 2021-07-23 | 尚华 | Optical function guide wire, detection system and detection method |
US20220133134A1 (en) * | 2020-11-04 | 2022-05-05 | Kotl, Llc | Imaging and pressure sensing apparatus and probes with a slidable sheath |
CN113476694B (en) * | 2021-07-05 | 2022-09-06 | 重庆医科大学 | Infusion alarm capable of being clamped and stopped based on optical fiber Fabry-Perot detection principle |
JP2023028739A (en) * | 2021-08-20 | 2023-03-03 | 世史明 川瀬 | Cardiac disease evaluation support system and program for evaluation support |
WO2023086344A1 (en) * | 2021-11-09 | 2023-05-19 | Certus Critical Care, Inc. | Systems, devices, and methods for monitoring physiologic conditions during a medical procedure |
WO2023148555A2 (en) * | 2022-02-03 | 2023-08-10 | White Swell Medical Ltd | Fluid management console and system |
WO2024019939A1 (en) * | 2022-07-18 | 2024-01-25 | Boston Scientific Scimed Inc. | Percutaneous circulatory support device including proximal pressure sensor |
Family Cites Families (76)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3738356A (en) * | 1971-01-22 | 1973-06-12 | Lowa State University Res Foun | Intravenous pressure monitor |
US4006735A (en) | 1974-07-16 | 1977-02-08 | Hittman Corporation | Pressure sensor apparatus |
DE3334152A1 (en) | 1983-09-21 | 1985-04-04 | Fischer & Porter GmbH, 3400 Göttingen | MAGNETICALLY INDUCTIVE FLOW METER |
US4771782A (en) * | 1986-11-14 | 1988-09-20 | Millar Instruments, Inc. | Method and assembly for introducing multiple catheters into a biological vessel |
US4850358A (en) * | 1986-11-14 | 1989-07-25 | Millar Instruments, Inc. | Method and assembly for introducing multiple devices into a biological vessel |
US5046497A (en) * | 1986-11-14 | 1991-09-10 | Millar Instruments, Inc. | Structure for coupling a guidewire and a catheter |
US4966148A (en) * | 1986-11-14 | 1990-10-30 | Millar Instruments, Inc. | Assembly for positioning diagnostic devices in a biological vessel |
US4901731A (en) * | 1988-04-27 | 1990-02-20 | Millar Instruments, Inc. | Single sensor pressure differential device |
US5178159A (en) * | 1988-11-02 | 1993-01-12 | Cardiometrics, Inc. | Torqueable guide wire assembly with electrical functions, male and female connectors rotatable with respect to one another |
US4991590A (en) * | 1989-01-30 | 1991-02-12 | Martin Goffman Associates | Fiber optic intravascular blood pressure transducer |
US4928693A (en) * | 1989-03-13 | 1990-05-29 | Schneider (Usa), Inc. | Pressure monitor catheter |
US5395311A (en) * | 1990-05-14 | 1995-03-07 | Andrews; Winston A. | Atherectomy catheter |
SU1802695A3 (en) * | 1991-02-07 | 1993-03-15 | Kokapeb Ahatoлий Mиxaйлobич | Apparatus for measuring central vein pressure |
US5280786A (en) * | 1992-01-21 | 1994-01-25 | Fiberoptic Sensor Technologies, Inc. | Fiberoptic blood pressure and oxygenation sensor |
US5228452A (en) * | 1992-02-19 | 1993-07-20 | Target Therapeutics Inc. | Proximal end fitting with an improved seal for use in a catheter guidewire assembly |
US5597377A (en) * | 1994-05-06 | 1997-01-28 | Trustees Of Boston University | Coronary sinus reperfusion catheter |
CA2198909A1 (en) * | 1994-09-02 | 1996-03-14 | Robert Z. Obara | Ultra miniature pressure sensor and guidewire using the same and method |
EP1380261B1 (en) * | 1995-04-20 | 2008-03-05 | ACIST Medical Systems, Inc. | Radiographic contrast material injector |
SE9600333D0 (en) * | 1995-06-22 | 1996-01-30 | Radi Medical Systems | Sensor arrangement |
US6166806A (en) * | 1995-09-29 | 2000-12-26 | Tjin; Swee Chuan | Fiber optic catheter for accurate flow measurements |
SE9600334D0 (en) * | 1996-01-30 | 1996-01-30 | Radi Medical Systems | Combined flow, pressure and temperature sensor |
US6146354A (en) * | 1996-05-24 | 2000-11-14 | Horizon Medical Products | Asymmetrical multi-lumen apheresis catheter with balanced flow rates |
US5782797A (en) * | 1996-06-06 | 1998-07-21 | Scimed Life Systems, Inc. | Therapeutic infusion device |
JPH10267775A (en) | 1997-03-25 | 1998-10-09 | Tokai Rika Co Ltd | Pressure sensor |
US6248083B1 (en) * | 1997-03-25 | 2001-06-19 | Radi Medical Systems Ab | Device for pressure measurements |
US5938624A (en) * | 1997-09-10 | 1999-08-17 | Radi Medical Systems Ab | Male connector with a continous surface for a guide wire and method therefor |
JPH11188010A (en) * | 1997-10-21 | 1999-07-13 | Kawasumi Lab Inc | Catheter with pressure sensor |
US6295990B1 (en) * | 1998-02-03 | 2001-10-02 | Salient Interventional Systems, Inc. | Methods and systems for treating ischemia |
JP3116032B2 (en) * | 1998-02-27 | 2000-12-11 | 日本ビー・エックス・アイ株式会社 | Guidewire blood flow meter |
US6089103A (en) * | 1998-05-06 | 2000-07-18 | Radi Medical Systems Ab | Method of flow measurements |
US6245053B1 (en) * | 1998-11-09 | 2001-06-12 | Medtronic, Inc. | Soft tip guiding catheter and method of fabrication |
WO2000053081A1 (en) * | 1999-03-09 | 2000-09-14 | Florence Medical Ltd. | A method and system for pressure based measurements of cfr and additional clinical hemodynamic parameters |
US6471656B1 (en) * | 1999-06-25 | 2002-10-29 | Florence Medical Ltd | Method and system for pressure based measurements of CFR and additional clinical hemodynamic parameters |
JP4191849B2 (en) | 1999-05-28 | 2008-12-03 | 泉工医科工業株式会社 | Balloon catheter |
US6383144B1 (en) * | 2000-01-18 | 2002-05-07 | Edwards Lifesciences Corporation | Devices and methods for measuring temperature of a patient |
US6672172B2 (en) | 2000-01-31 | 2004-01-06 | Radi Medical Systems Ab | Triggered flow measurement |
DE60132910T2 (en) * | 2000-11-01 | 2009-02-12 | David San Diego Mann | KIT FOR OBTAINING AN ENDOARTERIAL BIOPSY TEST |
AU2002220271A1 (en) | 2000-12-12 | 2002-06-24 | Datascope Investment Corp. | Intra-aortic balloon catheter having a fiberoptic sensor |
US20020072679A1 (en) | 2000-12-12 | 2002-06-13 | Schock Robert B. | Intra-aortic balloon catheter having a fiberoptic sensor |
US6616597B2 (en) * | 2000-12-12 | 2003-09-09 | Datascope Investment Corp. | Intra-aortic balloon catheter having a dual sensor pressure sensing system |
US6585660B2 (en) * | 2001-05-18 | 2003-07-01 | Jomed Inc. | Signal conditioning device for interfacing intravascular sensors having varying operational characteristics to a physiology monitor |
US7329223B1 (en) * | 2001-05-31 | 2008-02-12 | Abbott Cardiovascular Systems Inc. | Catheter with optical fiber sensor |
WO2002101347A1 (en) * | 2001-06-08 | 2002-12-19 | Radi Medical Systems Ab | Miniaturized pressure sensor |
US7611503B2 (en) | 2004-04-16 | 2009-11-03 | Medrad, Inc. | Fluid delivery system, fluid path set, sterile connector and improved drip chamber and pressure isolation mechanism |
US6868736B2 (en) * | 2002-02-22 | 2005-03-22 | Sentec Corporation | Ultra-miniature optical pressure sensing system |
US7134994B2 (en) * | 2002-05-20 | 2006-11-14 | Volcano Corporation | Multipurpose host system for invasive cardiovascular diagnostic measurement acquisition and display |
US6819951B2 (en) | 2002-09-24 | 2004-11-16 | Mayo Foundation For Medical Education And Research | Peripherally inserted central catheter with continuous central venous oximetry and proximal high flow port |
US8712549B2 (en) * | 2002-12-11 | 2014-04-29 | Proteus Digital Health, Inc. | Method and system for monitoring and treating hemodynamic parameters |
JP4338446B2 (en) * | 2003-06-05 | 2009-10-07 | 株式会社根本杏林堂 | Chemical injection device |
JP4137740B2 (en) | 2003-08-06 | 2008-08-20 | オリンパス株式会社 | Capsule type medical device and capsule type medical device guidance system |
DE10342709A1 (en) * | 2003-09-11 | 2005-04-21 | Biotronik Gmbh & Co Kg | catheter |
JP4554967B2 (en) * | 2004-03-25 | 2010-09-29 | テルモ株式会社 | Ultrasonic catheter and diagnostic imaging apparatus |
JP2005291945A (en) * | 2004-03-31 | 2005-10-20 | Masaki Esashi | Sensor device |
US8277386B2 (en) * | 2004-09-27 | 2012-10-02 | Volcano Corporation | Combination sensor guidewire and methods of use |
US7402151B2 (en) | 2004-12-17 | 2008-07-22 | Biocardia, Inc. | Steerable guide catheters and methods for their use |
US7689071B2 (en) * | 2004-12-22 | 2010-03-30 | Opsens Inc. | Fiber optic pressure sensor for catheter use |
RU47203U1 (en) * | 2005-04-08 | 2005-08-27 | Институт радиотехники и электроники РАН г.Москва | FIBER OPTICAL THERMOMETER |
US7771362B2 (en) | 2005-08-01 | 2010-08-10 | Datascope Investment Corp. | Calibration of in vivo blood pressure sensors |
WO2007041542A2 (en) * | 2005-09-30 | 2007-04-12 | Cornova, Inc. | Systems and methods for analysis and treatment of a body lumen |
US7775988B2 (en) | 2005-09-30 | 2010-08-17 | Radi Medical Systems Ab | Method for determining the blood flow in a coronary artery |
US20070255145A1 (en) * | 2006-04-28 | 2007-11-01 | Radi Medical Systems Ab | Sensor and guide wire assembly |
US7724148B2 (en) * | 2006-11-20 | 2010-05-25 | Radi Medical Systems Ab | Transceiver unit in a pressure measurement system |
PL2334227T3 (en) | 2008-09-11 | 2022-09-12 | Acist Medical Systems, Inc. | Physiological sensor delivery device and fluid injection system |
EP2408356B1 (en) * | 2009-03-17 | 2018-05-23 | Opsens Inc. | Eccentric pressure catheter with guidewire compatibility |
WO2011161212A1 (en) | 2010-06-23 | 2011-12-29 | P2-Science Aps | Combined flow directed intraarterial microcatheter for the infusion of hyperemic agent and concomitant pressure measurements for diagnostic purposes |
WO2012155040A1 (en) | 2011-05-11 | 2012-11-15 | Acist Medical Systems, Inc. | Intravascular sensing method and system |
US9339348B2 (en) | 2011-08-20 | 2016-05-17 | Imperial Colege of Science, Technology and Medicine | Devices, systems, and methods for assessing a vessel |
WO2013109815A1 (en) | 2012-01-19 | 2013-07-25 | Volcano Corporation | Interface devices, systems, and methods for use with intravascular pressure monitoring devices |
WO2013177577A2 (en) | 2012-05-25 | 2013-11-28 | Eberle Michael J | Optical fiber pressure sensor |
US9241641B2 (en) | 2012-07-20 | 2016-01-26 | Acist Medical Systems, Inc. | Fiber optic sensor assembly for sensor delivery device |
WO2014084377A1 (en) | 2012-11-29 | 2014-06-05 | 株式会社 東芝 | Circulatory function examination device and x-ray diagnostic device |
CN203458373U (en) | 2013-09-10 | 2014-03-05 | 南方医科大学 | Real-time measurement system for fractional coronary flow reserve |
US9877660B2 (en) | 2013-11-14 | 2018-01-30 | Medtronic Vascular Galway | Systems and methods for determining fractional flow reserve without adenosine or other pharmalogical agent |
JP6917976B2 (en) | 2015-07-17 | 2021-08-11 | コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. | Devices, systems, and methods for assessing vessels |
JP7117999B2 (en) | 2015-09-29 | 2022-08-15 | アイピー2アイピーオー イノベーションズ リミテッド | Endovascular processing system for assessment, planning and treatment of coronary interventions based on desired outcome |
CN105326486B (en) | 2015-12-08 | 2017-08-25 | 博动医学影像科技(上海)有限公司 | Vascular pressure difference and the computational methods and system of blood flow reserve fraction |
-
2009
- 2009-09-11 PL PL09813672.4T patent/PL2334227T3/en unknown
- 2009-09-11 CA CA2734698A patent/CA2734698C/en active Active
- 2009-09-11 CN CN200980143511.6A patent/CN102202562B/en active Active
- 2009-09-11 US US12/557,685 patent/US8298156B2/en active Active
- 2009-09-11 CA CA2762123A patent/CA2762123C/en active Active
- 2009-09-11 ES ES09813672T patent/ES2913941T3/en active Active
- 2009-09-11 AU AU2009291623A patent/AU2009291623B2/en active Active
- 2009-09-11 EP EP09813672.4A patent/EP2334227B1/en active Active
- 2009-09-11 WO PCT/US2009/056664 patent/WO2010030882A1/en active Application Filing
- 2009-09-11 RU RU2011113976/14A patent/RU2478338C2/en not_active IP Right Cessation
- 2009-09-11 KR KR1020117008315A patent/KR101754570B1/en active IP Right Grant
- 2009-09-11 KR KR1020177017924A patent/KR20170081278A/en not_active Application Discontinuation
- 2009-09-11 CA CA2939764A patent/CA2939764C/en active Active
- 2009-09-11 JP JP2011526994A patent/JP5746969B2/en active Active
- 2009-09-11 CA CA2803747A patent/CA2803747C/en active Active
- 2009-09-11 BR BRPI0918563A patent/BRPI0918563B8/en active IP Right Grant
-
2011
- 2011-03-10 IL IL211659A patent/IL211659A/en active IP Right Grant
-
2012
- 2012-01-13 US US13/350,158 patent/US8485985B2/en active Active
- 2012-03-13 US US13/418,491 patent/US9011342B2/en active Active
-
2013
- 2013-04-15 IL IL225761A patent/IL225761A/en active IP Right Grant
- 2013-06-13 US US13/917,354 patent/US8641639B2/en active Active
- 2013-08-08 US US13/962,410 patent/US9186072B2/en active Active
-
2014
- 2014-03-14 US US14/213,387 patent/US8998823B2/en active Active
-
2015
- 2015-03-09 US US14/642,439 patent/US9113843B2/en active Active
- 2015-05-11 JP JP2015096712A patent/JP2015180262A/en active Pending
- 2015-05-21 AU AU2015202756A patent/AU2015202756B2/en active Active
- 2015-08-24 US US14/833,912 patent/US10010251B2/en active Active
-
2016
- 2016-11-07 AU AU2016256664A patent/AU2016256664B2/en active Active
-
2017
- 2017-04-28 US US15/582,327 patent/US9901260B2/en active Active
- 2017-12-06 US US15/832,988 patent/US10105064B2/en active Active
-
2018
- 2018-10-22 US US16/166,472 patent/US10980426B2/en active Active
-
2021
- 2021-04-19 US US17/233,820 patent/US20210236002A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20210236002A1 (en) | Physiological sensor delivery device and method | |
US11826128B2 (en) | Physiological sensor delivery device and method | |
US20150141853A1 (en) | Multi-sensor lesion assessment device and method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request |
Effective date: 20140820 |